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“I do not know what I may appear to the world, but to myself I seem to 
have been only like a boy playing on the seashore, and diverting myself 
in now and then finding a smoother pebble or a prettier shell than 
ordinary, whilst the great ocean of truth lay undiscovered before me” 
Memoirs of the Life, Writings, and Discoveries of Sir Isaac Newton (1855) 
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Abstract 
 
Currently, there is a resurgence of interest in Clostridium acetobutylicum, the biocatalyst 
of the historical Weizmann process, to produce n-butanol for use both as a bulk chemical and 
as a renewable alternative transportation fuel. To develop a commercial process for the 
production of n-butanol via a metabolic engineering approach, it is necessary to develop 
genetic tools and to better characterize both the primary metabolism of C. acetobutylicum and 
its regulation. This thesis describes a method of homologous recombination by replicative 
plasmid to delete or introduce genes in C. acetobutylicum. This method was successfully used 
to delete genes, including CAC1502, CAC3535, CAC2879 (upp), to generate C. 
acetobutylicum cac1502upp and C. acetobutylicum cac1502uppcac3535. These strains 
are readily transformable without any previous plasmid methylation and can serve as hosts for 
a “marker-less” genetic exchange system. The strain C. acetobutylicum cac1502upp and 
this homologous recombination system have been used in further engineering experiments to 
obtain a strain that produces butanol with high selectivity and eliminates by-products. Many 
genes were successfully deleted, including ldhA, ctfAB, ptb, and buk. The hbd gene was 
simultaneously removed and replaced by the hbd1 gene from C. kluyveri DSM555, which 
encodes an NADPH-dependent enzyme. The thlA gene was replaced by an optimized 
synthetic atoB gene from Escherichia coli K12 MG1655. The mutant also contains an 
inactivated Rex protein reported to be an important regulator that senses the NADH/NAD+ 
ratio and represses many genes involved in the central metabolism. The final mutant C. 
acetobutylicum cac1502 upp ctfAB ptb300 buk rex hbd::hbd1 thlA::atoB (C. 
acetobutylicum CAB1060) was successfully generated. This final mutant produces mainly 
butanol, with ethanol and traces of acetate at a molar ratio of 7:1:1. This CAB1060 strain was 
subjected to a new continuous fermentation process using i) in situ extraction of alcohols by 
distillation under low pressure and ii) high cell density cultures to increase the titer, yield and 
productivity of n-butanol production to levels that have never been previously achieved in any 
organism.  
A second homologous recombination method using non-replicative plasmid for marker 
less gene modification is also described in this thesis. This method allows the simultaneous 
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inactivation of two genes. It has been successfully used to construct a mutant unable to 
produce hydrogen and useful, as a platform strain, for further engineering of C. 
acetobutylicum to continuously produce bulk chemicals and fuels. This strain has been 
successfully engineered to continuously produce lactate from glucose and 1, 3 propanediol 
from glycerol at yields, titers and productivities that have never been achieved before in C. 
acetobutylicum. 
As a contribution to the characterization of the regulatory network of C. acetobutylicum, 
a novel global regulatory protein Cap0037 has been discovered. Cap0037 and Cap0036 are 
arranged in one operon located upstream of the adhE2 gene. These two proteins are 
considered to be acidogenic indicators based on their significant up-regulation in acidogenesis 
and strong down-regulation in solventogenesis and alcohologenesis. The resultant mutant 
showed significantly different metabolic fluxes patterns in acidogenic (producing mainly 
lactate, butyrate and butanol) and alcohologenic (producing mainly butyrate, acetate and 
lactate) chemostat cultures but not in solventogenic or batch cultures. A quantitative 
transcriptomic analysis was employed for a deeper understanding of the corresponding effect. 
The Cap0037::int mutant has somewhat similar transcriptomic profiles to the Rex, Per and 
Fur mutants. The differences and similarities are discussed in detail. Moreover, 
Cap0037/Cap0036 was found to be self-regulated. The DNA binding sites of Cap0037 in the 
promoters’ regions of the Cap0037/Cap0036, adc and sol operons have been experimentally 
determined. Using these experimental results as references, the complete putative regulon of 
Cap0037 has been constructed by RegPredict. 
 
Keywords: metabolic engineering, C. acetobutylicum, butanol, regulatory network, Cap0037, 
homologous recombination 
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Résumé 
 
À l'heure actuelle, il y a un regain d'intérêt pour Clostridium acetobutylicum, le biocatalyseur 
du procédé Weizmann historique, pour produire le n-butanol un produit chimique de 
commodité et un bio-carburant alternatif et renouvelable. Pour développer un procédé 
commercial de production de n-butanol via une approche d'ingénierie métabolique, il était 
nécessaire de développer des outils génétiques permettant d’introduire de nombreuses 
modifications et de mieux caractériser à la fois le métabolisme primaire de C. acetobutylicum 
et sa régulation. Ce mémoire de thèse décrit un procédé de recombinaison homologue, 
utilisant  plasmide réplicatif, pour la délétion ou l'introduction de gènes chez C. 
acetobutylicum avec une élimination facile des marqueurs utilisés. Cette méthode a été 
utilisée avec succès pour déléter de nombreux gènes, comprenant CAC1502, CAC3535, 
CAC2879 (upp), afin de générer C. acetobutylicum cac1502upp et C. acetobutylicum 
cac1502uppcac3535. Ces souches sont facilement transformables sans méthylation 
préalable des plasmides et peuvent servir d'hôtes pour le système d'échange génétique sans 
marqueur qui a été développé. La souche de C. acetobutylicum cac1502upp et ce système 
de recombinaison homologue ont été utilisés dans d'autres expériences d'ingénierie pour 
obtenir une souche produisant du n-butanol avec une sélectivité élevée et en éliminant la 
plupart des co-produits. De nombreux gènes ont été délétés avec succès,dont ldhA, ctfAB, ptb 
et buk. Le gène hbd a ét simultanément délété et remplacé par le gène hbd1 de C. kluyveri 
DSM555, qui code pour une enzyme NADPH-dépendante. Le gène thlA a été remplacé par 
atoB un gène synthétique optimisé provenant d'Escherichia coli K12 MG1655. Le mutant 
contient également une délétion du gène codant pour la protéine Rex qui est un important 
régulateur du métabolisme central qui en fonction du rapport NADH / NAD
+
 réprime de 
nombreux gènes impliqués dans le métabolisme central. Le mutant final, C. acetobutylicum 
cac1502 upp ctfAB ldhA ptb300 buk rex hbd :: thlA hbd1 :: atoB (C. 
acetobutylicum CAB1060) a été généré avec succès. Ce dernier mutant produit 
principalement du n-butanol, et de faibles quantités d'éthanol et d'acétate. Cette souche 
CAB1060 a été utilisée dans un nouveau procédé de fermentation continu qui utilise i) 
l'extraction in situ des alcools par distillation sous pression réduite et ii) des cultures à haute 
densité cellulaire (et ne faisant pas intervenir de procédé membranaire) pour atteindre des 
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titre, rendement et productivité en n-butanol qui n’ont jamais été obtenus chez aucun micro-
organisme. 
Un second procédé de recombinaison homologue utilisant un plasmide non réplicatif pour la 
modification de gène sans marqueur est également décrit dans le présent mémoire. Cette 
méthode permet d'inactiver simultanément deux gènes. Il a été utilisé avec succès pour la 
construction d'un mutant incapable de produire de l'hydrogène et utile, comme souche plate-
forme, pour l'ingénierie de C. acetobutylicum pour produire en continu des produits chimiques 
de commodité et des bio-carburants. Cette souche a été modifiée avec succès pour produire en 
continu du lactate à partir du glucose et de 1, 3 propanediol à partir du glycérol à des 
rendements, des titres et des productivités qui n'ont jamais été atteints auparavant chez C. 
acetobutylicum. 
En tant que contribution à la caractérisation des réseaux de régulation chez C. acetobutylicum, 
une nouvelle protéine régulatrice Cap0037 a été découverte. Les gènes Cap0037 et Cap0036 
sont organisés en opéron et sont situés en amont du gène adhE2. Les deux protéines sont 
considérées comme des indicateurs d’acidogénèse car leur niveaux sont élevés en acidogénèse 
et fortement diminués en solventogénèse et en alcohologénèse. Le mutant inactivé pour 
Cap0037 a montré, lors de cultures en chémostat, des flux métaboliques significativement 
différents de la souche sauvage en acidogénèse (produisant principalement du lactate, du 
butyrate et du butanol) et en alcohologénèse (produisant principalement du butyrate, de 
l’acétate et du lactate), mais pas pour des cultures en solventogénèse. Une analyse 
transcriptomique quantitative a été utilisée pour une meilleure compréhension des effets 
observés. Le mutant Cap0037 ::int a des profils transcriptomiques assez semblables aux 
mutants Rex, Per et Fur. Les différences et les similitudes sont discutés en détail dans le 
manuscrit. En outre, il a été montré que l’opéron Cap0037 / Cap0036 était autorégulé par 
Cap0037. Les sites de fixation à l'ADN de Cap0037 dans les régions promotrices de Cap0037 
/ Cap0036, adc et de l’opéron sol  ont été déterminées expérimentalement. À partir de ces 
résultats expérimentaux, le régulon putatif complet de Cap0037 a été construit par RegPredict. 
Mots clés: metabolic engineering, C. acetobutylicum, butanol, regulatory network, 
Cap0037, homologous recombination 
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1 Chapter 1 Background 
 
1.1  The history of acetone-butanol-ethanol (ABE) fermentation 
In the early 19
th
 century, the scarcity of natural rubber raised interest in synthetic rubber 
production. The best source for the production of butadiene was butanol or isoamyl alcohol. 
In 1912, Weizmann stated that butanol or isoamyl alcohol was critical in the production of 
synthetic rubber. Between 1912 and 1914, he succeeded in the isolation of a strain called BY 
[1], later named Clostridium acetobutylicum. The BY strain was able to produce good yields 
of butanol and acetone (AB fermentation). AB fermentation by C. acetobutylicum is also 
more recently termed acetone-butanol-ethanol (ABE) fermentation. 
During World War I, acetone became a chemical in high demand as a solvent for 
nitrocellulose in the manufacture of cordite for the British army. Butanol became an unwanted 
by-product of the fermentation [2]. When the war ended, the demand for acetone decreased. 
Butanol and its ester, butyl acetate, were found to be ideal solvents for the production of a 
quick drying lacquer in the automobile industry, which was expanding rapidly. From 1920 to 
1950, AB fermentation plants were constructed in the USA, Australia, Canada, China, India, 
Japan, and many other countries. Great efforts were made to find substitute substrates to 
optimize AB production, such as molasses, grain, and corncob hydrolysate. The metabolic 
pathways of acetone and butanol synthesis were of great interest, but even today, these 
pathways are not completely understood [2]. 
In the early 1950s, ABE fermentation declined for two reasons. First, the petrochemical 
industry grew rapidly, and the fermentation process could not compete with the chemical 
process in production yields or cost. Secondly, molasses began to be used to feed cattle, 
increasing the feedstock cost [2].  
Now, with the negative impacts of fossil fuels on the climate and its exhaust, biofuels are 
the key to future clean energy. Thus, ABE fermentation is now attracting renewed interest, 
especially for n-butanol. Many research groups have studied fermentation with C. 
acetobutylicum and other Clostridial strains to produce cellulosic butanol from abundant 
agricultural feedstocks, which is a promising strategy for producing biofuels at a low cost 
(examples in Table 1-1). Others have worked extensively on the cellular functioning and 
metabolic engineering of C. acetobutylicum to further optimize the strain. 
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Strain Feedstock 
Butanol 
Yield 
Butanol 
Productivity 
(g/l/h) 
Condition References 
g/g g/L 
C. acetobutylicum KF 158795 Glycerol 0.35 13.6 0.14 
Batch, 30 L, 
optimized 
[3] 
C. acetobutylicum ATCC 824 Sweet sorghum juice 0.40 6.5 0.07 Batch [4] 
C. acetobutylicum  GX01 
Cassava starch, 
soybean meal 
 18.8  Batch, 30 L [5] 
C. acetobutylicum TSH1  
and B. cereus TSH2 
Glucose 0.18 11.0  
Micro aerobic, 
batch 
[6] 
C. celevecrescens N3 
 and C. acetobutylicum ATCC 
824 
Cellulose 0.15 3.7  Batch [7] 
C. acetobutylicum GX01 
Alkali pretreated 
sugarcane bagasse 
0.22 14.2 0.24 Fed-batch [8] 
C. acetobutylicum ABE 1201 Sweet sorghum juice 0.24 13.9 0.18 
Immobilized cells, 
gas stripping 
[9] 
C. beijerinckii B592 Pinewood hydrolysate  11.6 0.19 Batch [10] 
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C. cellulolyticum pM9 Crystalline cellulose  0.18  Batch [11] 
C. sporogenes BE01 Pretreated rice straw  4.46 0.05 Batch [12] 
C. beijerinckii TISTR 1461 Pretreated corncob  6.26  Batch [13] 
Table 1-1 Butanol production from lignocellulosic biomass  
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1.2  Clostridium acetobutylicum strain 
The Clostridium genus belongs to the phylum Firmicutes and contains approximately 
100 species identified by 16S rRNA analysis [14]. It is a diverse group of Gram-positive, rod 
shaped anaerobes. The Clostridium genus can be divided into pathogens and non-pathogens. 
Some well-known pathogens include C. botulinum, difficile, tetani, and perfringens, causing 
botulism, diarrhea, tetanus and gas gangrene, respectively. Extensive research is in progress 
addressing the impacts of those diseases. The genus Clostridium also includes organisms of 
importance to detoxification, remediation, and the carbon cycle, such as acetogens, which use 
the Wood-Ljungdahl pathway to generate huge quantities of acetate through fixing 20% of the 
CO2 on earth [15]. A large number of Clostridium strains have potential for industrial 
applications. For example, C. thermocellum can utilize cellulose as its sole carbon source to 
produce ethanol [16]; C. kluyveri is under study to produce polyester poly 4-hydroxybutyric 
acid [17]; and C. acetobutylicum have been using for the production of ABE. 
The strain C. acetobutylicum ATCC 824 is one of the best studied solventogenic 
clostridia. It was isolated in 1954 from the soil of a garden in Connecticut [18]. The ATCC 
824 strain was found to be closely related to the historical Weizmann strain [19]. The genome 
of the strain was mapped in the early 1990s. The strain has a 4 Mb chromosome with 11 
ribosomal operons and harbors a megaplasmid, pSOL1, approximately 200 kb in size that 
carries the genes involved in solvent formation [19]. The construction of a genomic map was 
expected to trigger the development of engineering tools to optimize the strain and has been 
useful for better understanding of the degeneration mechanism (i.e., loss of the strain’s ability 
to produce solvent). C. acetobutylicum DSM792 is another widely used strain that is identical 
to ATCC 824. C. acetobutylicum can consume various types of monosaccharides, 
disaccharides, starch, inulin, pectin, whey, and xylan but not crystalline cellulose [19]. 
The growth of C. acetobutylicum in a batch culture occurs in three different growth 
phases. The exponential growth phase produces biomass, acids, ATP, and hydrogen. The 
accumulation of acids decreases the medium pH to a threshold that is toxic to the cells. Thus, 
cell growth is inhibited, and the cells enter a stationary phase. Solventogenesis is triggered in 
the transition to the stationary phase. Acids are partially re-assimilated, and ABE solvents are 
produced at a ratio of 3:6:1. At the end of the stationary phase, the C. acetobutylicum cells 
sporulate. 
C. acetobutylicum can also be cultivated in continuous cultures and, under phosphate 
limitation, maintained in stable metabolic states [20–24]:  
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 Acidogenesis: when grown at neutral pH on glucose. 
 Solventogenesis: when grown at low pH on glucose. 
 Alcohologenesis (production of ethanol and butanol, but not acetone): when grown at 
neutral pH under conditions of high NAD(P)H availability [20]. There are multiple ways to 
achieve high intracellular NAD(P)H: cultivating the culture either under iron limitation or by 
sparging in carbon monoxide (to lower the electron flow towards hydrogen production), the 
addition of methyl viologen or neutral red and the replacement of part of the glucose with 
glycerol [20–24]. 
Steady-state continuous cultures provide better homogenous cells, which are useful for 
quantitative fluxomics, transcriptomics and proteomics research. 
1.3 The central metabolism of Clostridium acetobutylicum 
The primary pathway leading to the formation of acids and solvents is shown in Figure 
1-1. 
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Figure 1-1 Metabolic pathways of C. acetobutylicum. Enzymes involved in the 
fermentative pathways are shown in blue. 
LDH: lactate dehydrogenase (CAC0267), ALSS: acetolactate synthase (CAC3652), 
ALSD: acetolactate decarboxylase (CAC2967), PFOR: pyruvate ferredoxin oxidoreductase 
(CAC2229), HYD: hydrogenase (CAC0028), FNOR: NAD(P) ferredoxin oxidoreductase, 
ACK: acetate kinase (CAC1743), PTA: phosphotransacetylase (CAC1742), BUK: butyrate 
kinase (CAC3075), PTB: phosphotransbutyrylase (CAC3076), THL: thiolase (CAC2873), 
HBD: hydroxybutyryl-coA dehydrogenase (CAC2708), CRT: crotonase (CAC2712), BCD: 
butyryl coA dehydrogenase (CAC2711), ETFA/B: electron transfer flavoprotein subunit A/B 
(CAC2709/2710), ADHE1: aldehyde alcohol dehydrogenase (CAP0162), ADHE2 
(CAP0035), BDHA/B: butanol dehydrogenase (CAC3298/3299), ADC: acetoacetate 
decarboxylase (CAP0165), CTFA/B: coA-transferase subunit A/B (CAP0163/0164). 
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1.3.1 Glycolysis 
Hexose sugars such as glucose, sucrose and maltose can be metabolized completely via 
the Embden-Meyerhof glycolytic pathway. Pentose sugars such as xylose, ribose and 
arabinose are metabolized via the pentose phosphate pathway. Glucose is the most preferred 
hexose [25]. EMP produces 2 moles of pyruvate, 2 moles of ATP and 2 moles of NADH per 
mole of hexose.  
Pyruvate ferredoxin oxidoreductase (PFOR-CAC2229) catalyzes the decarboxylation 
of pyruvate to acetyl-CoA. Pfor from C. acetobutylicum was purified and characterized by 
Meinecke B et al. [26]. The purified protein possessed a specific activity of 25 U/mg. The 
monomer molecular weight was 123 kDa. One mole of enzyme monomer contains 0.39 mole 
of thiamine pyrophosphate, 4.23 moles of iron and 0.91 moles of sulfur [26]. The pH 
optimum was at pH 7.5, and the temperature optimum was at 60°C. The apparent Km values 
for pyruvate and coenzyme A were 322 M and 3.7 M, respectively [26]. The reaction 
catalyzed by Pfor in glycolysis reduces oxidized ferredoxin and releases CO2. The re-
oxidation of reduced ferredoxin occurs through the activity of hydrogenase (encoded by hydA, 
CA_C0028) in acidogenesis and of NAD(P) ferredoxin oxidoreductase in solventogenesis. 
1.3.2 Enzymes involved in electron fluxes 
Hydrogenase (HYD, EC 1.12.7.1) transfers electrons from electron donors, such as 
ferredoxin and flavodoxin, to protons.  
2H
+
 + Ferredoxinred  H2 + Ferredoxinox 
There are two Fe-Fe hydrogenases (HydA-CAC0028 and HydB-CAC3230) and one Ni-
Fe hydrogenase in C. acetobutylicum [27]. HydA fused with Strep-tag was homologously 
expressed and characterized [28]. For hydrogen evolution activity, both kcat and kcat/Km were 
higher for reduced ferredoxin than for reduced methyl viologen, 5 and 250 times, 
respectively. When using flavodoxin (encoded by CAC0587) to replace ferredoxin 
(CAC0303) as an electron donor, the catalytic efficiency kcat/Km  was 5.5 x 10
7
 M
-1
s
-1 
relatively higher compared to 4 x 10
7
 M
-1
s
-1 
for ferredoxin [27]. For hydrogen uptake activity, 
the catalytic efficiency (kcat/Km) was measured 100 fold higher for ferredoxin compared to 
methyl viologen as electron acceptor [27]. Maturation of hydrogenase requires the 
biosynthesis and insertion of the catalytic iron-sulfur cluster, the H-cluster. The maturation 
proteins HydEF and HydG were coexpressed with HydA or HydB in E. coli by King et al 
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[29]. HydB exhibits H2 evolutionary activity 10 fold less than HydA. As a result, HydA is the 
main enzyme responsible for the regeneration of reduced ferredoxin in C. acetobutylicum.  
Ferredoxin NAD(P)H oxidoreductase (FNOR, EC 1.18.1.3(2)) activities were 
measured in crude extracts of C. acetobutylicum cells at different states [21,30,31].  
2 Ferredoxinred + NAD(P)
+
 + H
+
  2 Ferredoxinox + NAD(P)H 
In the solventogenic state, in addition to hydrogenase, which regenerates reduced 
ferredoxin, there are also ferredoxin NAD+ reductase and ferredoxin NADP+ reductase, 
which also regenerate reduced ferredoxin coupling by regenerating NAD+/NADP+ to 
produce NADH/NADPH, which are required in the formation of butanol and ethanol. In the 
acidogenic state, ferredoxin NADH reductase activity was found to regenerate the NADH 
produced by EMP (Figure 1-2).  
 
Figure 1-2 Electron flow in C. acetobutylicum  [30,31] 
1-Hydrogenase, 2-ferredoxin NAD
+
 reductase, 3-ferredoxin NADH reductase, 4-
ferredoxin NADP
+
 reductase 
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1.3.3 Central pathway from acetyl-CoA to butyryl-CoA  
Thiolase (THL, E.C. 2.3.1.19) is an important enzyme that condenses two acetyl-CoA 
(C2) into one acetoacetyl-CoA (C4). There are two thiolase encoding genes in C. 
acetobutylicum: thlA and thlB [32]. ThlA was demonstrated to be primarily involved in the 
production of butyric acid and in AB formation. The thlB gene was found to be poorly 
expressed in both acidogenic and solventogenic cells [32]. ThlA from C. acetobutylicum 
ATCC 824 was purified and characterized [33,34]. It possessed high activity in the 
physiological range of internal pH from 5.5 to 7.0. In the condensation direction, the thiolase 
(ThlA) was very sensitive regarding the CoA-SH, which was inhibited by micro molar levels 
of CoA-SH. ATP and butyryl-CoA were also shown to be thiolase’s inhibitors. The native 
enzyme consisted of four subunits, each had a molecular weight of 44 kDa. The Km value 
toward acetyl-CoA substrate was 0.27 mM, measured at 30°C and a pH of 7.4. The Km value 
toward acetoacetyl-CoA substrate was 0.032 mM (at 30°C and pH 8.0), which is much lower 
than for acetyl-coA [34]. When thiolase (ThlA) was mutated at three positions, R133G, 
H156N, and G222V, it showed significantly less sensitivity to (50 M) CoA-SH [35]. When 
this mutated ThlA was expressed in C. acetobutylicum, there was a clear delay in ethanol and 
acetone formation. Additionally, the ethanol and butanol titers were increased by 46% and 
18%, respectively, while the final acetone concentrations were not affected. The crystal 
structures of ThlA in its reduced/oxidized states were studied [36], and ThlA was found to be 
regulated by redox-switch modulation through a reversible disulfide bond between two 
catalytic cysteine residues, Cys88 and Cys378. The ThlA
V77Q/N153Y/A286K
 mutant, which cannot 
form disulfide bonds, exhibits higher activity than wild-type ThlA and enhances butanol 
production upon over-expression [36].   
-Hydroxybutyryl dehydrogenase (HBD, E.C.1.1.1.35), catalyzing acetoacetyl-CoA 
hydration to (S) ß-hydroxybutyryl-CoA, was purified and characterized [37]. The reduction of 
acetoacetyl-CoA to (S) ß-hydroxybutyryl-CoA occurred over a wide pH range, between 4 and 
10, with pHopt at 5. In contrast, the reverse reaction occurred only within a small pH range 
from 9.5 to 10.5, with a maximum at pH 10. Hbd specificities were examined and are 
reviewed in [37]. Hbd from C. acetobutylicum is NADH-dependent. Hbd retained 50% 
activity in the presence of 20% (v/v) ethanol, 9% (v/v) butanol and 10% (v/v) isobutanol [37]. 
When Hbd was inactivated, ethanol production increased, whereas C4 products such as 
butyrate and butanol were significantly reduced [38]. 
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Hbd from C. butyricum (CbHbd) has better catalytic efficiency than Hbd from C. 
acetobutylicum (Kcat/Km of 1.2x10
8
 (M
-1
s
-1
), which is 343-fold higher) [39]. The crystal 
structure of C. butyricum Hbd was solved. The mutated C. butyricum Hbd
K50A/K54A/L232Y
 has a 
4.9-fold increase in Kcat/Km compared to the wild-type enzyme. Hbd1 from C. kluyveri is 
NADP-dependent and possesses Km values of 50 μM for acetoacetyl-CoA and 70 μM for 
NADPH2 [40]. 
 
 Vmax 
(U/mg) 
Km 
(mM) 
Kcat 
(s
-1
) 
Kcat/Km 
(M
-1
s
-1
) 
Acetoacetyl CoA 75.7 0.11 38.6 3.5 x 10
5
 
3-hydroxybutyryl CoA 53.5 0.29 27.1 9.4 x 10
4
 
NADH 61.5 0.14 31.4 2.3 x 10
5
 
NAD+ 55.1 0.27 28.1 1.0 x 10
5
 
NADPH 3.31 0.45 1.7 3.8 x 10
3
 
Table 1-2 Kinetic parameters of C. acetobutylicum Hbd [37] 
 
Crotonase (CRT, EC 4.2.1.150) reversibly converts (S)-3-hydroxybutyryl-CoA to 
crotonyl-CoA by eliminating a proton and a hydroxyl group, leading to the formation of a 
double bond at C2 and C3 of the enoyl moiety. The crotonase crystal structure was 
determined, showing that the protein forms a hexamer through the dimerization of two 
trimers. Phe143 and Phe233 are key residues in the binding pocket structure that 
accommodates crotonyl-CoA as a substrate [41]. 
Butyryl-CoA dehydrogenase enzyme (BCD, EC 1.3.99.2) catalyzes the reduction of 
crotonyl-CoA to butyryl-coA. BCD is encoded by bcd-etfB-etfA (CAC2711-CAC2710-
CAC2709). The enzyme complex was homologously expressed and purified in C. 
acetobutylicum and was demonstrated to be a strictly NADH-dependent enzyme with 
ferredoxin required for the reaction [42]. Under fully coupled conditions, 1 mole of ferredoxin 
is reduced by 2 moles of NADH and 1 mole of crotonyl-CoA, which is similar to BCD of C. 
kluyveri [42,43]. 
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Figure 1-3 Proposed mechanism of endergonic ferredoxin reduction with NADH 
coupled to exergonic crotonyl-CoA reduction catalyzed by Bcd/EtfAB complex of C. 
kluyveri [43] 
 
The five ORFs, ordered crt-bcd-etfB-etfA-hbd, were found to be transcribed as a 
transcriptional unit, and the promoter’s consensus sequences were identified upstream of the 
crt gene [44]. When over-expressing any two of crt, bcd, and hbd, butanol production 
increased by at least two fold, resulting in an increase in the final butanol titer of 28% [45]. 
When the butanol pathway genes, including acetyl-CoA acetyltransferase (thlA), 3-
hydroxybutyryl-CoA dehydrogenase (hbd), crotonase (crt), butyryl-CoA dehydrogenase (bcd, 
etfA, etfB) and butyraldehyde dehydrogenase (adhe2), were cloned and expressed in E. coli 
EG03(ΔfrdABCD ΔldhA ΔackA ΔpflB ΔadhE ΔpdhR::pflBp6-aceEF-lpd ΔmgsA), butanol 
(1,254 mg/L) was produced from glucose under anaerobic conditions [46]. 
1.3.4 Acetate formation 
During acidogenesis, acetyl-CoA is converted to acetate in a two-step process by a 
phosphotransacetylase (pta, CA_C1742) and an acetate kinase (ack, CA_C1743). Acetate 
kinase (ATP:phosphotransferase (ACK), EC 2.7.2.1) from C. acetobutylicum DSM 1731 was 
purified and characterized [47]. Ack protein exists in a dimeric form, and each subunit has a 
molecular weight of 43 kDa. Ack has high specificity for acetate and ATP. The maximal 
activity was obtained when Mn
2+
 was added to the reaction as a divalent cation. The Km 
values for acetate, ATP, acetyl phosphate and ADP were 73, 0.37, 0.58 and 0.71 mM, 
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respectively. The ack and pta genes were found to be arranged in an operon. Primer extension 
analysis identified a single transcriptional start site located 70 bp upstream of the start codon 
of the pta gene. When ack and pta were over-expressed in C. acetobutylicum, the final ratios 
of acetate to other major products were higher, and there was a greater proportion of C2-
derived compared to C4-derived products [48].   
1.3.5 Butyrate formation  
Butyryl-CoA is converted to butyrate by phosphotransbutyrylase (ptb, CA_C3076) and 
butyrate kinase (buk, CA_C3075). The ptb and buk genes are organized in an operon. The 
transcription start point was identified 57 bp upstream of the ptb start codon, and the putative 
Rho-independent terminator structure was identified 26 bp downstream from the buk stop 
codon [49,50].  
Phosphotransbutyrylase (PTB, EC 2.3.1.19) catalyzes butyryl-CoA to butyryl-
phosphate. Ptb of C. acetobutylicum was purified and characterized [50,51]. It was found to 
be very sensitive to pH shifts within the range of 5.5-7 and to be inhibited at pH below 6.0, 
suggesting a regulatory role of internal pH on Ptb catalytic activity [50,51]. In the reverse 
catalytic reaction, Ptb was less sensitive to pH variation [51]. The enzyme exhibited high 
activity toward butyryl-CoA, isovaleryl-CoA and valeryl-CoA [51]. The Km values for 
butyryl-CoA, phosphate, butyryl phosphate, and CoASH were 0.11, 14, 0.26, and 0.077 mM, 
respectively, at 30°C and pH 8.0 [51]. 
Butyrate kinase (BUK, E.C. 2.7.2.7) catalyzes the reversible formation of butyrate from 
butyryl-P. Two buk genes have been characterized in C. acetobutylicum [52–54]. The primary 
butyrate kinase gene, bukI, is encoded in an operon with the ptb gene, while bukII is a single 
gene [54]. BukI is a dimer with subunit molecular weight of 39 kDa, with a specific activity 
of 402 UI/mg [53]. Disruption of the bukI gene reduced butyrate kinase, not all enzyme 
activity was eliminated [55]. BukI has a wide substrate range and binds butyrate very tightly. 
BukI can act on butyrate, valerate, isobutyrate, propionate, isovalerate, and vinyl acetate with 
highly specific activities. When binding butyrate, BukI has a Km of 14 mM [56]. The second 
bukII was expressed, purified in E. coli and characterized [52]. The purified BukII has a 
subunit molecular weight of 43 kDa and functions as a dimer of 80 kDa [56]. BukII can act on 
a limited substrate range, with only the activity on butyrate retained among the substrates 
tested. BukII has an extremely lower binding affinity for butyrate (Km of 620 mM) compared 
to BukI [54]. 
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1.3.6 Lactate and acetoin formation 
Lactate dehydrogenase (LDH, EC 1.1.1.27) catalyzes the reduction of pyruvate. The 
reaction is irreversible, NADH-dependent and activated specifically by fructose-1,6-
bisphosphate [57,58]. The purified enzyme existed in tetramers of 159kDa, had optimum pH 
at 5.8 [57]. Expression of C. acetobutylicum Ldh in a ldh-deficient E. coli strain recovered the 
production of lactate [58]. 
Acetoin formation-related genes (alsSD, alsR) have been studied [59,60]. In many 
bacteria, acetoin production is controlled by AlsR, which binds and regulates the promoter of 
the alsSD operon. In Bacillus subtilis, when AlsR was disrupted, the alsSD operon was not 
expressed [61]. In C. acetobutylicum, the regulatory of acetoin production was different. The 
genes alsS and alsD do not share the same operon. The disruption of AlsR did not change 
either acetoin production or the expression of alsS and alsD. The over-expression of alsS did 
not improve acetoin formation [60]. However, Liu et al has successfully increased acetoin 
formation by over-expressing alsD in an adc-deficient mutant [59]. 
1.3.7 Acetone formation  
Acetoacetyl-CoA is converted to acetone in a two-step process via the intermediary 
acetoacetate. The two steps require a CoA-transferase and an acetoacetate decarboxylase. The 
CoA-transferase consists of 2 different subunits encoded by ctfA (CA_P0163) and ctfB 
(CA_P0164) genes, which are part of the sol operon. The acetoacetate decarboxylase gene 
(adc, CA_P0165) is located outside the sol operon and is transcribed in the opposite direction 
by its own promoter [62,63]. These two operons (adc and sol) were found to be induced at the 
onset of solventogenesis [64]. 
CoA transferase (CTFAB, EC 2.3.8.9) was purified and characterized by Wiesenborn 
DP et al. [65]. The purified enzyme is a hetero-tetramer with subunit molecular weights of 23 
and 25 kDa. The Km values at pH 7.5 and 30°C for acetate, propionate and butyrate were 
1200, 1000 and 660 mM, respectively. The Km values for acetoacetyl-CoA were from 7 to 56 
M, depending on the acid co-substrate. The acetate and butyrate conversion reactions are 
inhibited by the physiological acetone and butanol levels in vitro. High Km values and the 
inhibitory effects of acetone and butanol are the two regulatory factors for CoA transferase 
activity in vivo.  
It was experimentally confirmed that acetate re-assimilation occurred via the Adc/CtfAB 
pathway. In contrast, butyrate was not re-consumed via Adc/CtfAB but via Ptb/Buk because, 
despite the interruption of Adc and CtfA, the mutant was able to consume butyrate. However, 
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the mechanism of the production and re-consumption of butyrate via Ptb/Buk remains 
unknown [66]. 
Acetoacetate decarboxylase enzyme (ADC, EC 4.1.1.4) catalyzed the decarboxylation 
of acetoacetate to acetone. The expression of the adc gene was reported to be up-regulated by 
Spo0A protein [67]. However, the deletion of the Spo0A box did not fully eliminate the 
enzyme activity, suggesting additional regulatory factors for the pathway [67]. 
1.3.8 Ethanol and butanol formation 
Ethanol and butanol are synthesized from acetyl-coA and butyryl-coA, respectively. The 
conversion occurs in the following two steps: the first reduction of acetyl-CoA/butyryl-CoA 
to acetaldehyde/butyraldehyde and the second reduction of the aldehydes to ethanol/butanol. 
The C. acetobutylicum genome includes two bifunctional alcohol/aldehyde dehydrogenases 
(adhE1-CAP0162 and adhE2-CAP0035) and three alcohol dehydrogenases (bdhA-CAC3299, 
bdhB-CAC3298 and bdhC-CAC3392).  
The first bifunctional alcohol/aldehyde dehydrogenase is encoded by adhE1 and is part of 
the sol operon [68]. The lack of pSOL1 mega-plasmid, which carries the sol operon and adc, 
completely abolished solvent production [69]. The inactivation of adhE1 drastically decreased 
butanol formation, indicating that this gene product is crucial for butanol production [68]. The 
second bifunctional alcohol/aldehyde dehydrogenase, encoded by the adhE2 gene, is highly 
expressed in alcohologenic cells and poorly expressed in acidogenic cells [42]. Purified 
AdhE2 protein exhibited NADH-dependent butyraldehyde and butanol dehydrogenase 
activities. Two transcriptional start sites were determined, at 160 bp and 215 bp upstream of 
the adhE2 start codons [70]. 
Two NADH-dependent butanol dehydrogenase genes bdhA (bdhI) and bdhB (bdhII) have 
been purified and cloned [71]. Genes bdhA and bdhB were found to be induced or derepressed 
prior to significant butanol production in controlled pH 5.0 batch fermentations [72]. 
Recently, AdhE1, AdhE2, BdhA, BdhB, and BdhC were heterologously expressed in E. 
coli and purified as tag free proteins for biochemical characterization by Yoo et al. [42]. 
AdhE1 was found to exhibit only an NADH-dependent aldehyde dehydrogenase activity and 
to have lost its alcohol dehydrogenase activity. AdhE2 is an NADH-dependent bifunctional 
aldehyde/alcohol dehydrogenase activity, as described by Fontaine et al [70]. All three, 
BdhA/B/C, were reported to be NADPH-dependent butanol dehydrogenase enzymes (Table 
1-3).  
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ORF Gene name Enzyme activity 
Activity (U/mg) 
NADH NADPH 
CAC3299 bdhA Butanol dehydrogenase 0.15 2.57 
CAC3298 bdhB Butanol dehydrogenase 0.18 2.95 
CAC3392 bdhC Butanol dehydrogenase 0.24 2.21 
CAP0162 adhE1 Butanol dehydrogenase 0.04 ND 
CAP0035 adhE2 Butanol dehydrogenase 4.80 0.12 
CAP0162 adhE1 Butyraldehyde dehydrogenase 2.27 0.08 
CAP0035 adhE2 Butyraldehyde dehydrogenase 2.50 0.07 
Table 1-3 Activities of key enzymes catalyzing butanol formation [42] 
ND: not detected 
Based on transcriptomic, proteomic and biochemical data, Yoo et al. have proposed an 
activity distribution of the five enzymes for two-step catalysis in the butanol pathway (Figure 
1-4). In summary, the first step was performed by the aldehyde dehydrogenase activity of 
AdhE1 or AdhE2, whereas the second step was mainly performed by alcohol dehydrogenase 
activity of BdhB or AdhE2, depending on the fermentation states. 
33 
 
 
Figure 1-4 Butanol pathway analysis under acidogenesis (A), solventogenesis (B) and 
alcohologenesis (C) [42] 
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1.4  Metabolic engineering tools in Clostridium acetobutylicum 
Great efforts have been made worldwide to develop engineering tools to construct novel 
strains for different purposes, such as to reduce by-products, produce isopropanol-butanol-
ethanol, improve butanol tolerance, engineer for cheap substrate utilization, and so on. This 
section will summarize the tools developed for C. acetobutylicum and their applications in 
engineering C. acetobutylicum strains. 
1.4.1 Shuttle vectors for gene over-expression 
Previously, vector pFNK1 harboring the replicon derived from pIM13 of B. subtilis, 
considered as a B. subtilis/C. acetobutylicum shuttle vector, was used to over-express the adc 
and ptb genes. Plasmid pFNK1 was functional as long as the corresponding enzyme activities 
were elevated [73]. The difficulty was observed in the transformation of C. acetobutylicum 
ATCC 824 with vectors containing DNA from E. coli plasmids. A type II restriction 
endonuclease named Cac824I frequently recognizes the sequence 5'-GCNGC-3' and cuts 
ColE1 plasmids. Plasmid pAN1 and pAN2, expressing the 3TI methyltransferase gene of B. 
subtilis phage 3TI, are used to protect plasmids for easy transformation into C. 
acetobutylicum [74]. Recently, other common shuttle vectors such as pSOS94, pIMP1, 
pMTL80000 and their derivatives have been used for gene over-expression [73,75–77].  
A new study has developed a new shuttle plasmid, designated as pLK1-MCS, that can 
replicate in both C. acetobutylicum and E. coli [78]. The plasmid pLK1-MCS, carrying either 
the pIM13 or the pAMβ1 replicon, is more stable than previously reported plasmids 
(specifically, pGS1-MCS and pMTL500E) in the absence of antibiotic selective pressure. The 
transformation efficiency of pLK1-MCS into C. acetobutylicum was similar to that of other 
shuttle plasmids. The plasmid pLK1-MCS carrying the adhE1-ctfAB-adc operon 
compensated in the solvent-deficient C. acetobutylicum ML1 due to the loss of the 
megaplasmid pSOL1. The transformant restored anaerobic solvent production. 
1.4.2 Inducible promoter/repressor systems 
Several inducible promoter/repressor systems in C. acetobutylicum have been reported. A 
xylose-inducible gene expression system was constructed in C. acetobutylicum, based on the 
Staphylococcus xylosus promoter (xylA)-repressor (xylR) regulatory system [79]. A lacI 
expression system driven by the fdx promoter from C. pasteurianum can be induced in C. 
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acetobutylicum by adding IPTG [74]. Recently, an anhydrotetracycline-inducible Pcm-2tetO1 
promoter was reported, allowing reliable stringency and a broad range of inducibility [5]. The 
most recent system reported was the arabinose inducible system, consisting of AraR from 
Bacillus subtilis and the L-arabinose sensitive-phosphoketolase promoter from C. 
acetobutylicum [80]. 
1.4.3 Reporter systems 
Several reporter systems have been developed to study the expression of genes in C. 
acetobutylicum. The genes lacZ from Thermoanaerobacterium thermosulfurigenes (encoding 
β-galactosidase) and lucB from Photinus pyralis (encoding luciferase) were used as reporter 
genes in C. acetobutylicum to study the promoters of the genes required for solventogenesis 
and acidogenesis, including bdhA, bdhB, adc, sol, and ptb-buk. Both systems allowed the 
detection of differences in promoter strength of up to 100-fold. The luciferase assay could be 
performed much faster and further optimized for virtual measurement [81]. However, the β-
galactosidase from T. thermosulfurogenes EM1 LacZ was stable in the exponential phase of 
growth and degraded in the late exponential and stationary phases [76]. This behavior can 
limit the use of the LacZ reporter system. The gene gusA from E. coli was also developed for 
use as a sensitive reporter system and tested to study the expression of adc, ptb, hydA in C. 
acetobutylicum [79].  
1.4.4 Antisense RNA (asRNA) 
The asRNA technique employs the small single-stranded RNAs complementary to the 
target mRNA to inhibit its translation by base pairing. Antisense RNAs offer many 
advantages for gene down-regulation. First, the asRNA technique is fast. Second, the asRNA 
strategy can avoid the hidden difficulty of lethal mutations because it does not totally inhibit 
protein expression. Third, the down-regulation of multiple genes can be conducted by 
expressing multiple asRNAs on the same plasmid. Lastly, the expression of asRNA can be 
cleverly controlled using my inducible promoters [82]. 
As an example of asRNA application, studied by [82], 102-nucleotide asRNA with 87% 
complementarity to the butyrate kinase (buk) gene has been used successfully to reduce Buk 
activity by 90%. The ptb expression was also reduced. The strain produced 50% higher 
acetone and 30% higher butanol. When using asRNA with 96% complementarity against the 
ptb gene, the strain exhibited only 70%-80% lower Ptb and Buk activity. This strain produced 
significantly lower butanol and acetone but higher lactate. Butyrate and acetate formation 
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remained unchanged [82]. In C. acetobutylicum ATCC 824 which expressed asRNA against 
ctfB (ctfb-asRNA), acetone production was minimal; butyrate and acetate formation increased 
whereas butanol and ethanol production decreased [83]. When adhE1 was co-expressed with 
ctfb-asRNA, the butanol titer was restored to the level of the control strain. Ethanol was 
significantly increased, whereas acetone production remained 63% of its value in the control 
strain. Butyrate peaks were lower by 49% and 21% compared to the expressing-only ctfb-
asRNA strain and control strain, respectively. In contrast, peak and final acetate levels in this 
double mutant were 11% and 68% higher, respectively, compared to the acetate levels from 
the expressing-only ctfb-asRNA strain and control strain. Dramatic transcriptomic changes 
were observed; however, the regulatory mechanisms remained unknown [83].  
1.4.5 Group II intron  
The ClosTron employs a group II intron (L1. LtrB) from Lactococcus lactis and a retro-
transposition-activated marker (RAM) to selectively insert DNA into the targeted site to 
inactivate the target gene [74,84,85]. It also contains flippase recognition target (FRT) sites, 
which flank the marker cassette. After obtaining the mutant, the second plasmid carrying 
functional flippase is introduced into the mutant to excise the marker cassette from the 
genome. The marker-free mutant then could be used for another ClosTron round to inactivate 
another gene [84]. The tool is functional in various Clostridial species. The disadvantage of 
using ClosTron used to inactivate a gene is the polar effects it may cause to the downstream 
genes, which complicate the subsequent analysis of mutant phenotypes [86,87]. On the other 
hand, the excision of the marker cassette still leaves FRT’s scar in the genome. Many FRT 
scars would be problematic for the next round of flippase excision due to the combination of 
different identical FRTs existed. 
Other alternatives of ClosTron vector were demonstrated [88,89]. Because intron 
insertion happens frequently, stable and reproducible, it does not necessarily require selective 
pressure. An alternative group II intron not containing selective marker (plasmid pSY6) has 
been successfully used [88]. This strategy is time-saving due to avoiding marker excision. 
The other alternatives, in which erythromycin and thiamphenicol resistant genes were used on 
the plasmid backbone, provide flexibility for multiple genes knock-out constructions [89]. 
The intron insertion can be targeted to both strands: the sense and antisense strand. An 
intron inserted into the antisense strand cannot be spliced and promotes an unconditional 
disruption. In contrast, intron inserted into sense strand that can be spliced in the presence of 
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functional L1. LtrB, in this case, produces a conditional disruption [90]. As a result, when 
using conditional disruption, curing the plasmid after obtaining the mutant is a critical step. 
However, this step was not emphasized and was not paid enough consideration in many 
Clostridia-related publications.  
As an example of using ClosTron technology, a large-scale targeted mutagenesis in C. 
acetobutylicum ATCC 824 was conducted by Cooksley et al. [91]. Ten single knock-out 
mutants were generated, including phosphotransbutyrylase (ptb), acetate kinase (ack), 
acetoacetate decarboxylase (adc), CoA transferase (ctfA/ctfB), alcohol/aldehyde 
dehydrogenases 1 and 2 (adhE1, adhE2), butanol dehydrogenases A and B (bdhA, bdhB) and 
a putative alcohol dehydrogenase (CAP0059) [91]. The inactivation of the main hydrogenase 
(hydA) and thiolase (thl) could not be achieved. Phenotypic characterization showed that 
bdhA and bdhB mutants did not affect solvent production, whereas inactivation of the 
previously uncharacterized alcohol dehydrogenase (encoded by CAP0059) caused an increase 
in acetone, butanol, and ethanol formation. Other mutants showed predicted phenotypes: adc, 
ctfA and ctfB mutants did not produce acetone, ctfA and ctfB mutants could not re-assimilate 
acids, and the ack mutant drastically reduced acetate formation. The adhE1 mutant produced 
very little solvent. The mutant ptb did not restore its parental phenotype in the complementary 
experiment, which was caused by a frameshift mutation in the thlA gene. Therefore, the study 
also insisted on performing genetic complementation tests and Southern blots to confirm 
single ClosTron insertion and detect mutations elsewhere in the genome. 
1.4.6 Genomic mutagenesis by homologous recombination system 
1.4.6.1 Homologous recombination by replicative plasmid  
The first time homologous recombination by a replicative plasmid was used was to 
knock-out Spo0A (Figure 1-5, [92]). This first system uses no counter-selectable markers. 
The second cross-over event did not occur at the expected homologous region but 
accidentally at a ten-nucleotide homologous sequence (ACGACCAAAA). However, the spo0A 
gene was finally interrupted by an insertion of MLS
r 
gene and a small fragment from the 
pETSPO plasmid backbone. 
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Figure 1-5 Putative cross-over events during spo0A gene inactivation [92] 
A homologous recombination system to integrate DNA into C. acetobutylicum, called 
allele couple exchange (ACE), was developed. The ACE system is based on the use of a 
bidirectional marker, both positively and negatively selectable, namely pyrE in C. 
acetobutylicum, which encodes the pyrimidine biosynthesis enzyme orotate phosphoribosyl 
transferase. Cells that contain pyrE can be selected on growth medium lacking uracil, as it is 
required for uracil biosynthesis. Conversely, cells that lack pyrE can be selected on the 
growth medium supplemented with 5-FOA (5-Floroorotic acid), as this compound is highly 
toxic only to cells containing this pathway [93]. To use pyrE as a selective marker on the 
plasmid, the native pyrE gene was inactivated by deleting 300 bp from the 3’ end of the gene. 
The system also employs asymmetric homology arms. The long arm directs the first 
integration event. Afterward, at the short arm, a double cross-over event is facilitated by 
applying selective pressure. The ACE allowed the rapid insertion of heterologous DNA, 
without inherent limits on size or complexity, into the genome [93].  
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Figure 1-6 DNA integration at the thl locus of C. acetobutylicum [93]. 
Figure 1-6 illustrates the ACE technique. Plasmid pMTL-JH31 was used. The first 
recombination event occurred at the long homologous arm between the pMTL-JH31 plasmid 
and CAC2872/atpB on the chromosome. Single-crossover mutants were selected on plate 
containing thiamphenicol. The second recombination event to excise the plasmid occurred  at 
the short homologous arm between pMTL-JH31 and the 3′-end of thl when growing the single 
cross-over mutant on medium lacking uracil. 
The second alternative ACE system uses CodA as a counter-selectable marker [87]. 
CodA encodes cytosine deaminase (EC 3.5.4.1), which converts 5-fluorocytosine (5’-FC) into 
5-fluorouracil (5’-FU), which via uracil phosphoribosyltransferase (EC 2.4.2.9) encoded by 
upp in C. acetobutylicum, followed by a series of steps causing the permanent inhibition of 
thymidylate synthase and misincorporation of fluorinated nucleotides into DNA and RNA 
[87]. As a result, the introduction of a functional CodA into C. acetobutylicum results in a 
strain sensitive to the presence of 5’-FC. Most recently, a toxic gene mazF (codon optimized 
from E. coli encoding mRNA interferase protein) under the control of a lactose-inducible 
promoter (from C. perfringens) has also been used as a counter-selectable marker [94] 
1.4.6.2 Homologous recombination system based on I-SceI endonuclease  
This technique uses a replicative plasmid containing two homologous regions on either 
side of the target sequence and I-SceI recognition sites (flanking the homologous cassette). 
The plasmid was integrated into the Clostridium chromosome, resulting in single-crossover 
integrants. Afterward, the second plasmid carrying the synthetic gene (sceC) encoding the I-
SceI enzyme was introduced into the single crossover mutant, resulting in double-stranded 
breaks at the I-SceI recognition sites. This double-strand break event stimulates homologous 
recombination and yields double-crossover mutants. The method was applied to delete two 
genes (adc and glcG) from C. acetobutylicum ATCC 824 and one gene (adc) from C. 
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beijerinckii NCIMB 8052 and to introduce point mutations into xylR of C. beijerinckii 
NCIMB 8052 [95].  
 
Figure 1-7 I-SceI based-homologous recombination system [95] 
1.4.6.3 Non-replicative plasmid for gene inactivation 
The first development of a non-replicative plasmid for gene inactivation in C. 
acetobutylicum was published [55,96] for the inactivation of the ack, buk and adhE1 genes. 
The non-replicative plasmid was integrated into the target gene by a single recombination 
event, inactivating genes. The integrant was quite stable for 25 generations [96]. The 
segregation frequency (rate of plasmid loss per generation) was 35 x 10
2 
[96]. The resulting 
integrants of ack, buk and adhE1 decreased acetate, butyrate and butanol production, 
respectively (Table 1-4). 
Another genome-engineering tool was recently developed based on single-crossover 
homologous recombination and the flippase-mediated excision event [97]. The small non-
replicable plasmid pHKO1 was designed for efficient integration into the C. acetobutylicum 
genome. The plasmid pHKO1, containing an antibiotic resistance gene, can be excised in vivo 
by Flp recombinase expressed from the second plasmid pSHL-FLP. The excision leaves a 
flippase recognition target (FRT) sequence in the middle of the targeted gene. The second 
plasmid pSHL-FLP plasmid, carrying the Flp recombinase gene and a segregationally 
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unstable pAMβ1 replicon, could rapidly cure the mutant [97]. However, the technique leaves 
a second copy of the designed homologous region (approximately 650 bp, Figure 1-8) next to 
the FRT scar, which raises a concern about the stability of the mutant, as those two copies 
could randomly recombine to return to the wild-type genotype without any selective pressure. 
 
Figure 1-8 Single-crossover homologous recombination [97] 
1.4.6.4 Mutagenesis by recombineering technique 
The recombineering method employs the mechanism of RecT-mediated homologous 
recombination. The putative recT gene (CPF0939) from C. perfringens has been found to be 
functional in C. acetobutylicum. The short complementary oligonucleotides carrying point 
mutations are introduced and recombined by RecT protein to create mutations in the targeted 
locus [98]. 
1.4.7 Random mutagenesis by mariner transposon system  
In the forward genetic manipulation, a mariner transposon system was developed to 
produce highly efficient random mutagenesis in C. acetobutylicum ATCC 824. The mini-
transposon, which was under a xylose inducible promoter and incorporated with the catP 
gene, can be efficiently trans-positioned into the C. acetobutylicum genome. Sporulation-
deficient clones were screened among 200 transposon clones. One was found with transposon 
inserted into the well-known function spo0A [99]. 
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1.5  Clostridium acetobutylicum as an n-butanol producer-a challenging task 
Lütke-Eversloh [86] has summarized the metabolic engineering results in C. 
acetobutylicum up to 2014 (Table 1-4). An updated table is presented in this thesis. 
Great efforts have been made to engineer C. acetobutylicum to eliminate its by-products 
such as acetate, butyrate, and acetone (Table 1-4). It is quite difficult to compare those results 
because the strains were cultivated differently, with different medium components and pH 
regulation. However, we can see the general impact from the different data. The inactivation 
of pta or ack neither totally abolished acetate production nor had a significant impact on other 
product titers. In contrast, the inactivation of ptb or buk could minimize butyrate production 
and improved the ethanol or butanol titers. These mutants also produced higher levels of 
acetate. The double inactivation of an accurate butyrate biosynthesis pathway and the 
presence of acetate did not eliminate all acid production: BEKW, BBEKW, and PEKW 
exhibited a decrease in acetate production with no change or an increase in butyrate 
production. In the quadruple HCBEKW or the quintuple HYCBEKW mutant, pta and buk 
were inactivated; nevertheless, those mutants proved to be acid producers. To the best of my 
knowledge, the effort to construct a mutant that stops producing acids completely has not yet 
been successful.  
Table 1-4 also shows that inactivating the acetone pathway based on inactivating ctfA or 
ctfB resulted in a significantly greater reduction of acetone formation compared to even 
deactivated adc. Those acetone negative strains produced more acetate, butyrate, and lactate. 
Ethanol and butanol production was reduced.  
An interesting study [100] was performed on C. acetobutylicum M5, which has lost the 
pSOL1 megaplasmid that carries the main solvent producing genes (adc, ctfAB, adhE1, 
adhe2). This C. acetobutylicum M5 produced only butyrate, acetate and a small amount of 
ethanol. When over-expressing adhE1 (under ptb promoter) in this M5 strain, butanol was 
produced at the wild-type level, while butyrate decreased due to the increased flux from 
butyryl-CoA to butanol. Ethanol and acetate production also increased. To improve butanol 
production, thlA and adhE1 were co-expressed, but the resulting strain did not produce more 
butanol as expected. The two single mutants AKKO and BKKO (ack knock-out and buk a) 
were constructed from M5. These two mutants produced 60% less acetate and butyrate, 
respectively. When over-expressing adhE1 in the AKKO strain, acetate and butyrate were 
unexpectedly shifted to slightly lower values than M5 complementing adhE1. Ethanol and 
butanol concentration were approximately two-fold lower than for M5 expressing adhE1. 
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What was observed here was the production of butanol (by a pathway that consumes NADH) 
coupled with the acetate pathway (which produces NADH) in different strain backgrounds of. 
C. acetobutylicum. NAD(P)H ferredoxin oxidoreductase (FNOR) regenerates NAD+ and 
oxidizes ferredoxin to provide NADH for solventogenesis. It has been stated that because 
NFOR could be tightly controlled, the NADH production had to come from the additional 
acetate production to obtain a redox balance. Consequently, it would be challenging to 
construct a high butanol-producing strain without acids and acetone production, as we do not 
yet know the activating mechanism to increase butanol production [66,100]. 
There are also other approaches that can help to increase butanol selectivity. Recently, 
the inactivation of histidine kinase enzyme (encoded by CAC3319) has shown improved 
butanol tolerance and the production of 44% more butanol [101]. Previously, the over-
expression of phosphofructokinase (pfkA) and pyruvate kinase (pykA) increased the butanol 
titer (30%) and ethanol titer (85%) due to the boosted ATP and NADH concentrations and the 
enhanced butanol tolerance [102]. In a new publication [103], the biotin uptake and synthesis 
genes (CAC1360-CAC1362 and CAC0210) were over-expressed and shown to improve the 
ABE titers to 30% in the free biotin media. Over-expression of the C4 pathway (hbd, thlA, crt, 
bcd, adhE1, and ctfAB) in a strain containing the adc gene replaced by gshAB (from E. coli, 
involved in glutathione biosynthesis) increased the butanol titer from 5.17 g/L in the control 
to 14.8 g/L in the mutant [104]. 
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Mutant strain Inactivated gene Pathway 
Product pattern 
Reference 
Acetate Butyrate Lactate Acetone Ethanol Butanol 
PJC4PTA 
a,d
 pta Acetate biosynthesis - + uk 0 0 0 [55] 
pta::int(80) 
b
 pta Acetate biosynthesis 0 0 0 0 0 0 [66] 
EKW 
b
 pta Acetate biosynthesis - 0 uk + + + [89] 
WUR AK 
c
 ack Acetate biosynthesis - 0 0 0 0 0 [105] 
Cac-ack349a::CT
b
 ack Acetate biosynthesis - 0 + 0 + + [91] 
AKW 
b
 ack Acetate biosynthesis - + uk 0 0 0 [89] 
PJC4BK 
a,d
 buk Butyrate biosynthesis + - uk - + + [55] 
824 (buk-) 
b
 buk Butyrate biosynthesis uk uk uk 0 + + [88] 
BKW 
b
 buk Butyrate biosynthesis - - uk + + + [89] 
ptb::int(87) 
c
 ptb Butyrate biosynthesis + -- 0 0 ++ - [106] 
Cac-ptb50a::CT 
b
 ptb Butyrate biosynthesis ++ -- ++ -- ++ - [91] 
PKW 
b
 ptb Butyrate biosynthesis 0 0 uk 0 0 + [89] 
BEKW 
b
 pta and buk Acetate, butyrate biosynthesis - 0 uk - 0 + [89] 
BBEKW 
b
 pta, buk and bukII Acetate, butyrate biosynthesis - 0 uk - 0 - [89] 
PEKW 
b
 pta and ptb Acetate, butyrate biosynthesis - + uk - 0 - [89] 
2018adc 
b
 adc Acetone biosynthesis ++ 0 uk - - - [107] 
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acd::int(180) 
b
 adc Acetone biosynthesis ++ + 0 - - - [66] 
Cac-adc180s::CT 
b
 adc Acetone biosynthesis + + + - 0 - [91] 
pta::int(80)ΔRAM-adc::int(180) 
b
 pta and adc Acetate, acetone biosynthesis - ++ ++ - - - [66] 
ctfA::int(352) 
b
 ctfa Acetone biosynthesis ++ 0 0 -- - - [66] 
Cac-ctfA(398s) 
b
 ctfa Acetone biosynthesis + ++ ++ -- 0 - [91] 
Cac-ctfB(132s) 
b
 ctfb Acetone biosynthesis + ++ ++ -- 0 - [91] 
CKW 
b
 ctfb Acetone biosynthesis + + uk -- - - [89] 
CEKW 
b
 pta and ctfb Acetate, acetone biosynthesis - + uk -- - - [89] 
pta::int(80)ΔRAM-ctfA::int(352) 
b
 pta and ctfa Acetate, acetone biosynthesis - ++ ++ -- - - [66] 
CBEKW 
b
 pta, buk and ctfb 
Acetate, acetone, butyrate 
biosynthesis 
- + uk -- - - [89] 
hbd::int(69) 
b
 hbd 
Butanol, butyrate 
biosynthesis 
- -- 0 - ++ -- [38] 
PJC4AAD 
b,d
 adhE1 Alcohol biosynthesis + + uk -- + - [96] 
Cac-adhE1468s::CT 
b
 adhE1 Alcohol biosynthesis + ++ 0 - - - [91] 
Cac-adhE2696s::CT 
b
 adhE2 Alcohol biosynthesis 0 0 0 0 0 0 [91] 
Cac-bdhA459s::CT 
b
 bdha Alcohol biosynthesis 0 0 0 0 0 0 [91] 
Cac-bdhB475a::CT 
b
 bdhb Alcohol biosynthesis 0 0 0 0 0 0 [91] 
Cac0059-261s::CT 
b
 Cac0059 Alcohol biosynthesis - - + + + + [91] 
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HCEKW 
c
 pta, ctfb and adhE1 
Acetate, acetone, alcohol 
biosynthesis 
- ++ uk -- - -- [108] 
HCBEKW 
c
 pta, buk, ctfb and adhE1 
Acetate, butyrate, acetone, 
alcohol biosynthesis 
+ ++ ++ -- -- - [108] 
HYCBEKW 
c
 
pta, buk, ctfb, adhE1 
and hydA 
Acetate, butyrate, acetone, 
alcohol, hydrogen 
biosynthesis 
+ ++ + -- -- - [108] 
SolRH 
c,d
 
putative repressor of 
solventogenic genes 
solR 
Solventogenesis + 0 uk + + + [109] 
824 (solR-) 
b
 solR Solventogenesis uk uk uk + + + [88] 
Rex::int(95) 
b
 
redox sensing 
transcriptional regulator 
rexA 
Solventogenesis 0 - 0 - ++ + [110] 
HKKO 
c
 histidine kinase  + - uk + + + [101] 
Pta ::int(80) 
e
 pta Acetate biosynthesis -- 0 uk 0 - - [111] 
Adc ::int(180) 
e
 adc Acetone biosynthesis + -- uk -- - - [111] 
Adc ::int(80)ΔRAM pta ::int(80) 
e
 adc and pta Acetate, acetone biosynthesis + - uk -- - - [111] 
Adc::int(180) adc Acetone biosynthesis ++ ++ uk -- - - 
Acetoin -, 
[59] 
Adc::int(180) pSY8-alsD adc Acetone biosynthesis ++ ++ uk -- - - 
Acetoin ++, 
[59] 
Table 1-4 C. acetobutylicum mutants and changes in product profiles [86] 
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+, increased, ++, highly increased (>100%); 0, unchanged; -, reduced; --,none; uk, unknown 
a, pH 5.5 controlled batch; b, without pH controlled batch; c, pH 5.0 controlled batch; d, knock out mutant obtained by integration plasmids, all other 
mutants were generated using mobile group II intron; e, pH 4.5 chemostat. 
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1.6 Genome scale metabolic (GSM) models for Clostridium acetobutylicum 
Genome-scale metabolic models of Clostridium acetobutylicum have been reconstructed, 
updated and improved by many groups. The two primary models constructed were iJ432 
[112] and Sanger [113], published in 2008. The iJ432 and Sanger’s models were reported to 
successfully predict metabolic fluxes in acidogenesis and solventogenesis. The Sanger model 
could also predict the loss of butyric acid production in the buk
-
 strain and the loss of solvents 
in the degenerated M5 strain. The iCac490 model [114], integrating more reactions, and 
thermodynamic constraints based on enzyme specificity could simulate the fluxes of acetate, 
lactate, butyrate, acetone, butanol, ethanol, CO2 and H2 in the wild-type strain. The iCac802 
[115] in 2014 was another improvement in terms of the gene, reaction and metabolite 
numbers. In addition, this model integrated transcriptomic data regarding metabolic changes 
in response to butanol and butyrate stresses. The latest model, iCac967 [42], has updated the 
biochemical characteristics of 15 key metabolic enzymes for an accurate fluxomics data [42]. 
Strain 
Metabolic model 
Reference 
Genes Reactions Metabolites 
C. acetobutylicum ATCC 824 432 502 479 iJL432 [112] 
C. acetobutylicum ATCC 824 473 522 422 Sanger [113] 
C. acetobutylicum ATCC 824 490 794 707 iCac490 [114] 
C. acetobutylicum ATCC 824 802 1462 1137 iCac802 [115] 
C. acetobutylicum ATCC 824 967 1231 1058 iCac967 [42] 
Table 1-5 Genome scale metabolic models of C. acetobutylicum ATCC 824 
1.7  Regulatory network in Clostridium acetobutylicum 
1.7.1 Spo0A and Sigma factors 
In C. acetobutylicum, Spo0A is a transcriptional regulator that positively controls 
sporulation and solvent production. The inactivation of Spo0A (mutant SKO1) also drastically 
decreases solvent formation [92], as the SKO1 mutant cannot septate and form endospores. In 
the strain over-expressing Spo0A (824(pMSPOA)), butanol concentration was higher than in 
the control strain, and sporulation was enhanced and accelerated [92]. Spo0A has a conserved 
C-terminal in both C. beijerinckii and C. acetobutylicum. Spo0A binding motifs (TGNCGAA) 
were found in the promoter regions of the adc and ptb genes. Gel retardation confirmed the 
direct control of adc and ptb gene expression in C. acetobutylicum [67].  
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The sporulation process in C. acetobutylicum begins with the phosphorylation of Spo0A. 
The phosphorylated SpoA-P then activates other sigma factors such as σE, σF, σG, and σK, 
which are already well known. The σE inactivation mutant did not produce granulose but did 
produce solvents dependent on cell states, whereas the σG inactivation mutant produced 
granulose and exhibited a wild-type-like solventogenesis [116]. The factor σK is important in 
the early stage, prior to Spo0A expression, and also in the late stage for σG expression. The 
deletion of σK rendered the mutant unable to sporulate or produce solvents [117]. When σF 
was disrupted, the expression of other sigma factors, including σE and σG, was not detected, 
and differentiation was blocked [118]. Al-Hinai et al. provided an excellent comparative 
summary of the sporulation programs in B. subtilis and C. acetobutylicum [119]. The 
incomplete sporulation program in C. acetobutylicum, however, has been shown to be 
different from the one in B. subtilis. 
1.7.2 The controversial SolR 
Nair et al [120] claimed that SolR (located 663 bp upstream of the adhE start codon) was 
a putative binding transcriptional repressor that negatively regulates solventogenic 
metabolism. It was induced in acidogenesis and suppressed in solventogenesis. In the solR-
inactivated strain, the expression of the solventogenic genes is induced earlier and maintained 
throughout the solventogenic phase. Nair’s conclusion has proven to be controversial. 
Thormann et al [121] reported that during the construction of the DNA clone, the solR knock-
out phenotype also contained the binding site of a regulator, possibly SpoA, that affected the 
sol operon expression. 
1.7.3 Agr quorum sensing  
This study was conducted by Steiner et al [122]. In the C. acetobutylicum genome, there 
is an agr locus, agrBDCA, known to form a cyclic peptide-based quorum sensing system in 
Staphylococci. In Staphylococci, agrBD is necessary for the production of a peptide signal. 
The peptide signal accumulates extracellularly and is sensed by a two-component system 
encoded by agrCA. To understand the role of agrBDCA in C. acetobutylicum, the ClosTron 
technology was used to generate the agrB, agrC and agrA mutants, and their phenotypes were 
characterized. Those mutants and the wild-type displayed similar growth and no obvious 
differences in solvent formation under the conditions tested. However, on agar-solidified 
medium, spore formation was strongly affected, particularly in the agrA and agrC mutants. 
Similarly, granulose accumulation was almost undetectable in colonies of the agrB, agrA, and 
agrC mutants. AgrBD complementation in the agrB mutant restored granulose and spore 
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formation. In addition, when synthetic cyclic peptides based on the agrD sequence were 
added exogenously into the argB mutant culture, the parental phenotype was also restored. 
These findings support the hypothesis that agr-dependent quorum sensing is involved in the 
regulation of sporulation and granulose formation in C. acetobutylicum [122]. 
1.7.4 Heat-shock proteins: DnaK, GroESL, and Hsp21 
The so-called heat-shock proteins, including DnaK and GroEL (two highly conserved 
molecular chaperones), were induced by a temperature upshift (from 30 to 42°C) [123]. The 
dnaK operon includes four genes: orfA (a heat shock gene with an unknown function), grpE, 
dnaK, and dnaJ. The groE operon includes groES and groEL. A conserved inverted repeat 
was found upstream of dnaK and groEL and may be implicated as a cis-acting regulatory site. 
Those heat-shock genes were expressed at the beginning of solvent formation and after heat 
stress. The mRNA levels of heat-shock genes and solvent-producing genes reached a 
maximum at the same time during the metabolic shift [123]. In addition, over-expression of 
the heat shock proteins (GroES and GroEL) allowed an increase in the final solvent 
concentration, presumably by stabilizing solventogenic enzymes [124]. Therefore, the heat-
shock response in C. acetobutylicum might be part of a global regulatory network including 
different stress responses, such as heat shock, metabolic switching and sporulation [123].  
The small heat shock protein Hsp21 of C. acetobutylicum was identified as a 
rubrerythrin-like protein. The transcription of its encoding rbr3AB operon was induced by 
various environmental stress conditions: heat, oxidative stress, pH of the growth medium, 
addition of NaCl or butanol, and incubation temperature [125].  
1.7.5 PhoPR 
The phoPR gene locus of C. acetobutylicum comprises two genes, phoP and phoR. These 
PhoPR proteins are predicted to represent a response regulator and sensor kinase of a 
phosphate-dependent two-component regulatory system [126]. It was shown that a significant 
increase in the mRNA transcript levels of both phoP and phoR was observed when external 
phosphate concentrations dropped below 0.3 mM. The autophosphorylation of PhoR and 
phosphorylation of PhoP were shown in vitro. An electromobility shift assay proved that there 
was a specific binding of PhoP to the promoter region of the phosphate-regulated pst operon 
(comprising five genes, pstS, pstC, pstA, pstB, and phoU) of C. acetobutylicum [126]. 
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1.7.6 AbrB310 
SinR and AbrB are known to be transcriptional regulators involved in sporulation 
initiation in Bacillus subtilis. The role of SinR and AbrB in C. acetobutylicum was studied by 
Scotcher et al [127]. There were three highly similar homologs to B. subtilis abrB found in C. 
acetobutylicum: abrB310, abrB1941 and abrB3647. The promoters of abrB1941 and 
abrB3647 were inactive, whereas the abrB310 promoter was strongly active. The expression 
of abrB310 was elevated at the beginning of solventogenesis. Moreover, the promoter of 
abrB310 contains a putative 0A box. When abrB310 expression was repressed by asRNA, the 
acids (acetate and butyrate) accumulated to approximately twice their normal concentration. 
Acetone and butanol production were delayed and decreased. It was also found that 
sporulation in this mutant was delayed, but the morphology of the sporulating cells and spores 
was normal. Therefore, it was proposed that AbrB310 may act as a regulator of the transition 
between the acidogenic and solventogenic states. Regarding SinR, a single homolog to B. 
subtilis SinR was found. When the C. acetobutylicum strain was transformed with plasmids to 
increase or decrease SinR expression, no significant differences were observed either in 
growth or in acid or solvent production compared to the control strain [127]. 
1.7.7 Per and Fur 
Peroxide repressor (PerR)-homologous protein was identified as a key repressor that plays 
an important role in oxidative stress defense [128,129]. In vivo, PerR from C. acetobutylicum 
acts as a functional peroxide sensor. Transcriptomic data showed that genes involved in the 
detoxification system were regulated in PerR mutant, including reverse rubrerythrins (rbr3A-
rbr3B), desulfoferrodoxin (dfx), rubredoxin (rd), NADH-dependent rubredoxin 
oxidoreductase (NROR) and the oxygen-reducing flavodiiron proteins (FDPs, encoded by 
fprA1 and fprA2). Only a few targets of direct PerR regulation were identified. They include 
two highly expressed genes, gapN and CODH, that are putatively involved in the central 
energy metabolism. Under exposure to O2, C. acetobutylicum also activates the repair and 
biogenesis of DNA and Fe-S clusters. The genes that were downregulated when exposed to 
O2 were the ones involved in butyrate formation [129].  
In the same family as PerR, a ferric uptake regulator (Fur) that helps C. acetobutylicum 
sense and respond to the availability of iron was identified and characterized [130]. The Fur 
mutant was constructed and showed a slow-growing phenotype and an enhanced sensitivity to 
oxidative stress, but no dramatic change in the fermentation pattern was observed. However, 
the mutant overproduced riboflavin. The operon ribDBAH responsible for riboflavin synthesis 
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was significantly upregulated. Iron limitation and inactivation of Fur also affected the 
expression of several genes involved in energy metabolism. Two genes, encoding a lactate 
dehydrogenase (ldh) and a flavodoxin (fld), were highly induced [130]. 
1.7.8 CsrA 
Carbon storage regulator (CsrA, encoded by CAC2209) largely involved in regulating 
multiple pathways, including flagella assembly, oligopeptide transport, phosphotransferase 
transport systems, stage III sporulation and the central carbon metabolism [131]. The 
disruption of CsrA resulted in a decrease in solvent production. Genes involved in iron uptake 
and riboflavin synthesis were also reported to be regulated by CsrA in this study. 
1.7.9 CcpA 
Catabolite control protein (CcpA) mediates the utilization of hexose and pentose sugar in 
C. acetobutylicum. When CcpA was mutated at V302N, the utilization of xylose was greatly 
improved [132]. When this mutant was coupled with the over-expression of sol genes (ctfA, 
ctfB and adhE1), 30% more xylose was consumed compared to the wild-type when fermented 
in a mixture of glucose and xylose. EMSA experiments confirmed His-CcpA binding to the 
promoters of xylAB, sol, and CAC1353 (PTS system transporter subunit IIC). The mutated 
CcpA-V302N exhibited lower affinities to those promoters than the wild type [132]. 
The RegA protein of C. acetobutylicum, a homolog of the catabolite control protein CcpA 
in B. subtilis, has been found to inhibit the degradation of starch by the C. acetobutylicum 
staA gene product in E. coli [133].   
1.7.10 Rex 
A redox-sensing transcriptional repressor (Rex) was recently found to modulate its DNA-
binding activity in response to the NADH/NAD
+
 ratio and to participate in the solventogenic 
shift of C. acetobutylicum [110,134]. High NADH/NAD+ prevents the binding of Rex to 
DNA [110]. Rex binding sites were found in the promoters of different operons: adhE2, ldh, 
crt, thlA, asrT, ptb, and nadA [110,134], and those operons were upregulated in the Rex 
mutant. Among them, ldh1 was the most strongly induced gene, followed by adhE2. Genes 
encoding proteins involved in detoxification, including the reverse rubrerythrins (rbr3A-
rbr3B), desulfoferrodoxin (dfx), rubredoxin (rd), NADH-dependent rubredoxin 
oxidoreductase (nror) and the oxygen reducing flavoproteins (fprA1 and fprA2), were down 
regulated by 2 to 18-fold compared to the wild type. The Rex mutant produced high amounts 
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of ethanol and butanol and a significantly lower amount of acetone and hydrogen than the 
wild type [110,134]. 
1.7.11 AraR 
The L-arabinose utilization pathway has been studied extensively in bacteria, including 
Gram-positive B. subtilis. The permease encoded by araE transports L-arabinose into the 
cells. Subsequent genes involved in the conversion of L-arabinose belong to the operon 
araABDLMNPQ-abfA. The AraR gene encodes the regulatory protein for the L-arabinose 
metabolism in B. subtilis [135,136], which negatively controls the expression of the ara 
regulon. AraR exhibits a DNA binding domain at the N-terminal region and an effector 
binding domain at the C-terminal [136]. In the absence of arabinose, AraR represses the 
expression of the ara regulons. In the AraR mutant, there was a dramatic increase in the 
expression of the genes involved in arabinose utilization (two araEs, araD, two araAs and 
araK), the genes in the pentose phosphate pathway (ptk, tal and tkt), and genes involved in 
arabinoside degradation (epi and arb43). EMSA experiments confirmed the affinity of AraR 
for the promoter of araK, araE, araD, ptk and araR itself. In the presence of L-arabinose, 
AraR was released from the AraR-DNA complex [136]. 
1.7.12 Small regulatory RNA 
Small noncoding RNAs are widespread in all kingdoms of life, where they serve to 
regulate and tune gene expression, subsequently influencing a wide range of cellular 
processes that include environmental stress responses and virulence processes in pathogens 
[137]. Many sRNAs have been described in Gram-negative bacteria, but our understanding of 
their role in Gram-positive bacteria has been slower [137]. Hundreds of sRNAs have recently 
been identified in Clostridia. Chen et al [138] have developed a method to identify potential 
sRNAs in the Clostridium genus. By genomics comparison and the in-silico prediction of rho-
independent terminators and promoters, they have predicted sRNAs in the following 21 
Clostridial genomes: Clostridium acetobutylicum, C. beijerinckii, eight C. botulinum strains, 
C. cellulolyticum, C. difficile, two C. kluyveri strains, C. novyi, three C. perfringens strains, C. 
phytofermentans, C. tetani, and C. thermocellum. Most of the predicted sRNAs were found in 
noncoding regions. Seven of these sRNAs have Shine-Dalgarno (SD) sequences, and some 
possess a start codon downstream of the SD sequences. Thirty sRNAs (of 113 predicted) of C. 
acetobutylicum and 21 sRNAs of C. botulinum were validated by northern blot analysis and 
quantitative reverse transcription PCR (qRT-PCR). A conserved, novel sRNA was found to 
be responsive to the antibiotic clindamycin [138]. Lately, Venkataramanan et al. [139] have 
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used RNA deep sequencing to examine the sRNome of C. acetobutylicum that is responsive 
to butanol and butyrate and have identified 46 additional sRNAs. Under metabolite stress, 
these 159 sRNAs display divergent expression patterns. The expression of sRNAs affecting 
transcriptional (6S, S-box, and solB) and translational (tmRNA and SRP-RNA) processes and 
RNA chaperone Hfq were found to be stress-related [139]. 
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2 Chapter 2 Thesis Objectives 
 
This PhD thesis has two main parts, as follows: the metabolic engineering of C. 
acetobutylicum for the production of fuels and chemicals and understanding the regulatory 
role of an uncharacterized Cap0037 protein. 
The metabolic engineering part has three objectives: 
 Detail the homologous recombination technique by replicative plasmid that has 
been used successfully to construct C. acetobutylicum mutants. 
 Construct a C. acetobutylicum mutant that produces n-butanol with high 
selectivity and yield on glucose. By the homologous recombination method, the 
metabolic pathways leading to by-products including lactate, butyrate and acetone 
were eliminated. The carbon fluxes were guided to n-butanol formation by 
replacing hbd with hbd1 and thla with atoB genes. The final strain CAB1060 also 
contains inactivated Rex protein which globally regulates metabolism in response 
to the intracellular NADH/NAD
+
 concentration. This CAB1060 mutant was then 
evaluated for its ability to produce butanol at high yield and selectivity in a 
continuous bioreactor coupling alcohol extraction by vacuum distillation to a cell 
recycling in order to improve productivities. 
 Construct a C. acetobutylicum platform strain unable to produce hydrogen and 
useful for further engineering to produce chemicals and fuels. In this part, a new 
homologous recombination system using non-replicative plasmid was developed.  
In the second part, the Cap0037protein of unknown function was primarily studied. To 
do so, a Cap0037 inactivated mutant was constructed using group II intron. A thorough 
comparison of the Cap0037::int mutant and the wild-type strain was analyzed from the 
transcriptomics, fluxomics, and proteomics aspects. In addition, DNA binding activity of 
Cap0037 was also studied. The potential Cap0037 regulon was predicted by bio-informatics 
tools. 
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3.1 Abstract 
Clostridium acetobutylicum is a Gram-positive, spore-forming, anaerobic bacterium 
capable of converting various sugars and polysaccharides into organic acids (acetate and 
butyrate) and solvents (acetone, butanol, and ethanol). Clostridium acetobutylicum has 
become of interest in postgenomic era due to the complete sequencing and annotation of its 
genome, supplying a wealth of information on its protein machinery. This global knowledge 
has prompted new approaches to genetic analysis, functional genomics, and metabolic 
engineering to develop an industrial strain for the production of biofuels and bulk chemicals. 
The method used in this study to knock-out or knock-in genes in C. acetobutylicum combines 
the use of an antibiotic resistance gene for the deletion or replacement of the target gene, the 
subsequent elimination of the antibiotic resistance gene with the flippase (FLP) recombinase 
system from Saccharomyces cerevisiae, and a C. acetobutylicum strain that lacks upp, which 
encodes uracil phosphoribosyl transferase, for subsequent use as a counter-selectable marker. 
A replicative vector containing i) a pIMP13 origin of replication from Bacillus subtilis that is 
functional in Clostridia, ii) a replacement cassette consisting of an antibiotic resistance gene 
(MLSR) flanked by two FRT sequences, and iii) two sequences homologous to selected 
regions around target DNA sequence was first constructed. This vector was successfully used 
to consecutively delete the Cac824I restriction endonuclease encoding gene (CA_C1502) and 
the upp gene (CA_C2879) in the C.acetobutylicum ATCC824 chromosome. The resulting C. 
acetobutylicum Δcac1502Δupp strain is marker-less, readily transformable without any 
previous plasmid methylation and can serve as the host for the “marker-less” genetic 
exchange system. The third gene, CA_C3535, shown in this study to encode for a type II 
restriction enzyme (Cac824II) that recognizes the CTGAAG sequence, was deleted using an 
upp/5-FU counter-selection strategy to improve the efficiency of the method. The re- 
striction-less marker-less strain and the method was successfully used to delete two genes 
(ctfAB) on the pSOL1 mega-plasmid and one gene (ldhA) on the chromosome to get strains no 
longer producing acetone or L-lactate. The restriction-less, marker-less strain described in this 
study, as well as the maker-less genetic exchange coupled with positive selection, will be 
useful for functional genomic studies and for the development of industrial strains for the 
production of biofuels and bulk chemicals. 
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3.2  Introduction 
In recent years, Clostridium acetobutylicum ATCC824 has been of interest in the 
postgenomic era due to the complete sequencing and annotation of its genome [19], supplying 
a wealth of information regarding its protein machinery. This global knowledge has prompted 
new approaches to genetic analysis, functional genomics, and metabolic engineering in order 
to develop industrial strains for the production of biofuels and bulk chemicals. 
To this end, several reverse genetic tools have been developed for C. acetobutylicum 
ATCC 824, including a gene inactivation system based on non-replicative [55,96] and 
replicative plasmids [92–94,140] and the group II intron gene inactivation system [74,88]. 
Among these methods, only the method developed by Al-Hinai et al.[94] allows for in frame 
deletions and/or the introduction of genes at their normal chromosomal context without an 
antibiotic marker remaining. This system is made of two parts. The first part is a replicative 
vector containing (1) a pIMP13 origin of replication from Bacillus subtilis functional in 
Clostridia, (2) a replacement cassette consisting of an antibiotic resistance gene (Th
R
) flanked 
by two FRT sequences, (3) two sequences homologous to the selected regions around the 
target DNA sequence, and (4) a codon-optimized mazF toxin gene from Escherichia coli 
under the control of a lactose-inducible promoter from Clostridium perfringens to allow for 
the positive selection of double-crossover allelic exchange mutants. The second part is a 
plasmid system with inducible segregational instability, enabling efficient deployment of the 
FLP-FRT system to generate marker-less deletion or integration mutants. 
In 2006, our group patented a marker-less, in-frame deletion method [141] similar to the 
two-part method published by Al-Hinai et al. [94] in 2012. The first part of our method is 
based on the same replicative plasmid and the same replacement cassette, but it uses the uracil 
PRTase upp/5-fluorouracil (5-FU) system as a counter-selection strategy. The second part is 
based on a plasmid carrying (1) the FLP-FRT system to generate marker-less deletion and (2) 
the uracil PRTase upp/5-FU system to select for the plasmid loss after marker excision. This 
method was successfully used by the Metabolic Explorer Company to develop and patent an 
industrial recombinant strain of C. acetobutylicum for n-butanol production. As this method 
has not been described in detail and to make it available to and usable by the scientific 
community, we report how this method was developed and its use to create a restriction-less, 
marker-less strain of C. acetobutylicum. We show that this strain lacking upp (CA_C2879, 
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encoding the uracil–phosphoribosyl-transferase), CA_C1502 encoding Cac824I and 
CA_C3535 encoding Cac824II (the second type II restriction enzyme) can be transformed by 
non-methylated DNA at very high efficiency and can be used for rapid gene knock-in and 
knock-out using the upp/5-FU counter-selectable system for both functional genomic and 
metabolic engineering of C. acetobutylicum. This strain and the method were further used to 
delete three genes ctfAB and ldhA to create strains no longer producing acetone and lactate, 
respectively. 
3.3  Results and Discussion 
3.3.1 MGCΔcac1502 strain, a C. acetobutylicum strain that is transformable 
without previous in vivo plasmid methylation 
Cac824I, the type II restriction endonuclease encoded by CA_C1502, is a major barrier to 
the electrotransformation of C. acetobutylicum with E. coli–C. acetobutylicum shuttle vectors 
. The Cac824I restriction endonuclease recognition sequence 5′-GCNGC3′, where N can be 
any nucleotide, occurs infrequently in C. acetobutylicum DNA because of the high A + T 
DNA content (72 % A + T), but the sequence occurs frequently in E. coli plasmids. No 
methyltransferase that can be used in vitro to protect DNA from restriction by Cac824I is 
commercially available. Prior to the transformation of C. acetobutylicum, shuttle plasmids 
have to be methylated in vivo by transformation into E.coli ER2275 (pAN1) expressing the 
Bacillus subtilis phage φ3TI methyltransferase, which protects the shuttle plasmids from 
digestion by the Clostridial endonuclease Cac824I [142]. This step is time consuming and 
may be a drawback if the genes to be transferred to C. acetobutylicum are toxic when 
expressed in E. coli. Therefore, a C. acetobutylicum strain deficient for this particular 
restriction system would be valuable for efficient electrotransformation without previous 
treatment of the plasmid to be transformed. 
To delete the Cac824I encoding gene, the first step is the construction of a shuttle vector 
carrying the replacement cassette. The CA_C1502 replacement cassette was cloned into the 
BamHI site of the pCons2-1 and pCIP2-1 to generate the pREPcac15 and pCIPcac15 
plasmids, respectively. The difference between these two plasmids is the origin of replication. 
The pREPcac15 contains a pIMP13 origin of replication from B. subtilis (rolling circle 
mechanism) functional in Clostridia, whereas pCIPcac15 contains the origin of replication of 
the pSOL1 megaplasmid (θ replication mechanism). The pREPcac15 and pCIPcac15 plasmids 
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were methylated in vivo in E.coli ER2275 (pAN1) and were used to transform C. 
acetobutylicum ATCC824 by electroporation. After selection on plates for clones resistant to 
erythromycin at 40 µg/ml, one colony of each transformant was cultured for 24 h in liquid SM 
with erythromycin and was then subcultured four times in liquid 2YTG medium without 
antibiotic (Figure 3-1a). To select integrants that lost the pREPcac15 or pCIPcac15 plasmids, 
10
3
 erythromycin resistant clones were replica plated on both RCA with erythromycin and 
RCA with thiamphenicol at 50 µg/ml. Whereas several colonies resistant to erythromycin and 
sensitive to thiamphenicol were obtained with pREPcac15 transformants, no such colonies 
were obtained with the pCIPcac15 transformants, which indicates that the θ replication 
mechanism of pCIPcac15 is less favorable for promoting double-crossover in C. 
acetobutylicum than a rolling circle mechanism. The genotype of clones with the desired 
phenotype was checked by PCR (polymerase chain reaction) analysis (Figure 3-2a). The 
Δcac1502::mls
R
 strain, which had lost the pREPcac15, was isolated. This strain was 
transformed with the pCLF1 plasmid expressing the FLP1 gene of S. cerevisiae encoding for 
the FLP recombinase. The expression of FLP1 was under the control of the promoter and 
RBS (ribosome binding site) from the thiolase gene from C. acetobutylicum. After 
transformation and selection for resistance to thiamphenicol at 50 µg/ml, one colony was 
cultured in liquid SM with thiamphenicol. One hundred thiamphenicol resistant clones were 
replica plated on both RCA with erythromycin and RCA with thiamphenicol. The genotype of 
the clones with erythromycin sensitivity and thiamphenicol resistance was checked by PCR 
analysis with primers CAC 0 and CAC 5 (Figure 3-2a). Two successive 24-h liquid cultures 
of the Δcac1502 strain were conducted in the absence of antibiotics to remove pCLF1. The 
Δcac1502 strain that lost pCLF1 was isolated according to its sensitivity to both erythromycin 
and thiamphenicol. This strain was called MGCΔcac1502. 
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Figure 3-1 General diagram representing gene replacement via allelic exchange at the Y 
locus, and excision of the MLS
R
 marker by the FLP recombinase to create an unmarked 
Y deletion mutant. 
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The boxed regions of X and Z genes represent approximatively the regions of homology 
incorporated into the replicative plasmid used for the double-crossover event (~ 1 kbp each). a 
Initial strategy used for the construction of the MGCΔcac1502 and MGCΔcac1502Δupp 
strains, b counter-selection strategy with the 5-FU/upp system used for the construction of the 
MGCΔcac1502ΔuppΔcac3535 strain. 
 
 
Figure 3-2 Gene replacement via allelic exchange at the ca_c1502, upp and ca_c3535 loci.  
 
PCR confirmation of the different double-crossover deletion mutants using external 
primers annealing to the chromosome upstream and downstream of each deletion cassette 
used in the different pREP plasmids: a Δca_c1502 deletion mutants with CAC-0 + CAC-5 
primers, b Δupp deletion mutants with UPP-0 + UPP-5 primers, c Δca_c3535 deletion 
mutants with RM-0 + RM-5 primers (lanes 1, 2 and 3). For each experiment, lanes 2 and 3 
refer to before and after excision of the MLS
R
 marker by the FLP recombinase, respectively, 
giving finally an unmarked deletion mutant (Δ-unm). The previous unmarked deletions in the 
final Δca_c1502 Δupp Δca_c3535 were confirmed with CAC-0 + CAC-5 (c, lane 4) and 
UPP-0 + UPP-5 (c, lane 5) primers. Lane M, 1 kb DNA ladder (0.5–10 kb) (NEB) 
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The efficiency of transformation of this strain with methylated and unmethylated 
pCons2.1 plasmid was evaluated and compared to the wild-type strain. Both strains can be 
transformed with methylated pCons2.1 with similar efficiency, but only MGCΔcac1502 can 
be transformed efficiently with unmethylated DNA (Table 3-1). 
 
 C. acetobutylicum ATCC824 MGCΔcac1502  
Unmethylated pCons2.1 0 0.79 (±0.24) × 10
4
  
Methylated pCons2.1 0.46 (±0.11) × 10
4
  0.58 (±0.18) × 10
4
  
 
Table 3-1 Transformation efficiencies of C. acetobutylicum ATCC824 and 
MGCΔcac1502 for unmethylated and methylated pCons2.1.  
Values are expressed in number of transformants per μg DNA. Mean values and standard 
deviations from three independent experiments are given 25 ng pCons2.1 was used in each 
experiment. 
The following deletions described in this manuscript were conducted in this strain 
without previous in vivo plasmid methylation. 
3.3.2 Construction of the MGCΔcac1502Δupp strain: the first marker-free C. 
acetobutylicum strain with two deleted genes 
To develop a positive screening of integrants, we used the “upp/5-FU as counter 
selection marker” system. The C. acetobutylicumupp gene (CA_C2879) encodes uracil 
phosphoribosyl-transferase (UPRTase), which catalyzes the conversion of uracil into UMP, 
thus allowing the cell to use exogenous uracil [143]. The pyrimidine analog 5-fluoro uracil (5-
FU) can be converted by UPRTase into 5-fluoro-UMP, which is metabolized into 5-fluoro-
dUMP, an inhibitor of thymidylate synthetase, toxic for the cell. The use of the upp 
expression cassette as a counter-selection marker is linked to the construction of a C. 
acetobutylicum strain deleted for the upp gene, thus resistant to 5-FU. 
To delete upp, the upp replacement cassette was cloned into the BamHI site of pCons2-1 
to generate the plasmid pREPupp. The plasmid pREPupp was used to transform the 
MGCΔcac1502 strain by electroporation without previous in vivo methylation. After 
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selection on plates for clones resistant to erythromycin at 40 µg/ml, one colony was cultured 
for 24 h in liquid SM with erythromycin and was then subcultured in liquid 2YTG medium 
without antibiotic (Figure 3-1a). To select integrants having lost the pREPupp plasmid, 10
3
 
erythromycin resistant clones were replica plated on both RCA with erythromycin and RCA 
with thiamphenicol. The genotype of the clones resistant to erythromycin and sensitive to 
thiamphenicol was determined by PCR analysis (Figure 3-2b). The GCΔcac1502Δupp::mls
R
 
strain that lost pREPupp was isolated. When the resistance to 5-FU was analyzed, we showed 
that this strain was resistant to up to 1 mM 5-FU compared to 50 µM for the MGCΔcac1502 
strain. This strain was then transformed with the pCLF1 plasmid, and selection of MGC 
Δcac1502Δupp strain with sensitivity to both erythromycin and thiamphenicol was 
performed, as previously described for the MGCΔcac1502 strain (Figure 3-2b). 
3.3.3 Deletion of the CA_C3535 gene in the MGCΔcac1502Δupp strain using the 
upp/5-FU system as a counter-selectable marker for the loss of plasmid 
The CA_C3535 gene encodes Cac824II, a potentially bi-functional enzyme carrying both 
a type II restriction endonuclease and methylase activities. To delete CA_C3535, the 
CA_C3535 replacement cassette was cloned into the BamHI site of the pCons::upp to generate 
the plasmid pREPcac3535::upp. The plasmid pREPcac3535::upp was used to transform the C. 
acetobutylicum MGCΔcac1502Δupp strain by electroporation without previous in vivo 
methylation. 
After plate selection for clones resistant to erythromycin at 40 µg/ml, 100 transformants 
were replica plated on RCA with erythromycin, RCA with thiamphenicol and RCA with 5-FU 
at 400 µM (Figure 3-1b). All transformants were resistant to erythromycin and thiamphenicol 
and were sensitive to 5-FU compared to the parental strain, which was resistant to 5-FU. This 
result demonstrates that the expression of the upp gene carried by pREPcac::upp confers 
sensitivity to 5-FU. 
To select for Δcac3535::Em
R
 integrants that lost the pREPcac3535::upp plasmid, 
erythromycin- and 5-FU-resistant clones were selected on RCA plates containing 
erythromycin and 5-FU from 100 µl of a liquid culture of the MGCΔcac1502Δupp 
(pREPcac3535::upp) strain. Approximately 500 colonies were obtained, and 100 of them 
were replica plated on both RCA with erythromycin and RCA with thiamphenicol. Most of 
the clones (95 %) were resistant to erythromycin and sensitive to thiamphenicol. Four clones 
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were checked by PCR analysis (Figure 3-2c) All four clones had the correct phenotype, and 
one of the clones was selected as the MGC Δcac1502ΔuppΔcac3535::mls
R
 strain. This strain 
was then transformed with pCLF::upp, a derivative of the pCLF1 plasmid that also carries the 
upp gene, in order for the positive selection of plasmid loss after the excision of the mls
R
 
marker. After the first selection of clones resistant to thiamphenicol and sensitive to 
erythromycin, a second selection of clones resistant to 5-FU and sensitive to thiamphenicol 
was performed to obtain the MGC Δcac1502ΔuppΔcac3535 strain that was control by PCR 
(Figure 3-2c) for the presence of all the marker-less deletions. Finally, when compared to C. 
acetobutylicum ATCC824 wild-type, the growth of the restriction-less marker-less strain in 
MS medium at pH 4.5 (Figure 3-3) was shown to be unaffected by the different deletions. 
 
Figure 3-3 Growth curves of C. acetobutylicum ATCC824 and MGCΔcac1502 Δupp 
Δcac3535 at pH 4.5 in SM medium 
The unmethylated pCons2.1 plasmid was used to evaluate the transformation efficiency 
of the MGCΔcac1502 and the MGCΔcac1502Δupp Δcac3535 strains. The transformation 
efficiency of MGCΔcac1502ΔuppΔcac3535 for unmethylated pCons2.1 was ~eightfold 
higher than that of MGCΔcac1502 (Table 3-2) 
 
 MGCΔcac1502 MGC Δcac1502Δupp Δcac3535 
Unmethylated pCons2.1 0.79 (±0.24) × 10
4
 6.1 (±3.2) × 10
4
 
 
Table 3-2 Transformation efficiencies of MGCΔcac1502 and 
MGCΔcac1502ΔuppΔcac3535 for unmethylated pCons2.1.  
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Values are expressed in number of transformants per μg DNA. Mean values and standard 
deviations from three independent experiments are given 25 ng pCons2.1 was used in each 
experiment. 
3.3.4 Determination of the recognition sequence of Cac824II encoded by 
CA_C3535 
CA_C3535 encoded a 993 amino acid protein with a calculated molecular mass of 
116,842 Da. The amino acid sequence analysis revealed high similarities with two restriction 
endonucleases: AcuI from Acinetobacter calcoaceticus SRW4 [144] and Eco57I from E. coli 
RFL57 [145] with 44 and 46 % identity, respectively. Both enzymes belong to the IIg family 
of restriction enzymes and possess both a restriction and methylase activity. To 
heterologously express the AcuI-encoding gene in E. coli [144], it was necessary to first 
express the AcuIM methylase-encoding gene because the methylase activity of AcuI was not 
sufficient to protect DNA against its restriction activity. We applied the same strategy for the 
expression of CA_C3535-encoding Cac824II: we cloned into the pSOS2K2 gene and 
expressed in E. coli the CA_C3534 gene that encodes a putative methylase and that is located 
immediately downstream of CA_C3535 gene in the C. acetobutylicum chromosome. The 
pSC-CAC3534 plasmid expressing CA_C3534 has three AcuI recognition sites, but when we 
tried to digest it with AcuI, it was completely protected from the activity of this enzyme. To 
express, purify and determine the recognition sequences of Cac824II, we cloned CA_C3535in 
the pPAL vector using the E. coli BL21-AI cells containing the pSC-CAC3534 plasmid as 
host. The Cac824II endonuclease was purified, and its activity towards unmethylated 
pCons2.1 in the presence of SAM was determined. AcuI recognizes the 5′-CTGAAG-3′ 
sequence and cuts the pCons2.1 plasmid two times, resulting in two fragments of 2411- and 
882-bp. Figure 3-4 shows that Cac824II gives the same restriction pattern as AcuI. To confirm 
that the AcuI and Cac824II recognition sequences were identical, pCons2.1 was digested by 
50 μg of Cac824II in the presence of 1 U of AcuI. Figure 3-4 shows that the restriction pattern 
was unchanged, which definitively confirms that AcuI and Cac824II are isoschizomers. 
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Figure 3-4 Digestion properties of recombinant Cac824II as compared to commercial 
AcuI (New England Biolabs).  
250 ng of unmethylated pCONS2.1 plasmid were incubated for 1 h at 37 °C in a reaction 
volume of 20 µL containing 50 mM potassium acetate, 20 mM Tris–acetate (pH 7.9), 10 mM 
Magnesium acetate, 100 µg/mL BSA and 0.04 mM S-adenosyl-methionine with (A) No 
enzyme, (B) purified Cac824II (50 µg), (C) AcuI (5U), and (D) purified Cac824II 
(50 µg) + AcuI (5U). Lanes M, 1 kb DNA ladder (0.5–10 kbp, NEB). Reactions products were 
electrophoresed on a 0.8 % agarose gel. An arrow indicates the incomplete digestion product 
remaining after incubation with Cac824II. 
3.3.5 Deletion of the ctfAB genes in the MGCΔcac1502ΔuppΔcac3535 to create a 
strain no longer producing acetone 
The ctfAB genes (CA_P0163-CA_P0164) located on the pSOL1 megaplasmid encodes an 
acetoacetyl-CoA:acyl CoA-transferase involved in the first specific step of acetone formation 
[42]. To delete ctfAB, the ctfAB replacement cassette was cloned into the BamHI site of the 
pCons::upp to generate the plasmid pREPctfAB::upp. The plasmid pREPctfAB::upp was used 
to transform the C. acetobutylicum MGCΔcac1502ΔuppΔcac3535 strain by electroporation 
without previous in vivo methylation and cell containing the plasmid were selected on RCA 
plate with erythromycin at 40 µg/ml. To select for ΔctfAB::Em
R
 integrants that lost the 
pREPctfAB::upp plasmid, erythromycin- and 5-FU-resistant clones were selected on RCA 
plates containing erythromycin and 5-FU from 100 μl of a liquid culture of the 
MGCcac1502ΔuppΔcac3535 (pREPctfAB::upp) strain. Approximately 500 colonies were 
obtained, and 50 of them were replica plated on both RCA with erythromycin and RCA with 
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thiamphenicol. Most of the clones (90 %) were resistant to erythromycin and sensitive to 
thiamphenicol. Four clones were checked by PCR analysis (with primers CTF-0 and CTF-5 
located outside of the ctfAB replacement cassette and primers CTF-D and CTF-R located 
inside of ctfAB). All four clones had the correct phenotype, and one of the clones was selected 
as the MGC Δcac1502ΔuppΔcac3535ΔctfAB::mls
R
 strain. The fermentation profile of this 
strain was compared to the MGC Δcac1502ΔuppΔcac3535 control strain during batch 
fermentation at pH 4.5 (Figure 3-5). The production of acetone was totally abolished but the 
production of acetic acid was increased more than sixfold while butyric acid was only slightly 
increased, proving that the acetoacetyl-CoA:acyl CoA-transferase is mainly involved in the 
consumption of acetic acid. 
3.3.6 Deletion of the ldhA gene in the MGCΔcac1502ΔuppΔcac3535 to create a 
strain no longer producing lactate 
The ldhA genes (CA_C0267) encodes a lactate dehydrogenase involved in the last step of 
l-lactate formation [42]. To delete ldhA, the ldhA replacement cassette was cloned into the 
BamHI site of the pCons::upp to generate the plasmid pREPldhA::upp. The plasmid 
pREPldhA::upp was used to transform the C. acetobutylicum MGCΔcac1502ΔuppΔcac3535 
strain by electroporation without previous in vivo methylation and cell containing the plasmid 
were selected on RCA plate with erythromycin at 40 µg/ml. To select for ΔldhA::Em
R
 
integrants that lost the pREPldhA::upp plasmid, erythromycin- and 5-FU-resistant clones 
were selected on RCA plates containing erythromycin and 5-FU from 100 μl of a liquid 
culture of the MGCcac1502ΔuppΔcac3535 (pREPldhA::upp) strain. Approximately 500 
colonies were obtained, and 50 of them were replica plated on both RCA with erythromycin 
and RCA with thiamphenicol. Most of the clones (80 %) were resistant to erythromycin and 
sensitive to thiamphenicol. Four clones were checked by PCR analysis (with primers LDH-0 
and LDH-5 located outside of the ldhA replacement cassette and primers LDH-D and LDH-R 
located inside of ldhA). All four clones had the correct phenotype, and one of the clones was 
selected as the MGC Δcac1502ΔuppΔcac3535ΔldhA::mls
R
 strain. The fermentation profile of 
this strain was compared to the MGC Δcac1502ΔuppΔcac3535 control strain during batch 
fermentation at pH 4.5 (Figure 3-5). The production of l-lactate was totally abolished proving 
that ldhA encodes the main l-lactate dehydrogenase of C. acetobutylicum. 
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Figure 3-5 Solvent and acid production of MGCΔcac1502 Δupp Δcac3535, 
MGCΔcac1502 Δupp Δcac3535Δ ctfAB::Em
R
, and MGCΔcac1502 Δupp Δcac3535Δ 
ldhA::Em
R
 in batch culture at pH 4.5 in SM medium 
3.4 Discussion 
We developed a simple and efficient method to create mutations in the Clostridium 
acetobutylicum chromosome. This method is based on the use of (1) a replicative plasmid, (2) 
a deletion cassette containing both DNA sequences with homology to the flanking region of 
the target gene (to delete it) and an antibiotic resistance gene surrounded by FRT sequences 
(as an excisable marker), and (3) the upp gene, which encodes the uracil–phosphoribosyl-
transferase, as a counter-selectable marker. 
A plasmid that replicates via a rolling circle mechanism was more efficient in terms of 
double cross over frequency than a plasmid that replicates through a theta mechanism. This 
result is in agreement with previous findings in Bacillus subtilis showing that plasmid 
replication through a rolling circle mechanism favors recombination between homologous 
sequences [146,147]. 
The deletion cassette can be rapidly constructed through a three-step procedure using 
pre-constructed building blocks. After a fusion PCR and TOPO cloning of the product, a 
predesigned antibiotic resistance gene surrounded by two FRT sites in direct repeats is 
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inserted. The upp gene is located on the plasmid outside of the deletion cassette. This allows 
the positive selection of clones that have lost the plasmid and integrated the deletion cassette 
by a double recombination event. We demonstrate here that this event occurs at a frequency 
of 10
−5
, which means that without the selection procedure, it would be much more difficult to 
isolate the correct deletion mutant by replica plating alone. Once the deletion cassette is 
integrated into the chromosome, the expression of the flp recombinase allows (1) the excision 
of the antibiotic marker for a clean in-frame deletion of the targeted gene (without polar 
effect) and (2) consecutive gene deletions. Such a strategy was previously applied to marker-
less gene deletion in E. coli [148] and Mycobacterium smegmatis [149]. The plasmid 
expressing the FLP recombinase-encoding gene was further improved by coexpressing the 
upp gene to use it as a positive selection for the plasmid loss after excision of the MLS
R
 
marker. A similar tool was developed by Al-Hinai et al. [94] using a plasmid (1) that 
expresses the FLP recombinase-encoding gene and (2) that has an inducible segregational 
instability to promote the plasmid loss. 
In this study Cac824II (encoded by CA_C3535), the second type II restriction enzyme of 
C. acetobutylicum predicted by REBASE [100], was biochemically characterized and it was 
demonstrated that it is an isoschizomer of AcuI [144] recognizing the 5′-CTGAAG-3′ 
sequence. It was also shown that Cac824II methylase (encoded by CA_C3534) protects DNA 
against restriction by Cac824II and AcuI by probably methylating one of the adenine in the 5′-
CTGAAG-3′ sequence. Two Cac824II restriction sites are present (in the ampR gene and in 
the colE1 origin of replication) in most the shuttle vector use to transform C. acetobutylicum 
and it was then justified to construct a marker-less strain deleted from CA_C3535. The 
transformation efficiency of MGCΔcac1502ΔuppΔcac3535 for unmethylated pCons2.1 was 
much higher (~eightfold higher) than that of MGCΔcac1502 and it will be an interesting 
strain to develop new genetic tools based on suicide vectors [100]. 
The restriction-less marker-less strain and the method was successfully used to delete 
two genes (ctfAB) on the pSOL1 megaplasmid and one gene (ldhA) on the chromosome to get 
strains no longer producing acetone or l-lactate. This work demonstrate that (1) ctfAB encode 
an acetoacetyl-CoA:acetate CoA-transferase that coupled acetone formation to acetate 
consumption and (2) ldhA encodes the main lactate dehydrogenase in C. acetobutylicum 
although a second gene ldhB (CA_C3552) is also present [42]. A strain with clostron 
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inactivated ctfAB genes was previously constructed [91]. From the physiological analysis of 
this mutant and with the help of a mathematical model [150], it was demonstrated that 
butyrate was mainly reconsumed by the phosphotransbutyrylase-buyrate-kinase pathway and 
not by the acetoacetyl-CoA:acetate CoA-transferase in agreement with the data presented in 
our study.  
3.5 Conclusion 
The restriction-less, marker-less strain and the genome modification method presented 
here become simple and convenient tools that are useful for research groups involved in 
functional genomic studies of C. acetobutylicum and for further metabolic engineering of this 
strain to produce bulk chemicals and biofuel. As a demonstration of the efficiency of the 
method, we constructed two strains unable to produce l-lactate or acetone. Furthermore, this 
method was successfully used by the Metabolic Explorer Company to develop and patent an 
industrial recombinant strain of C. acetobutylicum for n-butanol production [151] at high 
yield. 
3.6  Experimental Procedure 
3.6.1 Bacterial strain, plasmids and oligonucleotides 
The bacterial strain and plasmids used in this study are listed in Table 3-3. The specific 
oligonucleotides used for PCR amplification were synthesized by Eurogentec Table 3-4.  
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Strain or plasmid Relevant characteristics
a
  Source or 
reference
b
  
Bacterial strains 
 E. coli  
  TOP10  Invitrogen 
  ER2275 RecA
−
 McrBC
−
  NEB 
 C. acetobutylicum  
  ATCC824 Wild-type ATCC 
  MGCΔcac1502  ΔCA_C1502  This study 
  MGCΔcac1502Δupp  ΔCA_C 1502Δ CA_C 2879  This study 
  MGCΔcac1502ΔuppΔcac3535  ΔCA_C 1502ΔCA_C 2879ΔCA_C 
3535  
This study 
  MGCΔcac1502ΔuppΔcac3535ΔctfAB  ΔCA_C 1502ΔCA_C 2879ΔCA_C 
3535ΔCA_P0162-3  
This study 
  MGCΔcac1502ΔuppΔcac3535ΔldhA  ΔCA_C 1502ΔCA_C 2879ΔCA_C 
3535ΔCA_C 0267  
This study 
 Plasmids 
  pAN1 Cm
r
, φ3TI, p15A origin [152] 
  pKD4 Ap
r
 Km
r
  [148] 
  pETSPO Cm
r
 MLS
r
  [92] 
  pUC18 Ap
r
  Fermentas 
  pUC18-FRT-MLS2 Ap
r
 MLS
r
  This study 
  pCons2-1 Cm
r
  This study 
  pCR-BluntII-TOPO Zeo
r
 Km
r
  Invitrogen 
  pCIP2-1 Cm
r
  This study 
  pREPcac15 Cm
r
 MLS
r
 ΔCA_C1502  This study 
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  pCIPcac15 Cm
r
 MLS
r
 ΔCA_C1502  This study 
  pREPupp Cm
r
 MLS
r
 Δupp  This study 
  pCP20 Ap
r
 Cm
r
 FLP  [153] 
  pSOS95 Ap
r
 MLS
r
, acetone operon, repL 
gene, ColE1 origin 
[154] 
  pCLF1 Cm
r
 FLP  This study 
  pCR4-TOPO-Blunt Ap
r
 Km
r
  Invitrogen 
  pCons::upp Cm
r
 MLS
r
 upp  This study 
  pREPCAC3535::upp Cm
r
 MLS
r
 upp ΔCA_C3535  This study 
  pREPctfAB::upp Cm
r
 MLS
r
 upp ΔctfAB  This study 
  pREPldhA::upp Cm
r
 MLS
r
 upp ΔldhA  This study 
Table 3-3 Bacterial strains and plasmids used in this study 
a
 RecA 
−
 homologous recombination abolished, McrBC 
−
 lacking methylcytosine-specific 
restriction system, Cm 
r
 chloramphenicol resistance, Ap 
r
 ampicillin resistance, MLS 
r
 
macrolide lincosamide and streptogramin B resistance, Zeo 
r
 zeomycin resistance, φ3TI φ3TI 
methyltransferase, repL Gram-positive origin of replication from pIM13 
b
 NEB New England BioLabs, ATCC American Type Culture Collection (Rockville, 
MD) 
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Primer name Oligonucleotide sequence 
PKD4.1 ctggcgccctgagtgcttgcggcagcgtgagggg 
PKD4.2 agcccggggatctcatgctggagttcttcgccc 
FRT-MLSR-F tacaggccttgagcgattgtgtaggctggagc 
FRT-MLSR-R aacaggcctgggatgtaacgcactgagaagccc 
PCONSAccI ccggggtaccgtcgacctgcagcc 
PCONSEcoRI gaattccgcgagctcggtacccggc 
ORI3-D ccatcgatgggggtcatgcatcaatactatcccc 
ORI4-R gcttccctgttttaatacctttcgg 
FLP1-D aaaaggatccaaaaggagggattaaaatgccacaatttggtatattatgtaaaacaccacct 
FLP1-R aaatggcgccgcgtacttatatgcgtctatttatgtaggatgaaaggta 
REP-UPP-F aaaacagctgggaggaatgaaataatgagtaaagttacac 
REP-UPP-R aaaacagctgttattttgtaccgaataatctatctccagc 
CAC 1 aaaggatccatgcacactcataaatttactgtaggaagtctg 
CAC 2 ggggaggcctaaaaaggggggtcccaaataatatttgccatagtaaccacc 
CAC 3 ccccctttttaggcctcccctcgaacttattagaatgattaagattccgg 
CAC 4 aaaggatcctcattaaatttcctccattttaagcctgtc 
CAC 0 gtgatataattttcctttaaatggaggaggatctg 
CAC 5 gccgttaatagacattataattccattggc 
CAC-D gaattcttaaaaatatttggatcattaagcgg 
CAC-R gttgtattggaatctttgttattatttctccc 
UPP 1 aaaaggatcctcctgatctattaattcttgatgaaccc 
UPP 2 ggggaggcctaaaaagggggattgcataaataaaaagggctgaaaaataaatttcag 
UPP 3 ccccctttttaggcctccccttatttcattcctccattgtattttttttctatttg 
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UPP 4 aaaaggatccgctattatgaataggttaaataagtcagctgg 
UPP 0 aatacaagcaaagagaataggctatgtgcc 
UPP 5 aatacaagcaaagagaataggctatgtgcc 
UPP-D ggcatatgaagtaacaagagaaatgcagc 
UPP-R ataatctatctccagcatctccaagacc 
RM3535 1 aaaaggatccgcagctttctggaaggactacggcg 
RM3535 2 ggggaggcctaaaaagggggcatttacttatggtacggttcacccc 
RM3535 3 ccccctttttaggcctccccgtctttaaaaagtaatttatcaaaggcatcaaggc 
RM3535 4 aaaaggatccctaactctctaaacgttacaatagtaatgcgc 
RM3535 0 cacattgtcatttataaaagtccctaggg 
RM3535 5 gtagtaattccaacttcaactcttgccac 
RM3535-D cttagaatagctgatattgcttgcgg 
RM3535-R agcatctctcttaatgattctccgg 
CTF1 aaaaggatcccagacactataatagctttaggtggtacccc 
CTF2 ggggaggcctaaaaagggggattataaaaagtagttgaaatatgaaggtttaaggttg 
CTF3 ccccctttttaggcctccccatatccaatgaacttagacccatggctg 
CTF4 aaaaggatccgtgttataatgtaaatataaataaataggactagaggcg 
CTF0 taccaccttctttcacgcttggctgcgg 
CTF5 tatttaaagaggcattatcaccagagcg 
LDH1 aaaaggatccgctttaaaatttggaaagaggaagttgtg 
LDH2 ggggaggcctaaaaagggggttagaaatctttaaaaatttctctatagagcccatc 
LDH3 ccccctttttaggcctccccggtaaaagacctaaactccaagggtggaggctaggtc 
LDH4 aaaaggatcccccattgtggagaatattccaaagaagaaaataattgc 
LDH0 cagaaggcaagaatgtattaagcggaaatgc 
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LDH5 cttcccattatagctcttattcacattaagc 
Cac3535-d-SpeI aaaactagtatgaatgatattaaaatagctttgaaaaaattggttgac 
Cac3535-R-BamHI aaaaggatccctacaaattatatatatctgttaccaatgcctc 
Table 3-4 Oligonucleotides used for PCR amplifications.  
3.6.2 Culture and growth conditions 
C. acetobutylicum was maintained as spores in synthetic medium (SM) as previously 
described [22,155]. Spores were activated by heat treatment at 80 °C for 15 min. All C. 
acetobutylicum strains were grown in anaerobic conditions at 37 °C in SM, in Clostridium 
growth medium (CGM) [34] in 2YTG [152] or in reinforced clostridial medium (RCM) 
(Fluka). Solid media were obtained by adding 1.5 % agar to the liquid media. Media were 
supplemented, when required, with the appropriate antibiotic in the following concentrations: 
for C. acetobutylicum, erythromycin at 40 µg/ml and thiamphenicol at 50 µg/ml; for E. coli, 
erythromycin at 200 µg/ml and chloramphenicol at 30 µg/ml. Transformations of C. 
acetobutylicum were conducted by electroporation, as previously described [142]. 5-FU was 
purchased from Sigma, and stock solutions were prepared in DMSO (dimethyl sulfoxide). 
3.6.3 DNA manipulation techniques 
Total genomic DNA from C. acetobutylicum was isolated as previously described [152]. 
Plasmid DNA was extracted from E. coli with the QIAprep kit (Qiagen, France). Pfu DNA 
Polymerase (Roche) was used to generate PCR products for cloning, and Taq Polymerase 
(New England BioLabs) was used for screening colonies by PCR with standard PCR 
protocols employed for all reactions. DNA restriction and cloning were performed according 
to standard procedures [156]. Restriction enzymes and Quick T4 DNA ligase were obtained 
from New England BioLabs (Beverly, MA) and were used according to the manufacturer’s 
instructions. DNA fragments were purified from agarose gels with the QIAquick gel 
purification kit (Qiagen, France). 
3.6.4 Construction of pUC18-FRT-MLS2 
Inverse PCR was performed using the pKD4 plasmid [148] as a template and 
oligonucleotides PKD4.1 and PKD4.2 as primers to amplify the plasmid region with the FRT 
sites but without the kanamycin resistance marker. This blunt end fragment was later ligated 
to the MLS
r
 gene obtained after a HindIII digestion of the pETSPO plasmid [92] and Klenow 
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treatment. The corresponding plasmid (pKD4-Ery1) was then used as a template to amplify 
by PCR the macrolide lincosamide streptogramin B resistance (MLS
r
) gene, functional in 
Clostridia and flanked by two FRT sites and two StuI sites, using the oligonucleotides FRT-
MLSR-F and FRT-MLSR-R as primers. This fragment was directly cloned into the SmaI 
digested pUC18 to generate the pUC18-FRT-MLS2 plasmid. 
3.6.5 Construction of pCons2.1 
Inverse PCR was performed using the pETSPO plasmid [92] as a template and 
oligonucleotides PCONSAccI (mutating a BamHI site) and PCONSEcoRI as primers. The 
PCR product, containing a pIMP13 B. subtilis origin of replication functional in Clostridia 
(rolling circle mechanism of replication) and a catP gene conferring resistance to 
thiamphenicol was phosphorylated and ligated to yield the pCons0 plasmid. This plasmid was 
then digested with BamHI to remove the spoA cassette, and the DNA fragment was purified 
and ligated to generate the pCons2-1 plasmid. 
3.6.6 Construction of pCIP2-1 
The pIMP13 origin of replication from pCons2-1 was replaced by the origin of 
replication of the pSOL1 megaplasmid. The origin of replication of pSOL1 was amplified by 
PCR using C. acetobutylicum total DNA as a template and oligonucleotides ORI3-D and 
ORI3-R as primers. This PCR product was cloned into the pCR-BluntII-TOPO vector, and the 
resulting plasmid was digested by EcoRI to obtain the 2.2 kb EcoRI fragment containing the 
origin of replication of pSOL1. The pCons2-1 plasmid was digested by EcoRI, and the 2.4 kb 
fragment was ligated to the 2.2 kb EcoRI fragment to generate the plasmid pCIP2-1. 
3.6.7 Construction of pREPcac15 
Two DNA fragments surrounding cac1502 were amplified by PCR using C. 
acetobutylicum total DNA as the template and two pairs of oligonucleotides as primers. Using 
the primers pairs CAC 1 and CAC 2 or CAC 3 and CAC 4, 1493 and 999-bp DNA fragments 
were obtained, respectively. Both primers CAC 1 and CAC 4 introduce a BamHI site, whereas 
primers CAC 2 and CAC 3 have complementary 5′ extended sequences that introduce a StuI 
site. DNA fragments CAC 1–CAC 2 and CAC 3–CAC 4 were joined in a PCR fusion with 
primers CAC 1 and CAC 4, and the resulting fragment was cloned into the pCR4-TOPO-
Blunt vector to generate pTOPO::cac15. At the unique StuI site of pTOPO::cac15, the 1372-
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bp StuI fragment of pUC18-FRT-MLS2 carrying the antibiotic resistance MLS
r
 gene with 
FRT sequences on both sides was introduced. The cac1502 replacement cassette obtained 
after BamHI digestion of the resulting plasmid was cloned into the BamHI site of the pCons2-
1 to generate the plasmid pREPcac15. 
3.6.8 Construction of pCIPcac15 
The cac1502 replacement cassette above was cloned into the BamHI site of the pCIP2-1 
to generate the plasmid pCIPcac15. 
3.6.9 Construction of pREPupp 
Two DNA fragments upstream and downstream of cac2879 were amplified by PCR 
using total DNA from C. acetobutylicum as the template and two pairs of oligonucleotides as 
primers. With the primer pairs UPP 1–UPP 2 and UPP 3–UPP 4, 1103- and 1105-bp DNA 
fragments were obtained, respectively. Both primers UPP 1 and UPP 4 introduce a BamHI 
site, whereas primers UPP 2 and UPP 3 have 5′ extended sequences that introduce a StuI site. 
DNA fragments UPP 1–UPP 2 and UPP 3–UPP 4 were joined in a PCR fusion with primers 
UPP 1 and UPP 4, and the resulting fragment was cloned into pCR4-TOPO-Blunt vector to 
generate pTOPO::upp. At the unique StuI site of pTOPO::upp, the 1372-bp StuI fragment of 
pUC18-FRT-MLS2 carrying the antibiotic resistance MLS
r
 gene with FRT sequences on both 
sides was introduced. The upp replacement cassette obtained after BamHI digestion of the 
resulting plasmid was cloned into the BamHI site of the pCons2-1 to generate the plasmid 
pREPupp. 
3.6.10 Construction of pCLF1 
The FLP1 gene was amplified by PCR using the pCP20 plasmid [153] as a template and 
oligonucleotides FLP1-D and FLP1-R as primers. These primers introduced BamHI and SfoI 
restriction sites on the ends of the PCR product. After a BamHI–SfoI double digestion, the 
PCR product was cloned into the BamHI–SfoI sites of the pSOS95 expression vector to 
generate the pEX-FLP1 plasmid. The 1585-bp SalI fragment of pEX-FLP1 containing the 
FLP1 expression cassette was cloned into the SalI site of pCons2-1 to generate the pCLF1 
plasmid. 
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3.6.11 Construction of pCons::upp 
The upp gene with its own ribosome binding site (RBS) was amplified by PCR from C. 
acetobutylicum total DNA with the oligonucleotides REP-UPP-F and REP-UPP-R as primers. 
The 664-bp PCR product was digested by PvuII and was cloned into pCons2.1, digested by 
BcgI and treated with T4 DNA polymerase to generate the pCons::upp plasmid. In this way, 
the upp gene was located just downstream of the catP gene to construct an artificial operon 
with upp expressed under the control of the catP promoter. 
3.6.12 Construction of pREPcac35::upp 
Two DNA fragments upstream and downstream of CA_C3535 were amplified by PCR 
using the total DNA from C. acetobutylicum as a template and two pairs of oligonucleotides 
as primers. With the primer pairs RM3535 1 and RM3535 2 or RM3535 3 and RM3535 4, 
1044- and 938-bp DNA fragments were obtained, respectively. Both primers RM3535 1 and 
RM3535 4 introduce a BamHI site, whereas primers RM3535 2 and RM3535 3 have 5′ 
extended sequences that introduce a StuI site. DNA fragments RM3535 1-RM3535 2 and 
RM3535 3-RM3535 4 were joined in a PCR fusion with primers RM3535 1 and RM3535 4, 
and the resulting fragment was cloned into the pCR4-TOPO-Blunt vector to generate 
pTOPO::cac3535. At the unique StuI site of pTOPO::cac3535, the 1372-bp StuI fragment of 
pUC18-FRT-MLS2 carrying the antibiotic resistance MLS
r
 gene with FRT sequences on both 
sides was introduced. The CA_C3535 replacement cassette obtained after BamHI digestion of 
the resulting plasmid was cloned into the BamHI site of the pCons::upp to generate the 
plasmid pREPcac3535::upp. 
3.6.13 Construction of pREPctfAB::upp 
Two DNA fragments upstream and downstream of ctfAB (CA_P0162-CA_P0163) were 
amplified by PCR using the total DNA from C. acetobutylicum as a template and two pairs of 
oligonucleotides as primers. With the primer pairs CTF 1 and CTF 2 or CTF 3 and CTF 4, 
1144- and 1138-bp DNA fragments were obtained, respectively. Both primers CTF 1 and 
CTF 4 introduce a BamHI site, whereas primers CTF 2 and CTF 3 have 5′ extended sequences 
that introduce a StuI site. DNA fragments CTF 1-CTF 2 and CTF 3-CTF 4 were joined in a 
PCR fusion with primers CTF 1 and CTF 4, and the resulting fragment was cloned into the 
pCR4-TOPO-Blunt vector to generate pTOPO::ctfAB. At the unique StuI site of 
pTOPO::ctfAB, the 1372-bp StuI fragment of pUC18-FRT-MLS2 carrying the antibiotic 
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resistance MLS
r
 gene with FRT sequences on both sides was introduced. The ldhA 
replacement cassette obtained after BamHI digestion of the resulting plasmid was cloned into 
the BamHI site of the pCons::upp to generate the plasmid pREPctfAB::upp. 
3.6.14 Construction of pREPldhA::upp 
Two DNA fragments upstream and downstream of ldhA (CA_C0267) were amplified by 
PCR using the total DNA from C. acetobutylicum as a template and two pairs of 
oligonucleotides as primers. With the primer pairs LDH 1 and LDH 2 or LDH 3 and LDH 4, 
1135- and 1161-bp DNA fragments were obtained, respectively. Both primers LDH 1 and 
LDH 4 introduce a BamHI site, whereas primers LDH 2 and LDH 3 have 5′ extended 
sequences that introduce a StuI site. DNA fragments LDH 1-LDH 2 and LDH 3-LDH 4 were 
joined in a PCR fusion with primers LDH 1 and LDH 4, and the resulting fragment was 
cloned into the pCR4-TOPO-Blunt vector to generate pTOPO::ldhA. At the unique StuI site 
of pTOPO::ldhA, the 1372-bp StuI fragment of pUC18-FRT-MLS2 carrying the antibiotic 
resistance MLS
r
 gene with FRT sequences on both sides was introduced. The ldhA 
replacement cassette obtained after BamHI digestion of the resulting plasmid was cloned into 
the BamHI site of the pCons::upp to generate the plasmid pREPldhA::upp. 
3.6.15 Construction of pCLF::upp 
The 1585-bp SalI fragment of pEX-FLP1 containing the FLP1 expression cassette was 
cloned into the SalI site of pCons::upp to generate the pCLF::upp plasmid. 
3.6.15.1 Cac3535 expression and purification 
For the general cloning methods of restriction endonuclease genes in E. coli, the first step 
to clone and express the recombinant CA_C3535 gene into E. coli was to pre-protect the host 
genomic DNA against the restriction activity of the Cac3535 bi-functional enzyme. The 
CA_C3534 methylase-encoding gene was thus amplified by PCR with Phusion DNA 
polymerase using C. acetobutylicum ATCC824 total genomic DNA as the template and 
Cac3534-d-AgeI and Cac3534-R-PvuI as primers. After digestion with AgeI and PvuI, the 
resulting 1748-bp fragment was then cloned into pAH105 [157] a pSC101 derivative, that has 
been previously digested with AgeI and PacI, resulting in the pSC-CAC3534 plasmid. In this 
construct, the CA_C3534 gene expression was placed under the control of the pGI 1.6 
promoter [158]. 
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The E. coli BL21-AI strain (Invitrogen) was then transformed by the pSC-CAC3534 
plasmid to give the BL21-AI-3534 strain. This strain, with host genomic DNA protected 
against the restriction activity of the Cac3535 bi-functional enzyme, was finally used as the 
host strain for the CA_C3535 gene over-expression using the T7-based expression system (see 
below). The Cac3535 protein was expressed in E. coli BL21 AI-3534 and was purified using 
the Profinity eXact Protein Purification System, following the recommendations of the 
manufacturer (Biorad). The CA_C3535 gene was amplified by PCR with Phusion DNA 
polymerase using C. acetobutylicum ATCC824 total gDNA as the template and Cac3535-d-
SpeI and Cac3535-R-BamHI as primers. The resulting 3002 bp fragment was cloned into the 
Zero Blunt TOPO vector (Invitrogen) to generate the TOPO-CAC3535 plasmid. After 
verification by DNA sequencing, the 2988-bp SpeI-BamHI fragment from the latter plasmid 
was then introduced into the pPAL7 vector previously digested with the same enzymes to 
give the final pPAl-3535-I_2.4 plasmid. 
After transformation, E. coli BL21-AI-3534 cells harboring the pPAl-3535-I_2.4 plasmid 
were grown in TB medium in the presence of 50 µg/ml carbenicillin and 100 µg/ml 
Spectinomycin at 37 °C to an OD550 ~ 0.45 and were then induced with 500 µM IPTG for 
4 h at 37 °C. After centrifugation, the cell lysate was obtained by sonicating the resuspended 
pellet in bind/wash buffer (0.1 M sodium phosphate buffer, pH 7.2). 
The tag-free Cac3535 protein was prepared using the Profinity eXact protein purification 
system, according to the standard protocol. After the Profinity Exact mini-spin column was 
bound by the protein and washed, the proteolytic activity of the affinity matrix was activated 
by applying two column volumes of room temperature 0.1 M sodium phosphate buffer, pH 
7.2, containing 0.1 M sodium fluoride. The column was incubated for 30 min to allow for the 
cleavage of the tag from the protein; then, the tag-free protein was released from the mini-spin 
column by centrifugation. The tag-free Cac3535 purified protein retains a Thr-Ser linker at its 
N-Terminus, ensuring optimal binding and cleavage during the purification steps (“Imprecise 
Fusion protein”). 
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4 Chapter 4 The Weizmann process revisited for the 
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4.1 Abstract 
The industrial production, by Clostridium acetobutylicum, of n-butanol for use as both a 
chemical and an alternative transportation fuel, is not currently economical due to low yield, 
titer and productivity. We used an advanced metabolic engineering approach to engineer C. 
acetobutylicum to produce n-butanol from glucose at a high yield: the deletion of genes 
encoding unwanted pathways was combined to the debottlenecking of the n-butanol pathway 
for maximizing both the yield of alcohol production and the n-butanol to ethanol ratio. We 
also designed a new continuous fermentation process using i) in situ extraction of alcohols by 
distillation under low pressure and ii) high cell density cultures to increase the titer, yield and 
productivity of n-butanol production to levels that have never been previously achieved in any 
organism. This process provides a means to produce n-butanol at performance levels that are 
now compatible with a commercial process. 
One Sentence Summary: Advanced metabolic engineering and process design were 
combined to develop an economical bioprocess to produce n-butanol at high yield, titer and 
productivity.   
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Figure 4-1 Optimization of n-butanol production in Clostridium acetobutylicum 
 (A) Elimination of by-products formation (strain CAB1057) by gene deletion. ldhA, 
lactate dehydrogenase; ctfAB, acetoacetyl-CoA transferase; adc, acetoacetate decarboxylase; 
ptb, phosphotransbutyrylase; buk, butyrylate kinase; adhE2, bifunctional aldehyde and 
alcohol dehydrogenase. (B) Optimization of acetyl-CoA conversion to n-butanol (Strain 
CAB1060) using a chimeric pathway derived from three different microorganisms.  Green 
boxes are Rex binding sites. atoB, acetoacetyl-CoA thiolase/synthase from E. coli; hbd1, 
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NADP
+
-dependent 3-hydroxybutyryl-CoA dehydrogenase from C. kluyveri; ldhA, L-lactate 
dehydrogenase; crt, crotonase; bcd-etfAB, butyryl-CoA dehydrogenase. 
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Figure 4-2  Schematic representation of the extractive continuous fermentation process 
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4.2 Main text 
The Weizmann process for acetone and butanol production by Clostridium 
acetobutylicum was the second largest fermentation process (after ethanol) of enormous 
industrial, social and historical importance [2,159,160]. Beyond its use during the First World 
War to produce acetone for smokeless gunpowder (cordite) manufacturing, it became a 
process used worldwide to produce these two industrial solvents from a variety of renewable 
substrates [2,8,15,22]. Its demise in the early 1960s was the result of the superior 
petrochemical-process economics due to the low yield, titer and productivity of the 
fermentation [161] and the inability to use continuous process technologies (as in the case of 
petrochemical processes) due to the loss of C. acetobutylicum’s capacity to produce solvents, 
known as « degeneration » [69,162]. Today, there is a resurgence of interest in C. 
acetobutylicum for the production of i) fuels after chemical transformation of the solvents 
mixture [163,164] or ii) n-butanol as the main product for use both as a chemical and an 
alternative petrol fuel [165,166]. However, to make this biological production economical, all 
of the limitations of the Weizmann process would have to be resolved as follows: the strain 
should primarily produce n-butanol at a yield close to the theoretical yield (because the wild-
type strain can produce n-butanol and acetone but also ethanol, acetate, butyrate or lactate), 
concentrated sugar solutions should be fermented to limit waste water treatment costs and the 
process should be continuous with productivity at least equal to that of the best corn wet 
milling ethanol plants using yeast as a biocatalyst.  
Here, we used an advanced metabolic engineering approach to construct a stable strain 
for the continuous production of n-butanol at high practical yield. In the CAB1057 strain, we 
have deleted all of the genes coding for unwanted metabolic pathways (Figure 4-1A), namely 
ptb and buk that code for the phospho-transbutyrylase and the butyrate kinase involved in the 
last two steps of butyrate formation [49–51], ctfAB that code for the acetoacetyl-CoA 
transferase involved in the first specific step of acetone formation [167] and ldhA that codes 
for the lactate dehydrogenase involved in the last step of L-lactate formation [167]. When 
CAB1057 was evaluated in chemostat culture, the expected phenotype was obtained for the 
deleted pathways but the butanol yield was not improved (Figure 4-3) as this mutant produces 
more acetate and ethanol than the wild-type strain. The redox-sensing transcriptional 
repressor (Rex) has been found to modulate its DNA-binding activity in response to the 
NADH/NAD
+
 ratio and to repress the expression of several operons including thlA, crt-bcd-
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etfAB-hbd, and adhE2 [110,134]. As thlA and crt-bcd-etfAB-hbd code for the enzymes 
converting acetyl-CoA to butyryl-CoA and adhE2 codes for the enzyme that reduces butyryl-
CoA and acetyl-CoA to butanol and ethanol, respectively, the rexA gene, encoding Rex, was 
deleted in CAB1057 (to yield CAB1058) with the objective of improving the C4/C2 ratio and 
the flux of alcohol formation. The yield of alcohol formation by CAB1058 was significantly 
improved, associated with a four-fold decrease of the hydrogen yield as the electrons from 
reduced ferredoxin were mainly used for NAD(P)H formation (Figure 4-4).  However, the 
higher alcohol yield was due only to an increase in the ethanol yield as the butanol yield 
remained almost unchanged and, consequently, the C4/C2 ratio was not improved. When the 
thiolase (catalyzed by ThlA) and 3-hydroxy-butyryl-CoA dehydrogenase (catalyzed by Hbd) 
activities were measured in CAB1057 and CAB1058, ThlA remained unchanged while Hbd 
was 1.5 fold higher, indicating that the rexA deletion has the expected effect on the expression 
of the crt-bcd-etfAB-hbd operon coding for the enzymes that convert acetoacetyl-CoA to 
butyryl-CoA (Figure 4-5) but not on thlA. ThlA is one of the most abundant intracellular 
protein [42] representing almost 5% of the cytosolic protein. Furthermore, the condensation 
reaction by ThlA was shown to be very sensitive to CoA-SH, with micro molar levels totally 
inhibiting the enzyme [34] and it was also found to be regulated by a redox-switch through a 
reversible disulfide bond that is formed between two catalytic cysteine residues, Cys88 and 
Cys378 [36]. As it might be difficult to further overexpressed ThlA and as its biochemical 
properties might also contributes to the low C4/C2 ratio in CAB1058 (Figure 4-3), ThlA was 
replaced by AtoB (Figure 4-1B), a thiolase from E. coli that has a higher catalytic efficiency, 
is less sensitive to CoA-SH [34,168,169] and not subject to a redox-switch. For this purpose, 
a synthetic atoB gene was designed, codon harmonized [170,171] for C. acetobutylicum, and 
used to replace in frame thlA  in CAB1058 (to yield CAB1059). In CAB1059, the butanol to 
ethanol ratio (mol/mol) only increased from 0.59 to 0.84 (Figure 4-3), while the thiolase 
activity increased 1.7 fold (Figure 4-5) suggesting that the C4/C2 ratio is not controlled by the 
thiolase level or by the levels of the other enzymes of the pathway and might be 
thermodynamically controlled. The condensation of two acetyl-CoA to acetoacetyl-CoA 
catalyzed by the thiolase is thermodynamically unfavorable [35]. Therefore, it is important 
that acetoacetyl-CoA is efficiently reduced by Hbd to pull the reaction [35]. Hbd is an 
NADH-dependent enzyme [37] and, as it likely works near the thermodynamic equilibrium, 
the acetoacetyl-CoA/3-hydroxybutyryl-CoA ratio will be dependent on the NADH/NAD
+
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ratio. As it has been demonstrated in solventogenic C. acetobutylicum cells that the 
NADPH/NADP
+
 ratio is at least 70 times higher than the NADH/NAD
+
 ratio [172], it would 
be advantageous to replace Hbd with a strictly NADPH enzyme to decrease the acetoacetyl-
CoA/3-hydroxybutyryl-CoA ratio and potentially improve the butanol/ethanol ratio. Such an 
enzyme has been identified and characterized in Clostridium kluyveri [40]. In strain 
CAB1060, we have replaced hbd by hbd1 from C. kluyveri (Figure 4-1B). A drastic 
improvement in the butanol/ethanol ratio was observed with an almost 6-fold increase (Figure 
4-3). Enzyme assays on crude extract confirm that in the genetic modification of CAB1060, 
the NADH-dependent 3-hydroxybutyryl-CoA dehydrogenase activity was very low while the 
NADPH-dependent activity was high; the reverse was observed for CAB1059 (Figure 4-5).  
CAB1060 produces n-butanol at high yield (34 wt%) that, to the best of our knowledge, has 
never been achieved with any microorganism. Furthermore, when the stability of CAB1060 
was evaluated in chemostat culture, we could maintain stable n-butanol (between 9 and 10 g/l) 
and biomass concentrations (Figure 4-6) and only slight changes in the ethanol/acetate ratio 
were observed (data not shown). 
Having a stable strain that produces n-butanol at a high yield in a continuous culture is a 
prerequisite, but it is clearly not sufficient for a commercial process as both the titer and the 
productivities are too low. To improve those two parameters, we envisioned a simple 
continuous high cell density bioreactor with in situ extraction of the alcohols (n-butanol + 
ethanol) by distillation under low pressure (0.18-0.46x10
4 
Pa, for a boiler temperature 
regulated between 35 and 37°C) without using any microfiltration membrane (Figure 4-2). 
After an initial batch phase without distillation, this setup was run in a continuous mode by i) 
starting vacuum distillation and ii) feeding the reactor with a medium at a high concentration 
of glucose (~500 g/l) while maintaining full cell retention until reaching an OD 600 nm of 90-
100 (Figure 4-7), which corresponds to ~28-30 g/l cell dry weight. As shown in Figure 4-7, 
the targeted cell density was reached in approximately 60 hours after vacuum distillation and 
feeding began, at which point a cell bleeding was implemented at a dilution rate of 0.05 h
-1
 to 
maintain a constant cell density. The concentration of butanol in the fermentor was between 9 
and 10.5 g/l while the average concentration of n-butanol was 550 g/l with concurrent average 
ethanol and acetate titers of 60 and 33 g/l. Starting at hour 60 and for 180 hours afterwards 
(i.e., up to 240 hours of continuous fermentation time), the volumetric productivities of 
butanol and ethanol remained essentially constant, along with the glucose volumetric 
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consumption. The average volumetric productivities of butanol and ethanol were 14 and 1.5 
g/l/hr, respectively, and the average glucose volumetric consumption rate was 39.4 g/l/hr. 
This resulted in an average butanol yield of 35 wt% (~83% of the theoretical maximum) and 
butanol + ethanol yield of 39% [173]. Such high values of n-butanol productivities, titer and 
yield have never been obtained and compare very well with the performances of the best corn 
wet milling continuous industrial ethanol processes that display ethanol titers of 
approximately 100 g/l, yield of 46 wt% and productivity of 10 g/l/hr [174]. If scaled-up at the 
industrial scale, the technology presented here should drastically decrease both the operational 
and capital expenditure costs of the historical Weizmann process and make the production of 
n-butanol economical. 
 
Figure 4-3 Product ratios in engineered C. acetobutylicum strains and wild-type 
All strains were evaluated in phosphate limited chemostat cultures at pH 4.4 for wild type 
and 5.0 for all the other strains . Product ratios (mol/mol). (C4+C3)/C2  = (Butanol+Butyric 
acid+Acetone)/ (Ethanol+Acetic acid). Butanol selectivity = Butanol/(of all products except 
butanol).  
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Figure 4-4 Butanol, hydrogen and electron yields in the engineered C. acetobutylicum 
and the wild-type 
 All strains were evaluated in phosphate limited chemostat cultures at pH 4.4 for wild 
type and 5.0 for all the other strains. 
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Figure 4-5 Enzymatic assays on crude extracts of C. acetobutylicum mutants 
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Figure 4-6 Chemostat culture of C. acetobutylicum CAB1060 
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Figure 4-7 Continuous high cell density bioreactor with in situ extraction of the alcohols (n-butanol + ethanol) by distillation under low 
pressure 
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4.4 Supplementary Materials and Methods 
4.4.1 Bacterial strains, plasmids and primers 
The bacterial strain and plasmids used in this study are listed in (Table 4-1 and 4-2). The 
specific oligonucleotides used for PCR amplification were synthesized by Eurogentec (Table 
4-3). 
Table 4-1 List of strains 
Strain Relevant characteristics Source 
Clostridium acetobutylicum 
ATCC824 
Wildtype ATCC 
Clostridium kluyveri DSM555  DSMZ 
MGCΔcac1502Δupp ΔCAC 1502Δ CAC 2879 [42,167] 
  MGCΔcac1502ΔuppΔcac3535
ΔctfAB  
ΔCAC 1502ΔCAC 2879ΔCAC 
3535ΔCA_P0162-3  
[167] 
CAB1057 ΔCAC1502ΔuppΔctfABΔptbΔbuk
Δldh 
This study 
CAB1058 ΔCAC1502ΔuppΔctfABΔptbΔbuk
ΔldhΔrexA 
This study 
CAB1059 ΔCAC1502ΔuppΔctfABΔptbΔbuk
ΔldhΔrexAΔthlA::atoB 
This study 
CAB1060 ΔCAC1502ΔuppΔctfABΔptbΔbuk
ΔldhΔrexA ΔthlA::atoB 
Δhbd::hbd1 
This study 
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Table 4-2 List of plasmids  
Plasmid Characteristics Source 
pSOS95-MLSr Ap
r
 MLS
r
, repL gene, ColE1 [175] 
pCLF1 Cm
r
 FLP  [167] 
pSOS95 Ap
r
 MLS
r
, repL, ColE1, acetone operon [154] 
pSOS95-atoBs Ap
r
 MLS
r
, repL, ColE1, atoB operon [171] 
pREPctfAB::upp Cm
r
 MLS
r
 upp ΔctfAB  [167] 
pREPldhA::upp Cm
r
 MLS
r
 upp ΔldhA  [167] 
pEryupp-atoB MLS
r
 upp ΔthlA atoB This study, 
[171] 
pEryUppAthlA MLS
r
 upp ΔthlA [171] 
pSOS95atoBs MLS
r
 upp atoB [171] 
pSOS95-upp-hbd1-catP-
oriRepA 
Ap
r
 MLS
r
, Δhbd ::hbd1, upp, Cm
r
, repL 
gene, repA gene 
This study 
pSOS95-MLSr-upp-Drex-
catP 
Ap
r
 MLS
r
, Δrex, upp, Cm
r
, repL, colE1 This study 
[171] 
pSOS2K2   
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Table 4-3 List of primers 
Primers Sequence 
Primer1b TTTTGGATCCGCTGTTTTACTTGGACATAATACTGAAAAA
ATGTC 
Primer2 TAAACAGACCTCCCTAATTAATTATTAGCAGCTTTAACTT
GAGCTATTAATTCTGG 
Primer3 TTAGGGAGGTCTGTTTAATGAGTATTAAAAGTGTAGCGGT
TTTAGGTA 
Primer4 TTTTGCCGGCTTTTAGGCCTTTAATAAGCGAAGAATCCTTT
TCCTGATTTTC 
Primer5 TTTTTGGCCATTTTAGGCCTTCAAAATAAGTTTACAAGAAT
CCCCATTATCA 
Primer6 TTTTAGATCTTTATAGCTGTATATTATTCTCTCTTGCATAA
TAAA 
Primer1-hbd1-sacII AAAAGCCGCGGTGATCCGCTGTTTTACTTGGACATAATAC
TGAAAAAATGTCAAAGG 
Primer6-hbd6-sacII AAAAACCGCGGTGATCTTTATAGCTGTATATTATTCTCTCT
TGCATAATAAAACAAATATTGCTGAGC 
oriRepA-XbaI-F AAAAATCTAGAGAGCTTGGCACCCAGCCTG 
oriRepA-5'-R GCATTGGTAACTGTCAGACCAATTCCCGACAGTAAG 
Amp3'-F GGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACC 
Amp-ScaI-R TTTTTTAGTACTCACCAGTCACAGAAAAGCATC 
etfB-3-F GACAGGGAGAAGTTATTGATAAGC 
cac2706-3-Rb GGCTTCTTAACACATAAAAGTACC 
catP-3D GGAAGGAAAGCCAAATGCTCCGG 
catP-5R GTACAAGGTACACTTGCAAAGTAGTGG 
Atob-1 ACTTATGAAATAGATTGAAATGGTTTATCTGTTACCCCGT
AGGATCCTCGAAGGTCGACCA 
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Atob-2 CTAATTTATAATTCTACAGAGTTATTTTTAACAATACTTTT
TAGTTTAGTCGTTCTATTACCA 
Rex 1 
AAGGAAAAAAGCGGCCGCAAGCTTACAAAGTGCTACA 
CGGGTTTTTTGCCC 
Rex 2 CATTACCGTACTAATCTCGGCTTTTTCGCGATTTGAC 
Rex 3 
CAAAAGTGATATTAAGTAAGAGGTGGTCAAATCGCGA 
AAAAGCCGAGATTAGTACGGTAATG 
Rex 4 
AAGGAAAAAAGCGGCCGCAAATCTTTCTGTTTCATCA 
ATTTCTGC  
Rex 0 GCATCTAGGAAATATCTATCATGAG 
Rex 5 GAAAGAATAACTCCTGTAGTACCGC 
 
4.4.2 Chemostat culture of recombinant strains  
The conditions described previously by Girbal et al. [30] were used for the phosphate-
limited continuous culture of C. acetobutylicum fed at 30 g/l glucose at a pH of 5.2.  
4.4.3 Continuous extractive high density cell recycle fermentation  
A 10% inoculum of mid-exponential phase (OD600nm of 0.8-1.5) CAB1060 culture was 
used to inoculate a 1 L glass bioreactor with a 0.5 L working volume of anaerobic synthetic 
medium [176] with 60 g/l glucose. Once the cultures reached an OD600nm of 3, extractive 
fermentation using low pressure distillation was initiated. Fermentation pH was controlled 
from dropping below 5.0 using 4M NH4OH. Low pressure distillation was accomplished by 
sending the whole broth to a 3 L Pyrex boiler (0.3 L working volume) equipped [177] to 
maintained at a constant temperature (35-37 °C) and a constant low pressure (0.18-0.46x10
4 
Pa) above the boiler. The residence time of the broth in the boiler was between 0.25 and 0.5 
hour. The distillate was condensate and demixed in a butanol rich and a water reach phase; the 
water rich phase was recycled to the distillation column while the butanol rich was collected. 
The fermenter was fed exponentially with a feed medium (see the composition below) 
containing high glucose concentration (530 g/l) and kept in complete cell retention until 
reaching an OD600nm of 90 – 100 (28-30 g/l cell dry weight), at which time a harvest was 
started at a dilution rate of 0.05h
-1
 and the volume of the fermenter was kept constant by the 
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addition of feed medium. The feed medium has the following composition (per liter of 
distilled water): glucose, 530g; KH2PO4, 1.8g; KCl, 5.7g; MgSO4.7H2O, 3.6g; FeSO4.7H2O, 
0.5g; NH4Cl, 18 g; Biotin, 0.18 mg; PAB, 0.14g; Yeast Extract, 4g.  
4.4.4 Measurement of fermentation parameters  
Biomass concentration was determined both by by the DCW method after centrifugation 
(16,000 g, 5 min, room temperature), two washes with Milli-Q water, and drying under 
vacuum at 80 °C. The concentrations of glucose, glycerol, acetate, butyrate, lactate, pyruvate, 
acetoin, acetone, ethanol, and butanol were determined based on high-performance liquid 
chromatography (HPLC), as described by Dusséaux et al. [178], except that the concentration 
of H2SO4 was changed to 0.5 mM, as required for mobile phase optimization. 
4.4.5 General protocol for gene deletion by homologous recombination system 
using replicative plasmid pSOS95-MLS
r
  
Gene disruption in specified chromosomal loci was carried out by homologous 
recombination as previously described [167] with the modifications of patent application 
WO2008/040387 [151]. Deletion cassettes consisting of the upstream homologous region-
FRT-catP-FRT-downstream homologous region were cloned in the pSOS95-MLSr-upp 
plasmid. The pSOS95-MLSr-upp plasmids with the different deletion cassettes were used to 
transform the successive recipient C. acetobutylicum strains which were constructed from the 
MGCΔcac1502Δupp platform strain [167]. As a general procedure, thiamphenicol-resistant 
transformants were selected on CGM 50g/L Glucose 0.1M MES pH 6.1 (CGMMG) plates 
containing thiamphenicol (10 μg/mL) (Tm). One colony was cultured for 24 hours in liquid 
CGMMG with thiamphenicol (10 μg/mL) and 100 μL of undiluted culture was plated on 
CGMMG with thiamphenicol (10 μg/mL) and 5-FU (1 mM). Colonies resistant to both 
thiamphenicol and 5-FU were replica plated on both CGMMG with thiamphenicol (5 μg/mL) 
and CGMMG with clarithromycin (40 μg/mL) to select clones where 5-FU resistance is also 
associated with clarithromycin sensitivity. The genotype of the clones resistant to 
thiamphenicol and sensitive to clarithromycin was checked by PCR. 
The catP resistance cassette was removed by transforming the strain with plasmid pCLF1 
(16) expressing the flp1 gene encoding the Flp recombinase from S. cerevisiae. One colony of 
a clarithromycin resistant clone was cultured on liquid CGMMG without clarithromycin and 
the culture was plated on CGMMG with 5-FU (1 mM). Colonies resistant to 5-FU were 
 
 
100 
 
replica plated on CGMMG with clarithromycin (40 μg/mL), CGMMG with thiamphenicol 
(10 μg/mL) and CGMMG without antibiotic to select clones. The 5-FU resistance was 
associated with the loss of the pCLF1 vector and the thiamphenicol sensitivity to the 
elimination of the catP marker. The genotype of sensitive clones was checked by PCR.  
CAB1057 was constructed from the MGCΔcac1502Δupp platform strain by successively 
applying this protocol to the deletion of ptb-buk, ctfAB and ldhA 
4.4.6 Construction of pSOS95-MLSr-upp-Drex-catP and CAB1058 strain 
To delete the rex regulator (encoded by CA_C2713), protocol 4.4.5 was used except that 
couples of primers Rex 1-Rex 2 and Rex 3-Rex 4 were used to amplify the 1135 bp upstream 
homologous region and the 1138 bp downstream homologous region of the rex locus 
respectively. Both primers Rex 1 and Rex 4 introduced NotI sites while primers Rex 2 and 
Rex 3 have a complementary region which introduced a NruI site. DNA fragments Rex 1-Rex 
2 and Rex 3-Rex 4 were joined in a PCR fusion experiment with primers Rex 1 and Rex 4 and 
the resulting fragment was cloned in pCR4-TOPO-Blunt (Invitrogen) to yield pTOPO:Rex. At 
the unique NruI site of pTOPO:Rex, the antibiotic resistance catP gene (Cm/Tm) with FRT 
sequences on both sides wass introduced from the 1230 bp StuI fragment of pUC18-FRT-
Pptb-catP. The Rex deletion cassette obtained after NotI digestion of the resulting plasmid 
was cloned into pSOS95-MLSr-upp at the NotI site to yield the pSOS95-MLSr-upp-Δrex-catP 
plasmid. 
The pSOS95-MLSr-upp-Drex-catP plasmid was used to transform by electroporation the 
Clostridium acetobutylicum CAB1057 strain. The genotype of clones resistant to 
thiamphenicol and sensitive to clarithromycin was checked by PCR analysis (with primers 
Rex 0 and Rex 5 located outside of the Rex deletion cassette). The ATCC824 Δrex-catP
R 
strain having lost pSOS95-MLSr-upp-Δrex-catP vector was isolated. 
The thiamphenicol resistance of the above strain was removed according to 4.4.5. The 
genotype of the ATCC824 Δrex strain having lost the pCLF1 plasmid was checked by PCR 
analysis with primers Rex 0 and Rex 5. 
4.4.7 Construction of pEryupp-atoB plasmid and CAB1059 strain 
A synthetic atoB operon coding for the AtoB thiolase of E. coli was synthesized as 
follow. A synthetic atoB gene was designed with both an optimized synthetic RBS 
 
 
101 
 
(translation initiation rate was calculated to be 60217, a value similar to the translation 
initiation rate of thlA) and a harmonized codon usage for C. acetobutylicum. The synthetic 
gene was synthesized by Life technology (atoBs) with a BamHl site in 5' and a Sfol site in 3' 
and was cloned in a BamHl- Sfol digested pSOS95 [154] to yield pSOS95atoBs. 
The synthetic atoB gene was PCR amplified with the Phusion DNA polymerase with 
pSOSatoBs as a template and the Atob-1 and Atob-2 oligonucleotides as primers. This DNA 
fragment was directly cloned into the Stul linearized pEryUppAthlA (for the construction of 
pEryUppAthlA, see Chapter 5 or [171]) by homologous recombination using the GeneArt® 
Seamless Cloning & Assembly kit to yield the pEryUppAtoB plasmid.  
The pEryUppAtoB plasmid was used to transform by electroporation to CAB1058 strain. 
After selection on Petri plates for clones having inserted the pEryUppAtoB plasmid by 
homologous recombination (resistant to erythromycin 20 μg/ml), two colonies were cultured 
for 24 hours in CGM Glucose MES 0.1M medium. Appropriate dilutions were plated on 
CGM Glucose MES 0.1M (CGMMG) with 5-FU 1mΜ. To select integrants having excised 
and lost pEryUppAtoB, 5-FU resistant clones were replica plated on both CGMMG + 5FU 
and CGMMG with erythromycin at 40 μg/ml. To identify clones having lost pEryUppAtoB 
and possessing an atoB insertion, (clones resistant to 5-FU and sensitive to erythromycin) 
were checked by PCR analysis (with primers Thl-0 and Thl-5 located outside of the AthlA 
locus (Chapter 5) and Atob-1 and Atob-2 primers binding specifically to atoB gene). The 
clones had thlA replaced by atoB were isolated to obtain pure clones to obtain CAB1059 
strain.  
4.4.8 Construction of pSOS95-upp-hbd1-catP-oriRepA and CAB1060 strain 
To amplify the two homologous regions flanking the CDS region of the hbd gene on the 
genome of C. acetobutylicum ATCC824, two couples of primers (primer 1-hbd1-sacII/primer 
2 and primer 5/primers 6-hbd1-sacII) were used. Two fragments of 909 bp and 989 bp were 
obtained. Primer 3 and primer 4 were used to amplify the hbd1 gene from genomic DNA of 
C. kluyveri DSM555 to obtain the third fragment of 886 bp. Fragment 1 and 3 was fused by 
overlapping PCR using primer 1-hbd1-sacII and primer4 to obtain the fourth fragment of 
1778 bp. After that, this fourth fragment was fused with the second fragment by primer 1-
hbd1-sacII and primer 6-hbd1-sacII to produce the fifth fragment of 2692 bp.  
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The colE1 origin on pSOS95-MLS
r
 [175] was replaced by repA origin. The repA origin 
was amplified from pSOS2KS by two primers oriRepA-XbaI-F and oriRepA-5’R to obtain a 
PCR product of 2296 bp. The partial ampicillin resistant gene from pSOS95-upp was 
amplified by Amp3’-F and Amp-ScaI-R to obtain a PCR product of 573bp. The two resultant 
PCR fragment was then fused by PCR using oriRepA-XbaI-F and Amp-ScaI-R. This 2849 bp 
fragment was introduced to pSOS95-upp to replace repL fragment by digestion with XbaI and 
ScaI restriction enzymes and ligation to obtain pSOS95-upp-repA. After that, the homologous 
fragment containing hbd1 CDS was introduced to this pSOS95-upp-orirepA by the SacII site 
to obtain pSOS95-hbd1-orirepA plasmid. The catP cassette (flanking by FRT sequences) was 
inserted into the StuI site carried by primer 4 and primer 5 in the homologous region to 
generate the final plasmid pSOS95-hbd1-catP-oriRepA. 
The final plasmid pSOS95-hbd1-catP-oriRepA was used to transform into CAB1059 
strain and followed protocol 4.4.5 for the deletion. The transformants on plates CGMMG 
Thiamphenicol 10g/ml were selected and checked by PCR for the single integration by two 
couples of primers etfB-3-F and catP-3D or cac2706-3Rb and catP-5R. The integrants were 
spread on plates CGMMG containing Thiamphenicol 10 g/ml and 5-FU 1mM to promote 
the second integration. Clones that were Thiamphenicol resistant and Clarithromycin sensitive 
were selected and checked for double cross-over events by PCR using two external primers 
etfB-3-F and cac2706-3Rb. The mutants were isolated to obtain CAB1060-catP strain. After 
that, pCLF1 [167] was introduced into CAB1060-catP strain to remove catP cassette to 
generate the marker-less strain CAB1060. 
4.4.9 Enzyme activity measurements 
Cell crude extract of C. acetobutylicum mutants was prepared in 100 mM Tris-HCl (pH 
7.6), 5 mM dithiothreitol, 2.5% glycerol. The cell suspension was sonicated in an ultrasonic 
disintegrator (Vibracell 71434; Bioblock, Illkirch, France), at 0°C in four cycles of 30 s with 
2-min intervals between each cycle. Cell debris was removed by three centrifugations at 
13,000 × g for 5 min . The supernatant was loaded to PD10 column.  
Thiolase activity was measured in the reverse thiolytic cleavage direction. The reaction 
containing 0.1 M Tris-HCl pH8 ; 0.2 mM CoASH; 60 µM Acetoacetyl-CoA; 10 mM  MgCl2; 
1 mM DTT and diluted crude extracts was incubated at 30
o
C and followed the decrease of 
acetoacetyl-coA at 303nm as described [35,179]. The enzyme activity was calculated by the 
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difference in the slope values of the sample and control and using the molar extinction 
coefficient of 14,000 M
−1
cm
−1
. 
HBD activity was measured as described by [179,180]. The reaction containing 0.1mM 
MOPS (pH 7.0) buffer, 1mM DTT, 0.1mM acetoacetyl-CoA, and 0.15mM NADH, and crude 
extract at different dilution was incubated at 35
o
C. The decreasing of NADH was followed 
spectrophotometrically at 345nm. The enzyme activity was calculated by the difference in the 
slope values of the sample and control and using the molar extinction coefficient of 
6,220 M
−1
cm
−1
.  
HBD1 activity was measured as described by [40]. Reaction components were 0.1M 
potassium phosphate, 25mM potassium citrate, 0.15mM NADPH, 0.6mM Acetoacetyl-coA 
and crude extract. The assay was done at 35
o
C and the decrease of NADPH was followed at 
340nm. The molar extinction coefficient of 6,220 M
−1
cm
−1
 was used to calculate the enzyme 
activity. 
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5 Chapter 5 Construction of a hydrogenase minus 
mutant of Clostridium acetobutylicum : a platform 
strain for the continuous production of fuels and 
chemicals 
 
 
Soucaille Philippe, Nguyen Ngoc-Phuong-Thao, Percheron Benjamin, Croux Christian, 
Meynial-Salles Isabelle 
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5.1 Main text 
In this chapter we want to answer the following question: what bio-chemicals could 
be continuously produced at high yield if we could get a hydrogenase minus mutant of 
Clostridium acetobutylicum? For this purpose, simulations have been performed using a 
Genome Scale Model [42] of Clostridium acetobutylicum recently developed in our group. 
The parameters were a growth rate of 0.05 h
-1
 and a specific carbon consumption rate of 50 
mC.g
-1
.h
-1
 that can be obtained in a phosphate (0.75 mM Phosphate in the fed) and carbon 
(1000 mM Carbon in the fed) limited chemostat culture run at a dilution rate of 0.05 h
-1
in 
synthetic medium [22,181]. All the simulations were done considering that no hydrogen was 
produced. The results of the simulation for five chemicals are presented in the following 
Table 5-1. 
 Lactate Ethanol n-Butanol Isobutanol 1,3-Propanediol 
Titer (g/l) 28.5 14.7 11.8 11.8 18.1 
Productivity (g.l
-1
.h
-1
) 1.42 0.73 0.59 0.59 0.90 
Yield (g/g) 0.95 0.49 0.39 0.39 0.6 
Substrate Glucose Glucose Glucose Glucose Glycerol 
Glycerol produced YES YES YES YES NO 
Table 5-1 Prediction of bio-chemical yield produced by a hydrogenase minus mutant 
 
The conclusions of these simulations are that if a hydrogenase minus strain could be 
obtained i) it would be advantageous in term of yield and stability of the strain in continuous 
culture as the metabolism would be redox constraint and ii) if glucose is used as a carbon 
source, glycerol will have to be produced to regenerate the NAD
+
 from the excess NADH 
associated to biomass formation.  
Three hydrogenases are potentially involved in hydrogen production: two Fe-Fe 
hydrogenases, HydA (encoded by CA_C0028) and HydB (encoded by CA_C3230), and one 
Ni-Fe hydrogenase, HupSL (encoded by CA_P0141–0142). It was previously shown in our 
group [42] that in phosphate limited chemostat culture, the hydB and the hupSL genes are not 
expressed, nor were the HydB and HupSL proteins detected by quantitative proteomic 
analysis. As HydA is the only hydrogenase, we then asked ourselves the question: Is it 
possible to obtain a hydA
-
 mutant of C. acetobutylicum? A previous study from the group of 
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Nigel Minton [91] using the Clostron as a tool to inactivate hydA, reported that they could not 
obtained insertion of an intron in hydA suggesting that it might be an essential gene for C. 
acetobutylicum. To unambiguously establish the essentiality of hydA, we used another intron-
based method developed in our laboratory [182] based on the pCONS::upp-intron vector for 
the 1) insertion of a marker-less group II intron and 2) positive selection for the loss of the 
plasmid in the presence of 5-FU. Use of the pCONS::upp-intron in C. acetobutylicum 
cac1502 upp was not successful for the disruption of hydA with a group II intron with an 
antisense orientation but we were able to disrupt hydA with a group II intron having a sense 
orientation (Figure 5-1). Furthermore, the integrants were unable to lose the plasmid even in 
the presence of 5-FU: all 5-FU-resistant clones possessed either a deletion of or a mutation in 
the upp gene, leading to survival in the presence of 5-FU even in the presence of the plasmid. 
This demonstrates that the ltrA gene located on the plasmid has to be functional to splice the 
intron in the hydA mRNA, thus allowing expression of hydA and growth of the 
microorganism. All the results obtained from hydA disruption experiments clearly 
demonstrate that hydA is essential in C. acetobutylicum.  
What are the hypothesis that might explain why hydA is an essential gene?  
- A hydA
-
 mutant cannot redirect its carbon flux (down regulation of the acetate, 
butyrate, acetone, acetoin pathways) to adjust to the change in the electron flux and produce 
only butanol, ethanol and lactate.  
- The glycerol production pathway is not sufficiently well expressed. 
Regarding the first hypothesis, having a thiolase negative mutant that would no longer 
produced butyrate, acetone and butanol would potentially help in getting a hydA mutant that 
would only produce ethanol and lactate as major products and glycerol as a minor one.
 
 
107 
 
 
 
 
 
Figure 5-1 Construction of hydA::int(s) and thlA ::int(s) mutants.  
(A) PCR on genomic DNA extraction of hydA::int(s) mutants (MT) and wildtype (WT) 
strains with hydaI-F and HydaI-R couple of primers to confirm intron insertion. (B) PCR on 
genomic extraction of thlA ::int(s) mutant (MT) and wildtype (WT) strains with ThlaI-F and 
ThlaI-R couple of primers to confirm intron insertion. 
 Two thiolase encoding genes have been identified: thlA (CA_C2873) and thlB 
(CA_P0078). It was previously shown in our group [42] that in phosphate limited chemostat 
culture, the thlB gene is poorly expressed and consequently the level of ThlB protein detected 
by quantitative proteomic analysis was less than 1% the level of ThlA. As ThlA is then the 
main expressed thiolase, we then asked ourselves the question: Is it possible to obtain a thlA
-
 
mutant of C. acetobutylicum? A previous study from the group of Nigel Minton [91] using the 
Clostron as a tool to inactivate thlA, reported that they could not obtained insertion of an 
intron in thlA suggesting that it might also be an essential gene for C. acetobutylicum. To 
unambiguously establish the essentiality of thlA, we used the same approach as for hydA using 
the pCONS::upp-intron vector. Use of the pCONS::upp-intron in C. acetobutylicum cac15 
upp was not successful for the disruption of thlA with a group II intron with an antisense 
orientation but we were able to disrupt thlA with a group II intron having a sense orientation 
(Figure 5-1). Furthermore, the integrants were unable to lose the plasmid even in the presence 
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of 5-FU: like for hydA, all the 5-FU-resistant clones possessed either a deletion of or a 
mutation in the upp gene, leading to survival in the presence of 5-FU even in the presence of 
the plasmid. This demonstrates that the ltrA gene located on the plasmid has to be functional 
to splice the intron in the thlA mRNA, thus allowing expression of thlA and growth of the 
microorganism. All the results obtained from thlA disruption experiments clearly demonstrate 
that thlA is essential in C. acetobutylicum.  
What are the hypothesis that might explain why thlA is an essential gene?  
- A thlA
-
 mutant cannot redirect its electron flux to adjust it to the change in the carbon 
flux (reduce acetyl-coA to ethanol and avoid acetate production).  
- The glycerol production pathway is not sufficiently well expressed 
As hydA inactivation might be compromised by the carbon fluxes redirection and thlA 
inactivation by the electron fluxes redirection, we made the hypothesis that if we could 
simultaneously inactivate hydA and thlA such a mutant would be viable and would produce 
ethanol and lactate with minor amount of glycerol.  
 
Figure 5-2 Schematic representation of the different steps for the simultaneous 
inactivation of hydA and thlA.  
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In order to simultaneously inactivate thlA and hydA, we developed the new method 
presented in Figure 5-2. It is based on the successive integration, by single crossing-overs, of 
two non-replicative plasmids possessing i) homologous region around the chromosomal 
regions to be deleted, ii) two different antibiotic resistance markers (ery
R
 and th
R
) and iii) a 
upp gene that confers sensitivity to 5-FU. The advantage of the method is that the first 
integration of the non-replicative plasmids by single crossing over does not inactivate the 
targeted genes; The inactivation is only effective after the second crossing over leading to the 
excision of the plasmids. The simultaneous excision of the two plasmids is obtained by 
plating the cells on 5-FU containing CGM plates and replica plating on erythromycin and 
thiamphenicol CGM plates and selecting the clones which are sensitive to both antibiotics.  
To differentiate the clones with a wild-type or the desired genotype, PCR analysis were 
performed with primers outside the recombination zones. In the case of hydA and thlA it 
should not be possible to get single deletions mutant as it was shown above that such mutants 
are not viable. We applied this strategy by constructing two vectors, the pEryUpp∆thlA that 
was made from two 1kb DNA fragments surrounding thlA and the pCatUpp∆hydA270 that 
contains a deletion cassette made of two 1kb DNA fragments with an in frame deletion of 270 
bp in a region coding for the catalytic domain of the main [Fe-Fe] hydrogenase. Integration of 
both plasmids was obtained both in 5’ and 3’ of the homologous region and a clone with 
integration of pCatUpp∆hydA270 plasmid in the 3’ homologous region and of pEryUpp∆thlA 
in the 5’ homologous region was chosen (Figure 5-3) and subject to 5-FU selection on CGM 
plates. Several clones (6 clones) with the right phenotype were obtained (resistance to 5-FU 
and sensitivity to erythromycin and thiamphenicol) and approximately half of them have the 
expected genotype (deletion of thlA and 270 bp of hydA) the others having a wild type 
genotype. One of the clones having the right genotype, C. 
acetobutylicumuppcac1502thlAhydA270 (Figure 5-3) was cultured in batch culture 
without pH regulation.  
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Figure 5-3 PCR analysis of intermediate (with pcatupp∆hydA270 plasmid integrated in 
3’ and pEryUpp∆thlA integrated in the 5’) and the final hydrogenase mutant C. 
acetobutylicum uppcac1502thlAhydA270.  
Lane 1 and 2: integration of pCatUpp∆hydA270 in the 3’ homologous region in the 
intermediate strain vs genotype of wildtype. Lane 3 and 4: deletion of 270bp in hydA gene of 
the final mutant vs genotype of the wildtype. Lane 5: marker. Lane 6 and 7: integration of 
pEryUpp∆thlA in the 5’ homologous region in the intemediate strain vs genotype of wildtype. 
Lane 8 and 9: deletion of thlA gene of the final mutant vs genotype of the wildtype. 
This strain produces ethanol and lactate as the major product and small amount of 
glycerol and acetate but H2 (Figure 5-4) 
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Figure 5-4 Metabolism of C. acetobutylicum uppcac1502thlAhydA270.  
Experimental conditions: Batch culture in MS glucose medium 20 g/l, Temp 35°C, initial 
pH 6.5, no pH regulation. 
 
In order to obtain a strain that produces L-lactate at high yield, the pSOL1 
megaplasmid was cured from the C. acetobutylicumuppcac1502thlAhydA270 strain by 
20 serial subcultures in MS glucose medium.  Cells having lost the pSOL1 megaplasmid were 
identified on an RCA agar plate containing starch (2%) and glucose (0.2%) and after iodine 
staining as they do not produce halo of starch hydrolysis [183]. Approximately 1 colony out 
of 1000 has lost the pSOL1 megaplasmid after 20 subcultures. The C. 
acetobutylicumuppcac1502thlAhydA270pSOL strain was obtained. This strain was 
cultured in batch culture without pH regulation and was shown to produce lactate as the main 
fermentation product with small amount of glycerol. This strain was then used for the 
continuous production of lactate in MS glucose medium. The results are shown in Figure 5-5. 
The best yield on glucose, titer and productivities obtained were respectively 0.94 g/g, 27.7 
g/l and 1.37 g/l.h. 
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Figure 5-5 Continuous production of lactate by the C. acetobutylicum 
uppcac1502thlAhydA270pSOL.  
Experimental conditions: MS glucose medium 30 g/l, pH 6.5, Temp 35°C, D=0.05h
-1
. 
 
The C. acetobutylicumuppcac1502thlAhydA270pSOL strain produced lactate at 
high yield. In order to obtain a strain that converts glycerol to 1,3-propanediol at high yield, 
the pSPD5 plasmid [154] that carries the genes coding for the B12-independent 1,3-
propanediol pathway from Clostridium butyricum was used to transform by electroporation 
the C. acetobutylicumuppcac1502thlAhydA270pSOL strain. After selection on Petri 
plates for clones containing the replicative pSPD5 plasmid (resistant to erythromycin at 
40µg/ml), 10 colonies were cultured for 24 hours in liquid 2YTGlycerol medium and then 
sub-cultured in liquid MS Glycerol medium. The clone having the fastest growth in MS 
glycerol medium was designated C. acetobutylicumuppcac1502thlAhydA270pSOL 
(pSPD5). This strain was used for the continuous production of 1,3-propanediol in MS 
glycerol medium for 150 days. The stable production of 1,3-propanediol is shown in Figure 
5-6. Acetate was the only by-product. The average yield on glycerol, titer and productivities 
obtained were respectively 0.6 g/g, 60 g/l and 3 g/l.h. 
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1,3-propandiol ~ 60g/L, yield 0.6g/g, productivity 3g/l.h 
Figure 5-6 Continuous production of 1,3-propanediol by the C. acetobutylicum 
uppcac1502thlAhydA270pSOL (pSPD5).  
Experimental conditions: MS glycerol medium 105 g/l, pH 6.3, Temp 35°C, D=0.05h
-1
 
 
5.2 Conclusions 
By using the Genome Scale Model developed in our group, we demonstrated that C. 
acetobutylicum can potentially continuously produce several bio-chemicals if we manage to 
block hydrogen production. 
By simultaneously inactivating hydA and thlA, we managed to obtain a platform strain 
that no longer produces hydrogen. 
This platform strain was further engineered to continuously produce L-lactate and 1,3-
propanediol at high yield, titer and productivities. 
Further work is currently carried out to construct strains producing either, isopropanol, 
1,3-butanediol or isobutene.  
5.3 Material and Methods 
5.3.1 Knockout of hydA and thlA using LltrB intron   
PCR primers were designed using a computer algorithm provided as part of the 
TargeTron Gene Knockout System kit [184]. The LltrB intron obtained from pACD4K-C was 
retargeted to the hupL gene by an antisense insertion (between nucleotides 421-422), to the 
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hydB gene by an antisense insertion (between nucleotides 113-114) and to hydA by an 
antisense (between nucleotides 370-371) and a sense insertion (between nucleotides 60-61). A 
SOEing (Gene Splicing by Overlap Extension) PCR was used to assemble and amplify a 353-
bp product containing the modified Intron Binding Site (IBS), Exon Binding Site 1d S1d, 
and Exon Binding Site 2 (EBS2) sequences responsible for intron-retargeting (Table 5-2).  
To inactivate a gene using TargeTron technology together with the positive selection for 
plasmid loss, a customized vector (pCONS::upp-intron) was constructed from the original 
pACD4 TargeTron vector (Sigma) The pCONS::upp -intron vector contains a pIM13 origin 
of replication functional in Clostridia, a catP gene conferring thiamphenicol resistance, a upp 
gene for 5-fluorouracil (5FU) sensibility and a LtrA ORF required for a functional expression 
of the group II intron. The LtrA ORF was obtained from restriction digestion of pACD4 with 
XbaI and PshAI and was then sub-cloned into the pSOS95 vector. The pSOS95 vector was 
digested with BamHI and SfoI and blunt-ended to remove the acetone formation genes, while 
leaving the thiolase promoter region. The LtrA ORF digest product and the linearized 
pSOS95 vector were ligated to create the pSOS-intron vector. The pSOS-intron vector was 
digested by NsiI and SapI to remove the thiolase promoter and LtrA ORF. The pCONS::upp 
was digested with SapI and blunt-ended. These fragments were ligated together to generate 
the pCONS::upp-intron vector.  
Disruption of the hydA gene was carried out by the insertion of sense or antisense intron 
II using the pCONS::upp-intron vector The mutated 353-bp PCR fragments, hydA sense and 
hydA antisense described above for ClosTron inactivation and the pCONS::upp-intron vector 
were digested by BsrGI and HindIII and then ligated to yield the pCONS::upp-intron hydA 
sense or the pCONS::upp-intron hydA antisense. Both resulting vector constructs were 
transferred into E. coli TOP10 cells (Invitrogen, USA), and the transformants were selected 
from LB plates supplemented with 30 µg/ml chloramphenicol. Plasmids purified from the E. 
coli transformants were then transferred into C. acetobutylicum RM1 Δcac15Δupp on 
reinforced clostridial agar (RCA) plates with thiamphenicol or erythromycin supplementation 
[74]. Clostridium transformants were further screened on RCA plates supplemented with 
thiamphenicol (g/ml) and 5-fluorouracil (500 µM), a counter-selectable marker [141]. 
The inactivation of ThlA (encoded by CAC2873) was also done by group II intron. The 
insertion was chosen to be at 810|811 sense strand of the CDS. Retargeting region was 
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constructed by SOE PCR using the four primers: thla-810|811s-IBS primer,   
thla-810|811s-EBS1d primer, thla-810|811s-EBS2 primer and the EBS universal primer 
(designed by Clostron tool using Perutka algorithm, Table 5-2). The PCR products were 
digested by BsrGI and HindIII and ligated to a double digested Targetron vector pCUI [182] 
by BsrGI and HindIII to yield pCUI-Thla-int810s vector. The plasmid was then transformed 
to C. acetobutylicum RM1 Δcac15Δupp [167] and selected on RCA plates containing 
thiamphenicol 10 µg/ml. Intron insertion in the transformants was checked by PCR using the 
primers flanking 810|811 position in thlA CDS (ThlAI-F and ThlAI-R). The removal of 
pCUI-Thla-int810s vector in the mutant was done by spreading the mutants on RCA plates 
containing 5-FU [141]. Clones resistant to 5-FU and thiamphenicol and erythromycin 
sensitivity were checked by PCR for the loss of the pCUI-Thla-int810s plasmid. 
5.3.2 Construction and integration by single crossing over of the  pEryUpp∆thlA 
plasmid in the chromosome of C. acetobutylicumuppcac1502 
Two DNA fragments surrounding the thlA gene (CAC2872) were PCR amplified with the 
Phusion DNA polymerase with total DNA from C. acetobutylicum as template and two 
specific couples of olignonucleotides as primers (Table 5-2). With the couples of primers thl-
1/thl-2 and thl-3/thl-4, 1025 bp and 1012 bp DNA fragments were respectively obtained. Both 
primers thl-1 and thl-4 introduce a BamHI site while primers thl-2 and thl-3 have 
complementary 5’ extended sequences which introduce a StuI site. DNA fragments ∆thlA 1-2  
and ∆thlA 3-4 were joined in a PCR fusion experiment with primers thl-1 and thl-4 and the 
resulting fragment was cloned in the pCR4-TOPO-Blunt vector to yield pTOPO:∆thlA. The thlA 
replacement cassette obtained after BamHI digestion of the resulting plasmid was cloned, at 
the BamHI, site into pEryUpp to yield the pEryUpp∆thlA plasmid.  
The pEryUpp∆thlA plasmid was used to transform by electroporation C. 
acetobutylicumuppcac1502. Clones (resistant to erythromycin 20 µg/ml) having inserted 
the pEryUpp∆thlA plasmid by homologous recombination were selected on Petri plates and 
checked by PCR analysis (with primers thl-0 and thl-5 located outside of the thlA replacement 
cassette). The C. acetobutylicumuppcac1502thlA::pEryUpp∆thlA strain with a plasmid 
integration in 5’ was obtained. 
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5.3.3 Construction and integration by single crossing over of the 
pCatUppHydA270 plasmid in the chromosome of C. 
acetobutylicumuppcac1502 
A cassette creating an in frame deletion of 270 bp in a region coding for the catalytic 
domain of the main [Fe-Fe] hydrogenase (HydA) was created using two DNA fragments 
surrounding this region that were PCR amplified with the Phusion DNA polymerase with 
total DNA from C. acetobutylicum as template and two specific couples of olignonucleotides 
as primers (Table 5-2). With the couples of primers hyd-1- hyd-2 and hyd-3– hyd-4, 1123 bp 
and 1008 bp DNA fragments were respectively obtained. Both primers hyd-1 and hyd-4 
introduce a BamHI site while primers hyd-2 and hyd-3 have complementary 5’ extended 
sequences. DNA fragments hyd-1- hyd-2 and hyd-3– hyd-4 were joined in a PCR fusion 
experiment with primers hyd-1 and hyd-4 and the resulting fragment was cloned in the pCR4-
TOPO-Blunt vector to yield pTOPO::hydA270. The hydA replacement cassette obtained after 
BamHI digestion of the resulting plasmid was cloned, at the BamHI, site into pCatUpp to 
yield the pCatUpp∆hydA270 plasmid. 
The pCatUpp∆hyda270 plasmid was used to transform by electroporation C. 
acetobutylicumuppcac1502thlA::pEryUpp∆thlA. Clones (resistant to erythromycin 20 
µg/ml and thiamphenicol 20 µg/ml) having inserted the pCatUpp∆hyda270 plasmid by 
homologous recombination were selected on Petri plates and checked by PCR analysis (with 
primers Dhyd-0 and Dhyd-3 located outside of the hydA replacement cassette). The C. 
acetobutylicumuppcac1502thlA::pEryUpp∆thlAhydA:: pCatUpp∆hyda270 strain with 
integration of both plasmids in 5’ was obtained. 
5.3.4 Simultaneous inactivation of thlA and hydA in C. 
acetobutylicumuppcac1502 
To simultaneously inactivate thlA and hydA, two colonies of the C. 
acetobutylicumuppcac1502thlA::pEryUpp∆thlAhydA:: pCatUpp∆hyda270 strain were 
cultured for 24 hours in liquid MS Glucose medium and then subcultured in liquid 2YTG 
medium without antibiotic. Appropriate dilutions were plated on RCA with 5-FU at 400 µM. 
To select integrants having excised and lost both the pEryUpp∆thlA and the 
pCatUpp∆hyda270 plasmids, 5-FU resistant clones were replica plated on both RCA + 5FU, 
RCA with erythromycin 40 µg/ml and RCA with thiamphenicol at 40 µg/ml. Clones resistant 
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to 5-FU and sensitive to erythromycin and thiamphenicol were checked by PCR analysis 
(with primers Dthla-0 and Dthla-5 located outside of the thlA replacement cassette and 
primers thl-D and thl-R located inside of thlA and with primers DhydA-0 and DhydA-3 
located outside of the hydA replacement cassette and primers hyd-D and hyd-R located inside 
of hydA). About half of the clones resistant to 5-FU and sensitive to erythromycin and 
thiamphenicol possess inactivated thlA and hydA genes. The C. 
acetobutylicumuppcac1502thlAhydA270 strain was obtained.  
The strain was evaluated in MS glucose batch culture [155] without pH regulation. 
Ethanol and lactate were the two major products with small amount of acetate and glycerol. 
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Table 5-2 List of primers 
Name Sequence 
thla-810|811s-IBS AAAAAAGCTTATAATTATCCTTACTTGGCGTAAAAGTGC
GCCCAGATAGGGTG 
thla-810|811s-EBS1d CAGATTGTACAAATGTGGTGATAACAGATAAGTCGTAA
AACCTAACTTACCTTTCTTTGT 
thla-810|811s-EBS2 TGAACGCAAGTTTCTAATTTCGGTTCCAAGTCGATAGAG
GAAAGTGTCT 
EBS universal CGAAATTAGAAACTTGCGTTCAGTAAAC 
HYDAs(IBS) AAAAAAGCTTATAATTATCCTTAATTACCATCCTTGTGC
GCCCAGATCGGGTG 
HYDAs(EBS1d) CAGATTGTACAAATGTGGTGATAACAGATAAGTCATCC
TTGATAACTTACCTTTCTTTGT 
HYDAs(EBS2) TGAACGCAAGTTTCTAATTTCGGTTGTAATCCGATAGAG
GAAAGTGTCT 
HYDAas(IBS) AAAAAAGCTTATAATTATCCTTATATCTCCTGGTAGTGC
GCCCAGATAGGGTG 
HYDAas(EBS1d) CAGATTGTACAAATGTGGTGATAACAGATAAGTCCTGG
TAAATAACTTACCTTTCTTTGT 
HYDAas(EBS2) TGAACGCAAGTTTCTAATTTCGGTTAGATATCGATAGAG
GAAAGTGTCT 
ThlaI-F GTTACAGCTGGTAATGCATCAGG 
ThlaI-R GGTCCATATCCCATTATTGCTGGG 
hydAI-F TAAATGGCAATGAAGTGCATACAGATAAAG 
hydAI-R CATGTTGAGTCATCAAGACAAACATCATCA 
Hyd-1 AAAGGATCCGTTTTTCTTAATATTTACCATATTGCACCT
CCC 
Hyd-2 ATATCTCTTAAGCTGTTAGTTTCCATTATAGTCATATCTG
CACCAAAG 
Hyd-3 CAGATATGACTATAATGGAAACTAACAGCTTAAGAGAT
ATTGATGCATCC 
Hyd-4 AAAGGATCCCTGGTACATCAGTATACGAAACAATGCC 
DhydA-0 CTGTATCCCTGCTTATAAATCTTTGAGC 
DhydA-3 GTTGTTTGAGGGAGCTAATCATTCTC 
Hyd-4F CTATATACTGCACTTAGAATGTTAGGCTTTG 
thl-1 AAAAGGATCCAAGCAGTTAATGAAAAGAATATTTTTAT
TACAGGAAATAC 
thl-2 GTTATTTTTAACAATACTTTAGGCCTTACGGGGTAACAG
ATAAACCATTTCAATCTA 
thl-3 AATTTAGGAGGTTAGTTAGAAGGCCTAAAGTATTGTTA
AAAATAACTCTGTAGAATTATAAATTAG 
thl-4 AAAAGGATCCAAGTTAACAATCATTTCTATTACGCTTTG
TTTCC 
Thl-D TGGAACATTTCAAGAGAAGAACAAGATGAG 
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Thl-R GCTCCTCCATTTACATTTACTTTATTCATATC 
DthlA-0 ACATGGAGATACGACTACAACATTTGCTG 
DthlA-5 TTCTTTTTATTGCAGTTGCATTTATTAAAAATGC 
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6.1 Abstract 
An operon comprising two genes, CA_P0037 and CA_P0036, which encode proteins of 
unknown function that were previously shown to be highly expressed in acidogenic cells and 
repressed in solventogenic and alcohologenic cells, is located on the pSOL1 megaplasmid of 
Clostridium acetobutylicum upstream of adhE2. A CA_P0037::int (189/190s) mutant was 
successfully generated by the Targetron technique. The resultant mutant showed significantly 
different metabolic fluxes patterns in acidogenic (producing mainly lactate, butyrate and 
butanol) and alcohologenic (producing mainly butyrate, acetate and lactate) chemostat 
cultures but not in solventogenic or batch cultures. Transcriptomic investigation of the 
CA_P0037::int (189/190s) mutant showed that inactivation of CA_P0037 significantly 
affected the expression of more than 258 genes under acidogenic conditions. Surprisingly, 
genes belonging to the Fur regulon, involved in iron transport (CA_C1029-CA_C1032), or 
coding for the main flavodoxin (CA_C0587) were the most significantly expressed genes 
under all conditions, whereas fur (coding for the ferric uptake regulator) gene expression 
remained unchanged. Furthermore, most of the genes of the Rex regulon, such as the adhE2 or 
ldhA genes, and of the PerR regulon, such as rbr3A-rbr3B or dfx were over-expressed in the 
mutant. In addition, the whole CA_P0037-CA_P0036 operon was highly expressed under all 
conditions in the CA_P0037::int (189/190s) mutant, suggesting a self-regulated expression 
mechanism. CA_P0037 was shown to bind to the CA_P0037-CA_P0036 operon, sol operon 
and adc promoters, and the binding sites were determined by DNA footprinting. Finally, a 
putative CA_P0037 regulon was generated using a bioinformatics approach. 
Importance Currently, there is a resurgence of interest in Clostridium acetobutylicum the 
biocatalyst of the historical Weizmann process, to produce n-butanol for use both as a bulk 
chemical and as a renewable alternative transportation fuel. To develop a commercial process 
for the production of n-butanol via a metabolic engineering approach, it is necessary to better 
characterize both the primary metabolism of C. acetobutylicum and its regulation. This study 
describes the discovery of Cap0037, a novel regulator which, when inactivated, drastically 
affects the primary metabolism of C. acetobutylicum under both acidogenic and alcohologenic 
fermentation conditions. 
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6.2 Introduction 
Clostridium acetobutylicum is a Gram-positive, strictly anaerobic, spore-forming 
bacterium now considered the model organism for the study of solventogenic Clostridia 
[185,186]. The superiority of butanol over ethanol as an alternative biofuel has attracted 
research interest in C. acetobutylicum and other recombinant bacteria producing butanol as a 
major product [187].  
In batch cultures, C. acetobutylicum shows a bi-phasic fermentation pattern: after 
producing acetate and butyrate during exponential growth, the microorganism switches to the 
formation of acetone, butanol and ethanol (ABE, at a ratio of 3:6:1) shortly before entering the 
stationary phase [185].  
In phosphate-limited chemostat cultures, C. acetobutylicum can also be maintained in 
three different stable metabolic states [20–22,181,188] without cellular differentiation [189]: 
acidogenic (producing acetate and butyrate) when grown at a neutral pH with glucose; 
solventogenic (producing acetone, butanol, and ethanol) when grown at a low pH with 
glucose; and alcohologenic (forming butanol and ethanol but not acetone) when grown at a 
neutral pH under conditions with high NAD(P)H availability [21,181,190].  
Understanding the complex regulatory network of C. acetobutylicum metabolism is 
crucial for further manipulating the genotype to obtain industrial strains, but our 
understanding of the cellular functioning remains very limited. Quantitative transcriptomics, 
proteomics and fluxomics analyses were established to characterize the three typical metabolic 
states of C. acetobutylicum in chemostat cultures [42]. Many studies on the solventogenic shift 
were conducted [23,191,192]. Transcriptional changes in response to metabolite stresses such 
as acetate, butanol and butyrate stress were also conducted to find regulons and DNA binding 
motifs of transcriptional factors [139,193–197].  
In terms of regulatory information, some common regulators have already been studied. 
A peroxide repressor (PerR)-homologous protein was identified to be a key repressor that 
plays an important role in the oxidative stress defense [128,129]. In the same family as PerR, a 
ferric uptake regulator (Fur), which helps C. acetobutylicum sense and respond to iron 
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availability at multiple levels using a sophisticated system, was identified and well 
characterized [130]. Spo0A was found to directly control the solventogenic switch, the 
expression of the adc and ptb genes [67] and the activation of the sporulation program in C. 
acetobutylicum [92]. The carbon storage regulator (CsrA) was also shown to directly or 
indirectly regulate multiple pathways including flagella assembly, oligopeptide transport, iron 
uptake, phosphotransferase systems (PTS), synthesis of riboflavin, stage III sporulation and 
central carbon metabolism [131]. A catabolite control protein (CcpA) was mutated at V302N 
to improve the utilization of xylose and solvent production [132]. RegA, an homolog of CcpA, 
was shown to inhibit the degradation of starch by the staA gene product [198]. Recently, a 
redox sensing transcriptional repressor (Rex) has been found to modulate its DNA-binding 
activity in response to the NADH/NAD
+
 ratio and plays a role in the alcohologenic shift of C. 
acetobutylicum [110,134]. 
The regulatory network of C. acetobutylicum remains largely unexplored. In this study, 
we identified Cap0037 to be a novel self-regulated protein that globally affects C. 
acetobutylicum metabolism. CA_P0037 is the first gene of a polycistronic operon with 
CA_P0036. This operon is located upstream of adhE2 on the pSOL1 megaplasmid and it was 
significantly expressed in acidogenic cells and repressed in solventogenic and alcohologenic 
cells [42,199]. Furthermore, the two proteins were present at a 1:1 molar ratio and were 
among the 30 most abundant proteins in the cell (around 50,000 molecules per cell) [42]. 
Another study found that Cap0037/Cap0036 expression was slightly down-regulated in an adc 
mutant, clearly up-regulated during solventogenesis in a pta mutant and an adc/pta double 
mutant and strongly repressed in a ptb mutant independent of the cultivation conditions [111]. 
Interestingly, Cap0037 and Cap0036 were found to appear in multiple spots (up to five in the 
case of Cap0037 and up to at least four in the case of Cap0036) in a 2-D gel analysis of 
acidogenic cells, suggesting posttranslational modifications such as phosphorylation, 
acetylation, glycosylation or methylation [199]. 
In order to investigate the roles of these proteins in the acidogenic state of C. 
acetobutylicum, we inactivated CA_P0037 via the mobile group II intron. The comparison 
between wild-type and mutants lacking CA_P0037 was conducted at the system scale level 
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through a combination of quantitative fluxomics, transcriptomics and proteomics analysis. 
DNA footprinting was used to determine DNA binding motifs of Cap0037 on its own 
promoter and in the upstream region of selected genes shown to be up- or down-regulated. 
Putative Cap0037 binding sites across C. acetobutylicum genomes were analyzed via a 
bioinformatics approach. The regulatory role of Cap0037 and the observed phenotypes will be 
discussed in light of the different omics datasets. This study builds a foundation to further 
investigate the regulatory mechanism of this novel protein in C. acetobutylicum, which should 
be beneficial for understanding the role of homologous proteins in other Firmicutes. 
6.3 Results and Discussion 
6.3.1 The phylogenetic tree and bioinformatics analysis of Cap0037/Cap0036 
Cap0037 and Cap0036 are proteins of unknown function. They are well conserved in 
other Firmicutes such as Clostridia (C. scatologenes, C. drakei and C. carboxidivorans), 
Bacillus (B. cereus and B. shackletonii) and Geobacillus (G. thermoglucosidasus and G. 
caldoxylosilyticus) (Figure 6-1). All of these proteins have never been characterized. 
Cap0036 was found to be homologous to some cytoplasmic proteins of the Bacillus 
species (such as Bacillus enclensis, Bacillus shakletoni and Bacillus cereus) and also to some 
bactofilin family proteins from the Geobacillus species (Figure 6-1A). Two bioinformatics 
tools, TMpred [200] and OCTOPUS [201], were employed for the prediction and 
identification of possible transmembrane domains in Cap0036 without success. Therefore, 
Cap0036 is a cytoplasmic protein rather than a membrane bactofilin family protein.  
Noticeably, Cap0037 is homologous to the YgaS-like protein in Bacillus cereus G9241 (a 
putative-DNA-binding-like protein), although the relationship is distant (Figure 6-1B). A 
helix-turn-helix DNA binding motif (ISKKELLEITHISYGQLYRWKR) was found in the N-
terminus of the Cap0037 protein sequence (by NPS@, [202]). As a result, Cap0037 is likely a 
novel transcriptional regulator. The 1:1 expression ratio of Cap0037 and Cap0036 [42] 
suggested an interaction of these two proteins that forms a system acting as an unknown 
regulatory mechanism in C. acetobutylicum. Interestingly, a transmembrane domain 
(LIRKLGIAICFLMLIPNEIYI) and an outer membrane region 
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(ENTASLVLKVNARECLEELKSKLSL) were found at the C-terminus of Cap0037 
(OCTOPUS program, [201]). 
 
A. Cap0036 
 
B. Cap0037 
 
 
Figure 6-1 Phylogenetic trees of Cap0036 (A), Cap0037 (B) sequences from Clostridium 
acetobutylicum and neighbor proteins from other bacteria.  
The neighbor proteins were selected by running BLAST on NCBI database. Cap0036 and 
Cap0037 from C. acetobutylicum were shown in blue. 
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6.3.2 Disruption of CA_P0037 by pCUI-cap37 (189s) 
The Clostron technique was first applied to inactivate CA_P0037. Clostron plasmid 
pMTL007C-E2::cap37 (277a), targeting an insertion into the 277/278 antisense of CA_P0037 
CDS, was constructed and used as described elsewhere [84,85]. Intron insertion in CA_P0037 
was not detected in all of the obtained integrants. Therefore, we used another intron-based 
method developed in our laboratory [182] for knocking out CA_P0037 based on the pCUI-
cap0037 vector as mentioned in the Methods section. The mutant was successfully obtained 
with the use of plasmid pCUI-cap37: a 1 kbp-long intron (Figure 6-2A) was inserted at the 
189/190 sense strand position of CA_P0037. PCR using two external primers flanking the 
targeted position confirmed the insertion of the intron into the gene (Figure 6-2B). After 
selecting for the Cap37::int mutant, the strain was subjected to 5’-FU selection to cure the 
pCUI-cap37 plasmid to avoid intron splicing by LtrA, whose encoding gene is present on the 
plasmid backbone. Southern blotting was conducted to confirm a single intron insertion into 
the genome (Figure 6-2C). 
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Figure 6-2 Construction of Cap37::int mutant.  
(A) DNA configuration of mutant with group II intron inserted at 189/190s. (B) PCR on 
genomic extraction of mutant (MT) and wild-type (WT) by different couples of primers to 
confirm intron insertion (by Intron probe-F and CAP0037-Fb, CAP0037-Rb and CAP0037-
Fb) and to detect the presence of pCUI1-cap37(189s) (by LtrA 5D and LtrA 3R). (C) Southern 
blot for intron insertion in Cap37::int mutant. The intron probe was hybridized to EcoRI 
digested genomic DNA of Cap37::int mutant (lane 1) and to the positive control (lane 2) with 
expected size of 4388 bps and 1700bps, respectively. 
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6.3.3 Carbon and electron fluxes of the Cap37::intron mutant under different 
physiological conditions 
The Cap0037::intron mutant was first evaluated under acidogenic conditions and 
normalized metabolic fluxes compared to previously published data for the control strain. The 
mutant strain underwent a profound change in its metabolism: butyrate and acetate normalized 
fluxes decreased 2.5- and 5.7-fold, respectively, while its lactate and butanol normalized 
fluxes increased 85- and 9.7-fold, respectively, compared to the control strain (Figure 6-3A). 
Ethanol normalized fluxes, on the other hand, remained unchanged. Such drastic flux changes 
were accompanied by a 2.9-fold decrease in hydrogen production and by other changes in 
electron fluxes (Figure 6-4), which are described in detail below. In a complementation 
experiment, the Cap0037::intron mutant was transformed with the pSOS95-Cap0037 plasmid 
to express the CA_P0037 gene under the control of the thlA promoter. When this strain was 
evaluated  in acidogenic chemostat culture, in the presence of clarithromycin (40 g/ml) for 
the maintenance of the plasmid, the normalized metabolic fluxes were not significantly 
different from the wild-type strain (Figure 6-3A), demonstrating that the Cap0037::intron 
mutant phenotype was only attributable to CA_P0037 inactivation. The production of butanol 
by the Cap0037::intron strain under acidogenesis is explained by the higher adhE2 expression 
(~50-fold higher than the control strain, with 21 mRNA molecules/cell) (Figure 6-5), and 
although the expression of the sol operon (ctfA, ctfB, adhE1) was increased ~6-fold, the 
amount of mRNA molecules remained low (0.5) compared to adhE2 (21). The increase in 
lactate formation was associated with an 83-fold increase in ldhA expression (Figure 6-5, 
Dataset S1). For the Cap0037::intron mutant, the acetate flux decreased 5.7-fold compared to 
the control strain, although pta-ack (CA_C1742–CA_C1743) expression was unchanged 
(Figure 6-5, Dataset S1). Thus, flux is controlled at the enzyme level via a decrease in the 
acetyl-CoA pool, probably due to the 2-fold higher expression of most of the genes 
(CA_C2708–CA_C2712) coding for the enzymes converting acetoacetyl-CoA to butyryl-CoA.  
The alcohologenesis state (pH 6.3, in mixture of glucose and glycerol) was the second 
most affected state following the disruption of CA_P0037 (Figure 6-3B). Although all of the 
glucose provided in the medium was consumed, the normalized flux of glycerol consumption 
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was reduced more than 15-fold compared to the control strain. While the control strain 
produced mainly ethanol (normalized flux of 8.6 %), butyrate (normalized flux of 25.1 %) and 
butanol (normalized flux of 61.1 %), the mutant produced mainly acids: butyrate (normalized 
flux of 63.6 %), acetate (normalized flux of 21.9 %) and lactate (normalized flux of 11.8 %) 
(Figure 6-3B). The ethanol and butanol fluxes were 1.8-fold and 9.8-fold lower than the 
parental strain, respectively. In the mutant, the alcohologenesis state was barely induced, and 
it behaved like the control strain in the acidogenesis state. Such drastic flux changes were 
accompanied by a 1.4-fold increase in hydrogen production and by other changes in electron 
fluxes (Figure 6-4), which are described in detail below. The lower glycerol consumption of 
the Cap0037::intron strain is explained by the lower expression (4–6-fold decrease) of the 
gene cluster coding for glycerol transport and utilization (CAC1319–CAC1323). The increase 
in lactate formation was associated with a 32-fold increase in ldhA expression and the lower 
production of butanol was associated with a 10-fold lower adhE2 expression. On the other 
hand, the butyrate flux increase was not associated with a change in the expression of ptb-buk 
(CA_C3074–CA_C3075), which remained unchanged (Figure 6-5, Dataset S1). Thus, flux is 
controlled at the enzyme level via an increase in the butyryl-CoA pool, probably due to the 
10-fold lower expression levels of adhE2. 
The mutant strain was then evaluated under solventogenic conditions and compared to 
previously published data for the control strain. The Cap0037::intron mutant was not able to 
consume all glucose and therefore the titers of products were lower, but the fluxes were not 
significantly different from the wild-type strain (Figure 6-3C). Both the sol operon and adhE2 
were more expressed in the mutant (2- and 4-fold, respectively), although the amount of 
mRNA molecule for adhE1 (12) was much higher than for adhE2 (~1). Surprisingly, the 
expression of adc was down-regulated 3-fold in the mutant, although the amount mRNA 
molecules per cell (4.3) remained high. 
The butanol pathway was analyzed for three different conditions in the Cap0037::intron 
mutant by calculating the contribution of each of the five enzymes potentially involved in 
each of the two steps to the fluxes (see [42] for the calculation). Under acidogenesis, adhE2 
(21 mRNA molecules per cell, 5x10
4
 protein molecules per cell) was more highly expressed 
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than adhE1 (0.5 mRNA molecules per cell, 4x10
3
 protein molecules per cell), and AdhE2 was 
the main contributor (93% of the flux) to the conversion of butyryl-CoA to butyraldehyde in 
the Cap0037::intron mutant (Figure 6-6A). The butanol dehydrogenase flux is primarily 
attributable to AdhE2 (92% of the flux), BdhB (5% of the flux), BdhA (2% of the flux) and 
BdhC (1% of the flux), in decreasing order of activity. Under solventogenesis, adhE1 (12 
mRNA molecules per cell, 10
5
 protein molecules per cell) was more expressed than adhE2 (1 
mRNA molecules per cell, 2.2x10
3
 protein molecules per cell), and adhE1 was the main 
contributor (98% of the flux) to the conversion of butyryl-CoA to butyraldehyde in the 
Cap0037::intron mutant (Figure 6-6C). Similar to the control strain, the butanol 
dehydrogenase flux in the Cap0037::intron mutant is primarily due to BdhB (82% of the flux), 
AdhE2 (7%), BdhA (5% of the flux) and BdhC (3% of the flux), in decreasing order of 
activity. Under alcohologenesis, although the butanol flux decreased 9.8-fold, the 
Cap0037::intron mutant behaved the same as the control strain in terms of enzyme 
contribution, as AdhE2 was mainly responsible for both the conversion of butyryl-CoA to 
butyraldehyde (97% of the flux) and the conversion of butyraldehyde to butanol (70% of the 
flux). 
The normalized electron fluxes were analyzed for the Cap0037::intron mutant under three 
different conditions (Figure 6-4). In acidogenesis, the primary use of reduced ferredoxin was 
switched from hydrogen to NADH production in response to the high expression of adhE2 
and ldhA in the mutant. In acidogenesis, the normalized hydrogen production fluxes decreased 
~3-fold while the normalized fluxes of NADH production from reduced ferredoxin increased 
2.4-fold. The decrease in hydrogen production was not attributable to the expression of hydA 
(CA_C0028), which remained unchanged, but to the lower flux of reduced ferredoxin 
production, as due to high ldhA expression lactate became the major product. The 2-fold 
increase in the normalized Ferredoxin-NAD+ reductase fluxes might be explained by the 500–
fold higher expression of CA_C0587 encoding the major flavodoxin and the 1.5-fold lower 
expression of CA_C0303 encoding the major ferredoxin, as well as the possibility that reduced 
flavodoxin might be a better substrate than ferredoxin for the Ferredoxin-NAD+ reductase. In 
solventogenesis, the normalized electron fluxes were not significantly changed in agreement 
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with the conserved product pattern. In alcohologenesis, butyrate was the main fermentation 
product of the Cap0037::intron mutant, and the normalized hydrogenase flux increased 1.4-
fold while the normalized Ferredoxin-NAD+ reductase fluxes decreased 2.6-fold. The high 
normalized hydrogen production and low normalized Ferredoxin-NAD+ reductase fluxes and 
normalized butanol fluxes can be explained by the 5-fold down-regulation of CA_C3486 
encoding a potential multimeric flavodoxin and the proposed physiological role [42] in 
alcohologenic culture of the wild-type strain, providing a better substrate for the Ferredoxin 
NAD+ reductase than for hydrogenase. 
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A. Acidogenesis 
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B. Alcohologenesis 
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C. Solventogenesis 
 
Figure 6-3 Metabolic fluxes of mutant Cap0037::int versus control strain in different 
metabolic states (A) Acidogenesis (B) Alcohologenesis (C) Solventogenesis.  
All values are normalized to the flux of the initial carbon source (mmol/gDCW/h). 
Glucose flux is normalized as 100 for acidogenesis and solventogenesis, and the sum of 
glucose and half of the glycerol normalized as 100 for alcohologenesis. The values of 
corresponding mutant are shown in blue letter, and those of control strain are shown in green 
letter. The control data was from [42] 
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Figure 6-4 Electron fluxes of mutant Cap0037::int versus control strain in different 
metabolic states (A) Acidogenesis (B) Alcohologenesis (C) Solventogenesis. 
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Figure 6-5 Relative transcript levels of central metabolic genes of Cap0037::int mutant 
in acidogenesis, alcohologenesis and solventogenesis conditions. 
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Figure 6-6 The butanol pathway in the Cap0037 ::int mutant (MT) and the wild-type 
(WT) in acidogenesis (A), alcohologenesis (B) and solventogenesis (C) 
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6.3.4 Determination of the CA_P0037 DNA binding site (BS) 
To study the possible regulatory function of Cap0037 in central metabolism, we analyzed 
the ability of Cap0037 to bind to the promoter regions of several genes coding for key 
enzymes of the central metabolism of C. acetobutylicum that were either up-regulated 
(CA_P0037/CA_P0036, ldhA, the sol operon, fld1 (CA_C0587)) or down-regulated (adc) in 
the Cap0037::int mutant under acidogenesis. A shift was only observed for the promoter 
regions of CA_P0037/CA_P0036, the sol and adc operon (Figure 6-7 and Figure 6-8), 
indicating that the up-regulation of ldhA and fld1 (CA_0587) was an indirect effect of 
CA_P0037 inactivation (data for ldhA and fld1promoters are not shown).  
We used DNA footprinting to determine the DNA binding sites of Cap0037 in the 
promoter regions of CA_P0037, the sol operon and adc (Figure 6-7 and Figure 6-9). Cap0037 
was found to bind to the 5’-ATATTTTCATATAAAT-3’ sequence overlapped the putative -10 
region of the CAP0037-CAP0036 operon promoter (determined by BPROM tool by [203]), 
suggesting that Cap0037 might repress its own transcription. This hypothesis is in agreement 
with the 50.7- and 68.6-fold higher expression levels of the CA_P0037- CA_P0036 operon 
observed in alcohologenesis and solventogenesis of the Cap0037::intron mutant. Two binding 
sites were found in the adc promoter region. The first was 5’-ATAAGTTTATATAAAT-3’, 
located upstream of the -35, which contains three mismatches compared to the binding site 
found in the CA_P0037 promoter. Cap0037 could potentially bind to this sequence to activate 
the expression of adc, which fit with the transcriptomic data for Cap0037::int mutant, in 
which adc was down-regulated under all conditions. The second binding site in the adc 
promoter region, 5’-TAATGTAAATATAAAT-3’, is less conserved compared to the CAP0036-
CAP0037 operon promoter binding with five mismatches, and it is located between the -10 
and +1 promoter region suggesting that it might me also involved in the repression of adc 
under conditions that have not been characterized yet. It is worth noting that a Spo0A~P 
binding box was found upstream of the -35 region of the adc promoter [67]. This box is only 
six base pairs downstream of the first Cap0037 binding site (Figure 6-10). Hence, there might 
be some synergy between Spo0A~P and Cap0037 for the activation of adc.  
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In the sol promoter region, Cap0037 binds to the 5’-TAAATATACTGATAAT-3’ sequence 
located upstream the Spo0A~P and the -35 region of the sol operon promoter (Figure 6-10). 
Interestingly this Cap0037 binding site overlapped the R1 sequence (TCTAAATATA) that has 
been proposed [204] to be the binding site of an additional activator protein, which acts in 
concert with Spo0A~P to activate the transcription of the sol operon. Binding of CAP0037 
would prevent the binding of this activator and would explain the up regulation of the sol 
operon in the Cap0037::int mutant in acidogenesis and solventogenesis (Figure 6-5, Dataset 
S1).  
Based on these experimentally validated binding sequences, we can search for putative 
Cap0037 binding sites across the genome using the RegPredict tool. 
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Figure 6-7 Analysis of Cap0037 binding to the promoter region of the 
CA_P0037/CA_P0036 operon.  
(A) EMSAs using the promoter region of the CA_P0037/CA_P0036 operon and Cap0037 
protein. Lanes 1-6: 0/0.1/0.2/0.3/0.5/0.6 µg protein; lanes 7-10: 0/0.1/0.2/0.5 µg protein. (B) 
DNAase I protection assay (DNA Footprinting) of Cap0037 interacting with 
CA_P0037/CA_P0036 promoter region (probe 85). End-labeled DNA fragment carrying the 
promoter region of the CA_P0037/CA_P0036 operon was incubated with different 
concentrations of Cap0037, subjected to DNAase I cleavage, and analyzed on sequencing gel. 
Sequencing reaction was performed with plasmid pDrive_86kurz. Line 1-4: 0-1438 nM 
Cap0037. The assigned region on the right side indicates the region protected by Cap0037 and 
the respective sequence. 
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Figure 6-8 EMSAs using the promoter region of adc, sol operon and Cap0037 protein. 
(A) EMSAs using the promoter region of the adc operon and Cap0037 protein. Lanes 1-
8: 0/0.2/0.3/0.5/0.6/0.7/0.8/0.9 µg protein; lanes 9-12: 0/0.2/0.6/0.9 µg protein. (B) EMSAs 
using the promoter region of the sol operon and Cap0037 protein. Lanes 1-5:/0.28/0.42/0.7/1 
µg protein; lanes 6-8: 0/0.42/1 µg protein. 
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Figure 6-9 DNA footprinting of Cap0037 interacting with adc and sol promoter 
(A) DNAase I protection assay I (DNA Footprinting) of Cap0037 interacting with adc promoter region (probe 144). End-labeled 
DNA fragment carrying the promoter region of the adc operon was incubated with different concentrations of Cap0037, subjected to 
DNAase I cleavage, and analyzed on sequencing gel. Sequencing reaction was performed with plasmid pDrive_144.  
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(B) DNA footprinting of Cap0037 interacting with adc promoter region (transcription start) (probe adcStart). End-labeled DNA 
fragment carrying the promoter region of the adc operon (transcription start) was incubated with different concentration of Cap0037, 
subjected to DNAase I cleavage, and analyzed on sequencing gels. Sequencing reaction was performed with plasmid pDrive_adcStart.  
(C) DNA Footprinting of Cap0037 interacting with sol promoter region (probe sol). End-labeled DNA fragment carrying the 
promoter region of the sol operon was incubated with different concentration of Cap0037, subjected to DNAase I cleavage, and 
analyzed on sequencing gels. Sequencing reaction was performed with plasmid pDrive_sol.  Line 1-7: 0-2308 nM Cap0037. The 
assigned region on the right side indicates the region protected by Cap0037 and the respective sequence. 
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Figure 6-10 DNA sequence analysis of the promoter regions of (A), adc, and (B) sol operon.  
Cap0037 binding sites (Cap0037 BS) determined in this study are shown in red boxes. Spo0A binding sites (Spo0A BS) are 
shown in orange boxes [121,205]. Promoter -35 and -10 elements are shown in blue letters [205,206]. Putative -35 and -10 sequences 
of CAP0037/CAP0036 operon were analyzed by BPROM tool. Three imperfect repeats on sol promoter are shown in green letters 
[205]. Coding sequences are in brown letters. 
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6.3.5 Determination of putative Cap0037 regulon 
The 5’-ATATTTTCATATAAAT-3’ sequence and the conserved motif (Figure 6-11) were 
used as references for the construction of a putative Cap0037 regulon by whole C. 
acetobutylicum genome analysis using RegPredict. The sequences that scored with values 
higher than 5.0 (which allow 3 mismatches or less) were selected and further analyzed for 
their relative position to the CDS of the corresponding gene. In addition to the three Cap0037 
binding sites previously identified in the electromobility shift assays, eight other putative 
Cap0037 binding sites were discovered (Table 6-1). Of these eight sites, the transcription of 
the genes potentially regulated by Cap0037 binding was analyzed for the Cap0037::int mutant 
and compared to the wild-type in the three metabolic states. 
The first putative Cap0037 binding site was located between the -35 and -10 promoter 
regions of an operon (CA_C1029-CA_C1032) encoding an iron transport system of the Feo 
family. This operon was strikingly up-regulated under all conditions in the Cap0037::int 
mutant. Previously, this operon was shown to be controlled by Fur (encoded by CA_C1682), 
the ferric uptake regulator, and was found to be highly induced by iron limitation or in the 
fur::int mutant [130]. There is one Fur box located downstream of the -10 promoter region of 
CA_C1029-CA_C1032. The inhibition of transcription via Fur occurs through the 
polymerization of the Fur-Fe
2+
 complex in the operator region, subsequently blocking RNA 
polymerase access to the promoter. During iron starvation, iron dissociates from the metallo-
regulatory protein, resulting in dissociation of the complex and the alleviation of the 
transcriptional repression of genes involved in the acquisition of iron [207]. Here, we 
determined the putative Cap0037 binding position between the -35 and -10 promoter region of 
CA_C1029-CA_C1032. The expression of the Fur encoding gene was unchanged in the 
Cap0037::int mutant under all continuous cultures conditions. Thus, Cap0037 might be the 
second repressor of this iron transport system, raising the question of how Cap0037 and/or 
Cap0037 together with Fur carry out a regulatory role. 
The second putative Cap0037 binding site was located 7 bp upstream of the -35 promoter 
region of an operon (CA_C2777-CA_C2778) encoding a glutaredoxin and a rubredoxin. This 
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operon was up-regulated under all conditions in the Cap0037::int mutant. Previously, this 
operon was shown to be controlled by PerR (encoded by CA_C1682), the peroxide repressor, 
and was found to be induced by oxygen exposure or in a perR mutant [129]. There is one 
PerR box located downstream of the -10 promoter region of CA_C2277-CA_C2278. Thus, in 
addition to the iron transport discussed above, which could be regulated by the Cap0037 and 
Fur proteins, we have potentially identified another operon that can be controlled by two 
regulators, Cap0037 and PerR. 
The third and the fourth putative Cap0037 binding sites were in the promoter region of 
two genes encoding potential transcriptional regulators of the MarR family for CA_C3283 and 
of a CRO repressor-like DNA binding protein for CA_C3645. The Cap0037 binding site was 
located downstream of the TSP of CA_C3283, which is part of a three-gene operon 
(CA_C3283-CA_C3281) including two genes encoding a potential ABC transporter. All three 
genes were up-regulated in the Cap0037::int mutant under acidogenesis and alcohologenesis. 
The regulatory effects of Cac3283 on the transcription of the two ABC transporter encoding 
genes and the role of this ABC transporter are still unknown. CA_C3645 is expressed as a 
monocistronic operon, and the Cap0037 binding site was located downstream of the TSP. Its 
transcription was up-regulated under acidogenesis only in the Cap0037::int mutant.  
The last four putative Cap0037 binding sites were located in the promoter region of a 
three-gene operon (CA_C0984-CA_C0986) encoding membrane proteins of unknown 
function, a three-gene operon (CA_C0460-CA_C0462) involved in butanoate metabolism, a 
gene CA_C3231 encoding a potential HAD (haloacid dehalogenase-like) type of phosphatase 
and the CA_C0091 gene (encoding ketol-acid reductoisomerase, involved in valine, leucine 
and isoleucine biosynthesis). However, the transcription levels of all of these genes were 
poorly affected in the Cap0037::int mutant (Table 6-1).  
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Figure 6-11 Putative Cap0037 binding sequence. (A) alignment and (B) sequence logo 
showing frequencies of residues  
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Table 6-1 Prediction of putative Cap0037 regulon and the correspondent relative transcript levels of those genes of 
Cap0037::int mutant in the three metabolic states: acidogenesis (AC), alcohologenesis (AL), and solventogenesis (SO).  
Letters in orange are mismatched nucleotides compared to the binding box ATATTTTCATATAAAT in Cap0037 promoter. 
 
ORF 
Putative binding 
sequence 
Genes Function 
Fold regulation 
AC AL SO 
CAP0037/0036 ATATTTTCATATAAAT 
CAP0037 Uncharacterized protein 0.962 50.716 68.558 
CAP0036 Uncharacterized protein 1.116 45.455 59.483 
CAC3283/3282/3281 ATATTTTTATATAAAT 
CAC3283 
Transcriptional regulator, 
MarR/EmrR family 
2.515 2.151 1.223 
CAC3282 
ABC-type 
multidrug/protein/lipid transport 
system, ATPase component 
4.146 2.427 1.858 
CAC3281 
ABC-type 
multidrug/protein/lipid transport 
system, ATPase component 
3.030 1.759 1.054 
CAC3231 AGATTTTAATATAAAT CAC3231 
Predicted phosphatase, HAD 
superfamily 
1.515 1.419 1.285 
CAC2777/2778 ATATTTTTATTTAAAT CAC2777 Glutaredoxin 7.201 3.447 1.623 
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CAC2778 Rubredoxin 8.474 4.304 2.002 
CAC0091 GTTTTTTTATATAAAT CAC0091 Ketol-acid reductoisomerase 1.157 0.584 0.746 
CAC0460/0461/0462 ATATATAAATATAAAT 
CAC0460 
CBS-domain containing 
protein, YHDP B.subtilis 
ortholog 
1.758 1.066 1.280 
CAC0461 
Mercuric resistance operon 
regulatory protein, MerR family 
1.562 1.177 1.047 
CAC0462 Trans-2-enoyl-CoA reductase 1.677 1.085 1.300 
CAP0165 ATAAGTTTATATAAAT CAP0165 Acetoacetate decarboxylase 0.150 0.397 0.382 
CAC0984/0985/0986 ATATTGACATTTAAAT 
CAC0984 
ABC transporter, ATP-binding 
protein 
1.098 0.559 2.064 
CAC0985 
ABC transporter, permease 
component 
0.802 0.452 2.207 
CAC0986 
Lipoprotein, attached to the 
cytoplasmic membrane, NLPA 
family 
0.976 0.714 2.681 
CAC1029/1030/1031/1
032 
ATATATACATTTAAAT 
CAC1029 
FeoA-like protein, involved in 
iron transport 
195.62 243.32 76.236 
CAC1030 
FeoA-like protein, involved in 
iron transport 
252.12 283.60 83.150 
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CAC1031 
FeoB-like GTPase, responsible 
for iron uptake 
220.99 337.12 68.679 
CAC1032 
Predicted transcriptional 
regulator 
318.15 452.71 82.493 
CAC3645 ATTTTTTCTTTTAAAT CAC3645 
CRO repressor-like DNA-
binding protein 
2.422 0.702 0.798 
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6.3.6 Global transcription changes in the Cap37::int mutant 
6.3.6.1 Overview 
The assessment of global transcriptional changes is summarized in Figure 6-12. To filter 
the data for only significant results, the same criteria used to compare the wild-type strain 
under different physiological conditions [42] were used to compare the mutant to the control 
strain. The first criterion was > 4.0-fold higher expression or > 4.0-fold lower expression of 
the Cap37::int genes compared to the control strain under the same physiological conditions, 
and the second criterion was > 0.2 mRNA molecules per cell in at least one of the two strains 
being compared.  
Venn diagrams (Figure 6-12A and B) show the number of significantly up-regulated and 
down-regulated genes in all three metabolic states of the mutant. There are 23 genes up-
regulated and 13 genes down-regulated under all conditions. Noticeably, the up-regulated 
genes in alcohologenesis were also generally up-regulated in acidogenesis. The down-
regulated genes in the three states were diverse.  
Figure 6-12C and D statically categorized the up- and down- regulated genes into COGs 
(Cluster Orthologous Groups, data from http://eggnogdb.embl.de and 
http://www.microbesonline.org). There were many genes belonging to the “not determined” 
(N.D.) group, as orthologs could not be found in the Gram-positive bacteria database. There 
was also a significant number of genes belonging to the “function unknown proteins” (S) 
COG, especially in the down-regulated gene set. However, the graphs show the diversity of 
genes that were affected by Cap0037 inactivation. In the up-regulated gene set, C, E, F, H, M, 
P, R, S, and N.D. COGs were enriched. The most enriched groups were the amino acid 
transport and metabolism and inorganic ion transport and metabolism groups. The down-
regulated genes were divided across the C, G, H, I, K, M, N, S, T, and N.D COGs. The most 
enriched group was G, which is the carbohydrate transport and metabolism group, while the S 
and N.D. groups were not very informative. The results will be discussed in more detail 
below.  
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(D) 
 
Figure 6-12 Statistical analysis of transcriptomics of C. acetobutylicum Cap0037::int 
mutant in acidogenesis, alcohologenesis and solventogenesis.  
Venn’s diagram of the comparison of upregulated genes (A) and of down regulated genes 
(B) in the three metabolic states. Distribution into COG functional group of upregulated genes 
(C) and down regulated genes (D) in the three metabolic states. COG C: energy production 
and conversion; COG D: cell division and chromosome partitioning; COG E: amino acid 
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transport and metabolism; COG F: nucleotide transport and metabolism; COG G: 
carbohydrate transport and metabolism; COG H: coenzyme metabolism; COG I: lipid 
metabolism; COG J: translation, ribosomal structure and biogenesis; COG K: transcription; 
COG L: DNA replication, recombination and repair; COG M: cell envelope biogenesis and 
outer membrane; COG N: cell mobility secretion; COG O: post translational modification, 
protein turn over, chaperones; COG P: inorganic ion transport and metabolism; COG Q: 
secondary metabolites biosynthesis, transport and catabolism; COG R; general function 
prediction only; COG S: unknown function; COG T: signal transduction mechanisms; COG 
U: intracellular trafficking, secretion and vesicular transport; COG V: defense mechanism; 
N.D. not determined. 
6.3.6.2 Amino acid transport and metabolism 
6.3.6.2.1 Arginine transport and metabolism 
The genes involved in arginine biosynthesis, argDBCJ (CA_C2388-CA_C2391), argGH 
(CA_C0973-CA_C0974) and carA (CA_C2645), were up-regulated in acidogenesis and 
expressed differentially in solventogenesis and alcohologenesis. These genes were predicted 
to be regulated by ArgR; however, the expression of argR was unchanged in the mutant. In 
addition, there were many other genes predicted to be regulated by ArgR [193] whose 
expression was unchanged or only slightly changed. This information can be found in Figure 
6-13A. The arginine synthesis pathway was found to be up-regulated in response to butyrate 
stress, especially at low concentrations, or to butanol stress at high concentrations in C. 
acetobutylicum [193]. The arginine synthesis pathway was also induced in response to 
oxidative stress in the fungus Candida albicans [208] but repressed in C. acetobutylicum in 
the oxygen-exposed wild-type strain and in a per inactivated mutant [129]. 
6.3.6.2.2 Histidine biosynthesis 
Genes involved in the histidine biosynthesis CA_C0935-CA_C0944 were up-regulated 
more than 2-fold in acidogenesis but only slightly affected under the other conditions (Figure 
6-13B). In S. typhimurium, to synthesize one histidine molecule, 41 ATP equivalents are 
required [209]. Thus, histidine biosynthesis is associated with a high energy cost for the cells. 
No regulatory protein was found to control the transcription regulation of biosynthesis genes 
in E. coli and S. typhimurium [210]. Additionally, the expression levels of histidine 
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biosynthesis genes in E. coli, S. typhimurium and Corynebacterium glutamicum were 
stimulated by the two effector molecules guanosine tetraphosphate (ppGpp) and guanosine 
pentaphosphate (pppGpp), which accumulated when the cells responded to amino acid 
starvation [209–211]. However, histidine biosynthesis regulation appears to be different in C. 
acetobutylicum. It was found that CA_C2675 encodes a protein orthologous to the HisR of 
Staphylococcaceae and that a cis-element in the upstream region of CA_C0935- CA_C0944 
was highly similar to the DNA binding motif of HisR [193]. Using RegPredict [212], a HisR 
regulon in C. acetobutylicum was proposed to contain the operon CAC0935-0944 and hisC 
(CA_C3031). Those genes also responded differently to different levels of butanol and 
butyrate stresses [193]. In addition, induction of the histidine biosynthesis pathway 
contributed to acid tolerance in Lactococcus casei [213].  
6.3.6.2.3 Tryptophan biosynthesis 
The tryptophan biosynthesis operon pabBA/trpDCFBA (CA_C3163-CA_C3157), which 
encodes proteins that convert chorismate into tryptophan, was up-regulated > 2-fold in 
acidogenesis and alcohologenesis and was slightly down-regulated in solventogenesis. 
Previously, the tryptophan biosynthesis operon was reported to be down-regulated by the 
addition of butyrate during the continuous culture of a ptb mutant [111] or in batch culture 
under butyrate stress [193,197] (Figure 6-13B). 
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Figure 6-13 Expression profiles of genes involved in Arginine (A), Histidine and 
Tryptophan (B) and Cystein (C) transport and metabolism in acidogenesis, 
alcohologenesis and solventogenesis  
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6.3.6.2.4 The putative CymR and IscR regulons 
Two putative CysK proteins (encoded by CA_C0931 and CA_C2235) involved in L-
cysteine biosynthesis from O-acetyl-L-serine (OAS) were up-regulated in acidogenesis and 
solventogenesis in the Cap37::int mutant (Figure 6-13C). In Bacillus subtilis, CysK plays 
important roles in the response to environmental changes by signaling cysteine availability to 
a CymR repressor via sensing the concentration of its substrate OAS [214]. CysK forms a 
complex with CymR and stabilizes the CymR-DNA interaction. In the presence of cysteine, 
the pool of OAS is low and the formation of CymR-CysK occurs and represses the 
transcription. In the absence of cysteine, the pool of OAS is high, and the CymR-CysK 
complex dissociates and de-represses the transcription [214]. In C. acetobutylicum, the protein 
encoded by CA_C2236 had more sequence similarity to CymR than the protein encoded by 
CA_C1675, whereas the protein encoded by CA_C1675 showed more similarity to IscR than 
the protein encoded by CA_C2236 [193]. However, the IscR and CymR DNA binding motifs 
had a significant number of sequence similarities. Thus, more experimental data is necessary 
to distinguish and validate the functions of these two proteins. In addition, in the Cap37::int 
mutant, the expression of the putative CymR-encoding gene was up-regulated in acidogenesis 
and solventogenesis, whereas the putative IscR-encoding gene was down-regulated under all 
conditions. All other putative genes belonging to the CymR regulon predicted by RegPredict 
[193] were up-regulated, especially the CA_C0102-CA_C0110 operon, which was 
significantly up-regulated in acidogenesis (up to 58-fold) and solventogenesis (up to 50-fold) 
and was significantly down-regulated in alcohologenesis (more than 7-fold). This CA_C0102-
CA_C0110 operon has been found to be up-regulated in response to butanol/butyrate stress 
(Wang et al., 2013, Alsaker et al., 2010); under alcohologenesis in wild-type strains [42] and 
in the Δptb strain [111]. The two putative cysteine ABC transporter operons belonging to the 
CymR regulon (CA_C0878-CA_C0880 and CA_C3325-CA_C3327) were also up-regulated in 
acidogenesis. However, the expression patterns of these two operons were slightly different 
under solventogenesis and alcohologenesis conditions. Genes potentially belonging to the 
CymR regulon, such as CA_C0985-CA_C0986, which is involved in the D-methionine 
transport system, did not exhibit remarkable changes. 
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6.3.6.3 The up-regulation of genes involved nucleic acid transport and metabolism 
Genes involved in pyrimidine biosynthesis, such as pyrDZFIB (CA_C2650-2654) and 
carAB (CA_C2644-CA_C2645), were strikingly up-regulated under all three conditions 
(between 17- and 100-fold)  Figure 6-14. Those operons are shown to be up-regulated after n-
butanol pulse in wild-type C. acetobutylicum [194] but down-regulated under acetate and 
butyrate stresses[197]. The putative uracil permease-encoding gene, pyrP (CA_C2112), was 
slightly up-regulated under all conditions. 
Genes involved in purine biosynthesis, purECFMNHD (CA_C1390-1396) and purQ/J 
(CA_C1655), were up-regulated more than 2-fold in acidogenesis but insignificantly down-
regulated in solventogenesis and alcohologenesis. Purine metabolism was reported to be 
strongly up-regulated in response to high butyrate stress levels, suggesting its involvement in 
acid resistance [193] Those genes were up-regulated under low butanol stress conditions but 
down-regulated under high butanol stress conditions [193,194]. In C. acetobutylicum cells 
exposed to oxygen, this purine biosynthesis pathway was also up-regulated in order to repair 
damaged DNA [129]. 
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Figure 6-14 Expression profiles of genes involved in nucleic acid metabolism in 
acidogenesis, alcohologenesis and solventogenesis  
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6.3.6.4 The expression of cation transporter-encoding genes 
Three potassium transport-related genes, kdpX (CA_C3679), kdpC (CA_C3681) and 
kdpD (CA_C3680), were significantly up-regulated in acidogenesis whereas the sodium efflux 
pump encoding the operon consisting of natA (CA_C3551) and natB (CA_C3550) was down-
regulated (Figure 6-15). Those cation transporters were previously found to be up-regulated in 
response to acetate and butyrate stresses [197]. 
 
 
Figure 6-15 Expression profiles of genes involved in cation transport, glycerol lipid 
transport and metabolism in acidogenesis, alcohologenesis and solventogenesis  
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6.3.6.5 Glycerol lipid metabolism 
The Cap37::int mutant was only able to consume low amounts of glycerol in 
alcohologenesis. The transcriptomic data reveals significantly down-regulated genes involved 
in glycerol uptake and the oxidation pathway (CA_C1319-CA_C1322). Glycerol-3-P ABC 
transporter-encoding genes (CA_C0427-CA_C0430) were significantly down-regulated in 
acidogenesis and alcohologenesis but remained unchanged in solventogenesis (Figure 6-15).  
6.3.6.6 Motility and chemotaxis 
The cell motility genes encode products responsible for the chemotactic response and 
flagella assembly. Table S-  shows the expression changes in cell motility related genes in the 
Cap37::int mutant. It was reported that in Clostridia and Bacilli, those genes were down-
regulated in cells undergoing sporulation processes [215]. Response regulators CheA, CheB, 
CheC, CheD, CheR, CheV, CheY, CheW, and CheX, the methyl-accepting chemotaxis proteins 
and the genes involved in flagella assembly, including FlgGEDBCKM and 
FliDEFGHJKRSPQYZ, were down-regulated in the Cap37::int mutant under acidogenesis and 
solventogenesis; however, they were differentially regulated under alcohologenesis. These 
motility and chemotaxis systems were also down-regulated in the buk-knockout mutant and in 
the spo0A-over-expressing strain [195,216]. 
6.3.6.7 Sporulation 
In Bacillus subtilis, AbrB inhibits sporulation by repressing sigH, subsequently 
suppressing the expression of spo0A [94]. In C. acetobutylicum, the role of AbrB is unclear. 
There are many abrB annotated genes in the C. acetobutylicum genome. The abrB310 
(CA_C0310) was the only gene found to be actively transcribed based on the chloramphenicol 
acetyltransferase reporter gene analysis. When this gene is knocked down by antisense RNA, 
solventogenesis and differentiation are delayed [127]. In our Cap37::int mutant, abrB310 was 
significantly down-regulated under acidogenesis and alcohologenesis conditions. However, 
the other abrB (CA_C3647) gene was significantly up-regulated under these conditions. 
The expression of spo0A was not affected in the Cap37::int mutant. To activate Spo0A 
via phosphorylation, histidine kinases were employed. Many histidine kinases have been 
found in the C. acetobutylicum genome, including Cac0323, Cac0903, Cac3319 and Cac0437 
(with exceptional dephosphorylation activity) [119]. In the wild-type strain, CA_C3319 
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exhibits the highest expression among the four. In the acidogenic Cap37::int mutant, the 
CA_C3319 histidine kinase-encoding gene (as well as the other three) and sigF were 
significantly down-regulated. In the solventogenic Cap37::int mutant, the phosphorylation of 
Spo0A was not affected as the histidine kinase-encoding gene expression remained 
unchanged. In addition, we observed a significant up-regulation of all of the sporulation sigma 
factors: sigE, sigF, sigG, sigK and spoIIAA (Figure 6-16). The high expression of sigF along 
with the high expression of sigE and sigG was in agreement with previous findings that SigF 
is necessary for the expression of other sigma factors [119]. 
 
 
Figure 6-16 Expression profiles of genes involved in sporulation in acidogenesis, 
alcohologenesis and solventogenesis state 
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6.3.6.8 CA_P0037 inactivation affects the expression of the Rex, Fur and PerR 
regulons 
6.3.6.8.1 In the Cap37::int mutant the Rex regulon transcription is affected. 
The redox sensing transcriptional repressor (Rex) has been found to modulate its DNA-
binding activity in response to the NADH/NAD
+
 ratio and plays a role in the solventogenic 
shift of C. acetobutylicum. Rex binding sites were determined in the promoters of different 
operons: adhE2, ldhA, crt, thlA, asrT, ptb, and nadA [110,134]. Those operons were up-
regulated in the Rex mutant. The gene ldhA was the most induced gene followed by adhE2 
[134]. In the Cap37::int mutant, Rex expression was only 1.4-fold higher in acidogenesis and 
was unchanged in alcohologenesis and solventogenesis. However, except for the thlA gene, all 
of the other genes of the Rex regulon, such as adhE2, ldhA, crt-bcd-etfAB-hbd, nadABC, and 
ptb-buk, were up-regulated to varying degrees (Table 6-2). As there are no putative Cap0037 
binding sites in the promoter region of all the genes or operons shown to be controlled by 
Rex, it is tempting to speculate that the effect of Cap0037 inactivation might be indirect and 
occur through an increase in the NADH/NAD
+
 ratio. The fact that thlA was unchanged or 
slightly down-regulated in the Cap37::int mutant but highly up-regulated in the Rex mutant 
suggests a more complex regulatory mechanism of thlA expression. 
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Table 6-2 Expression profiles of Rex regulon in the three metabolic states: acidogenesis 
(AC), alcohologenesis (AL) and solventogenesis (SO) 
ORF Function 
Relative expression MT/WT (fold) 
AC AL SO RexMT/WT
*
 
CAC0267 L-lactate dehydrogenase 83.37 31.58 3.54 13.75 
CAC1023 Nicotinate-nucleotide pyrophosphorylase 2.62 0.84 0.34 1.79 
CAC1024 Aspartate oxidase 2.25 0.86 0.63 1.79 
CAC1025 Quinolinate synthase 2.33 0.93 0.54 2.53 
CAC1512 Formate/nitrite family of transporter n.d. n.d. n.d. 2.04 
CAC1513 Anaerobic sulfite reductase (Fe-S subunit) n.d. n.d. n.d. 2.41 
CAC1514 Anaerobic sulfite reductase, B subunit 0.61 0.72 0.77 2.67 
CAC1515 Anaerobic sulfite reduction protein C, reductase n.d. n.d. n.d. 1.69 
CAC2708 -hydroxybutyryl-CoA dehydrogenase 1.86 0.32 0.53 2.79 
CAC2709 Electron transfer flavoprotein alpha-subunit 2.60 0.51 0.75 1.55 
CAC2710 Electron transfer flavoprotein beta-subunit 2.02 0.38 0.68 2.17 
CAC2711 Butyryl-CoA dehydrogenase 1.46 0.96 0.83 2.81 
CAC2712 Crotonase (3-hydroxybutyryl-COA dehydratase) 1.85 0.94 1.04 2.43 
CAC2873 Acetyl-CoA acetyltransferase 0.98 0.25 0.43 12.46 
CAC3075 Butyrate kinase, BUK 0.89 0.65 0.71 1.97 
CAC3076 Phosphate butyryltransferase 1.41 0.79 0.86 6.07 
CAP0035 Aldehyde-alcohol dehydrogenase, ADHE2 49.81 0.11 4.47 164.75 
CAC2713 AT-rich DNA-binding protein 1.44 0.79 0.92 n.a. 
* Data from Zhang et al. 2014, n.a.: not available; n.d.: not detected 
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6.3.6.8.2 In the Cap37::int mutant the PerR regulon transcription is affected. 
 In a perR mutant or after the wild-type strain is exposed to oxygen, the genes encoding 
for proteins involved in oxygen and ROS detoxification, including the reverse rubrerythins 
(rbr3A-rbr3B), desulfoferrodoxin (dfx), glutaredoxin (CA_C2777), rubredoxin (rd, 
CA_C2778), NADH-dependent rubredoxin oxidoreductase (nror), the oxygen-reducing 
flavoproteins (fprA1 and fprA2) and a flavodoxin (CA_C2452), were up-regulated [129]. The 
Cap0037::int mutant behaved quite similarly to the perR mutant under acidogenic and 
alcohologenic conditions (Table 6-3). As shown above, a putative Cap0037 binding site was 
located 7 bp upstream of the -35 promoter region of CA_C2777-CA_C2778 encoding a 
glutaredoxin and a rubredoxin, respectively. However, no putative Cap0037 binding sites 
were identified in the promoter region of all of the other genes or operons shown to be 
controlled by PerR, and it is probable that the effect of Cap0037 inactivation is indirect.  
6.3.6.8.3 In the Cap37::int mutant the Fur regulon transcription is affected.  
Interestingly, we also found a common regulatory effect of Cap0037 with the fur mutant. 
Table 6-3 compares the Cap0037::int mutant with the fur mutant and the iron-limiting wild-
type. One of the most critical similarities is the over-expression of genes involved in iron 
transport and metabolism. As discussed above, the ferrous transport system FeoA (encoded by 
CA_C1029-CA_C1032), which contains a putative Cap0037 box and a Fur box in the 
promoter, was strikingly over-expressed in the Cap37::int mutant, the Fur mutant and in the 
iron-limited WT. The second putative ferrous iron-uptake system FeoB (encoded by 
CA_C0447-CA_C0448) for Fe
2+
 and the ferrichrome-dependent system (encoded by 
CA_C0788-CA_C0791) were also highly up-regulated in all cases, although less significantly 
in the iron-limited wild-type strain. A flavodoxin (fld1)-encoding gene (CA_C0587) was 
strikingly up-regulated in the iron-limited WT, a fur mutant and the Cap37::int mutant (Table 
6-3). A Fur box was found in the promoter of fld1 (CAC0587), but no putative Cap0037 box 
was identified. It has been well-documented that ferredoxin is reduced dramatically in 
Clostridia under low iron conditions, fld is induced and flavodoxin replaces ferredoxin as a 
single electron carrier. However, in the Cap37::int mutant, the expression level of fdx 
(CA_C0303), encoding the main ferredoxin, was not reduced. In iron deficiency, or in a fur 
mutant or Cap0037 inactivation, the levels of genes belonging to the ribGBAH operon, which 
is involved in riboflavin synthesis, are strongly induced. Riboflavin biosynthesis genes were 
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previously shown to be up-regulated only by butyrate stress and not by acetate or butanol 
stress [197]. Riboflavin is a precursor of the FMN and FAD coenzymes. The expression of the 
rib operon was shown to be regulated by a FMN-sensing riboswitch element [217] in B. 
subtilis, but the regulatory mechanism in C. acetobutylicum has yet to be characterized.  
To summarize, the Cap37::int mutant cells behave as if they are Fe
2+
-limited, although 
they exist under iron excess. However, the up-regulated Fur regulon in the mutant is an 
indirect regulatory effect rather than reflecting a real shortage in the intracellular Fe
2+
 
concentration, and except for the FeoA-encoding operon (CA_C1029-1032), no Cap0037 box 
was identified in the promoter regions of the up-regulated genes. 
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Table 6-3 Transcriptional profiles of selected genes in Cap0037::int mutant in the three metabolic states compared with those of oxygen 
exposed WT, ΔPerR mutant, iron limited WT and Fur::int mutant 
ORF Gene Protein function 
Cap0037 ::int vs WT ΔPerR vs WT
a
 Fur ::int vs WT
b
 
AC AL SO 
Cap37 
box 
+O2
/-O2 ΔPerR 
Per 
box 
−Fe/
+Fe 
Fur : 
: int 
Fur 
box 
CAC1027 fprA1 Flavoprotein 0.97 1.06 1.01 − 4.4 16.1 + n.a. n.a. − 
CAC2449 fprA2 Flavoprotein 7.01 3.28 1.21 − 7.3 22.5 + n.a. n.a. − 
CAC2448 nror NROR 6.30 2.54 1.12 − 7.8 16.8 + n.a. n.a. − 
CAC2450 dfx 
desulfoferrodoxin, 
superoxide reductase 2.39 1.11 0.39 − 18.4 29.6 + n.a. n.a. − 
CAC2777   Glutaredoxin 7.20 3.45 1.62 + 3.5 6.0 + n.a. n.a. − 
CAC2778 rd Rubredoxin 8.47 4.30 2.00 + 5.2 14.4 + n.a. n.a. − 
CAC3306 tpx Thiolperoxidase 2.16 0.77 0.63 − 3.0 3.4 + n.a. n.a. − 
CAC3597 rbr3B Reverse rubrerythrin 1.69 0.78 1.45 − 5.6 26.9 + n.a. n.a. − 
CAC0447 feoB 
Feo protein, involved in 
Fe
2+
 transport 18.67 70.71 5.65 − 2.3 1.22 − n.a. n.a. − 
CAC0448 feoB Fe
2+
 transport protein B  6.58 17.92 2.71 − 2.8 1.34 − 3.76 n.a. − 
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CAC0788   
Ferrichrome transport 
permease 76.51 32.37 33.6 − 3.3 n.a. − 207 33.6 + 
CAC0789 fhuB Permease 125.0 50.73 59.5 − 3.4 n.a. − 199 37.4 + 
CAC0790 fhuD 
Ferrichrome-binding 
periplasmic protein 195.4 128.3 50.7 − 2.6 n.a. − 86.7 54.4 + 
CAC0791 fhuC 
Ferrichrome ABC 
transporter, ATP-binding 
protein  90.69  − 2.3 n.a. − 122.2 67.0 + 
CAC1029 feoA  
FeoA-like protein, 
involved in iron transport 195.6 243.3 76.2 + 5.8 0.99 − 100.5 140.5 + 
CAC1030 feoA   
FeoA-like protein, 
involved in iron transport 252.1 283.6 83.1 + 8.1 1.06 − 113.8 154.7 + 
CAC1031   
FeoB-like GTPase, 
responsible for iron 
uptake 220.9 337.1 68.6 + 15.9 1.13 − 246.7 235.9 + 
CAC1032   
Predicted transcriptional 
regulator 318.1 452.7 82.4 + 4.3 0.94 − 218.1 159.9 + 
CAC0587  fld1 Flavodoxin 461.9 1197 119 − 11.4 n.a. − 275.7 312.4 + 
CAC2452  fld Flavodoxin 6.15 3.90 1.58 − 3.6 11.6 + n.a. n.a. − 
CAC0590 ribD 
Pyrimidine deaminase and 
8.13 1.78 3.36 − 2.08 1.22 − 65.4 78.9 + 
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pyrimidine reductase 
CAC0591 ribB 
Riboflavin synthase 
subunit α 9.07 1.31 3.68 − 1.72 1.1 − 55.3 57.2 + 
CAC0592 ribA 
GTP cyclohydrolase/3,4-
dihydroxy-2-butanone 4-
phosphate synthase 10.83 1.30 3.56 − 1.5 1 − 44.2 61.9 + 
CAC0593 ribH 
6,7-dimethyl-8-
ribityllumazine synthase 5.88 1.02 1.98 − 1.71 1.05 − 41.0 49.0 + 
a, b Data from Hillmann et al. 2009 and Vasileva et al. 2012, respectively; n.a.: not available 
 
 
172 
 
6.4 Conclusion 
Collectively, these results demonstrate that in the strict anaerobe C. acetobutylicum, 
Cap0037 directly or indirectly controls a large set of genes belonging to the Rex, PerR and 
Fur regulons. This control drastically affects metabolism under both acidogenic and 
alcohologenic conditions. More experiments will be needed to understand the role of Cap0037 
in the regulatory network of C. acetobutylicum.  
6.5 Experimental Procedure 
6.5.1 Bacterial strains, plasmids and culture media 
The bacterial strains, plasmids and primers used in this study are listed in Table S- . C. 
acetobutylicum ∆cac1502∆upp and its derivative mutants were grown in Clostridial growth 
medium (CGM) for routine manipulation and in synthetic medium (SM) for sporulation and 
the production of solvents. A Reinforced Clostridial Agar (RCA) plate with antibiotic at a pH 
of 5.8 was used after electroporation and a pH of 6.5 was used for the replication of 
transformants. The E. coli strain was grown in Luria-Bertani (LB) medium at 37°C. 
Antibiotics were used at the following concentrations: erythromycin and clarithromycin at 40 
g/ml and thiamphenicol at 10 g/ml for C. acetobutylicum and ampicillin at 50 g/ml for E. 
coli. 
6.5.2 Plasmid construction 
Plasmid pMTL007C-E2::Cap0037 (277a) was generated from pMTL007C-E2 [84]. The 
retargeting region was designed via a Perutka algorithm and was constructed using the 
relative primers in Table S- . The pMTL007C-E2::Cap0037 (277a) plasmid was then 
transformed into Clostridium acetobutylicum ∆cac1502∆upp by electroporation without prior 
methylation  [167], and the transformants were selected on an RCA plate at a pH of 6.5 
containing thiamphenicol at 40 g/ml. After that, integrants were selected on an RCA plate at 
a pH of 6.5 containing erythromycin at 40 g/ml and were analyzed by PCR using the 
CAP0037_F and CAP0037_R primers that flank the 277/278 position. We were unable to 
detect the intron inserted at the target position in the integrants. As the integrants were Erm 
resistant, the intron should have been integrated elsewhere in the genome. Another 
construction used was pCUI-Cap0037 (189s). This plasmid is derived from the pCUI plasmid, 
which was developed by our lab [182]. The intron in this vector is smaller than in the 
pMTL007C-E2 system because it does not contain a marker gene. Therefore, in order to 
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select for mutants, screening by PCR with 2 external primers must be performed. In the 
plasmid pCUI-Cap0037 (189s), the retargeting region was designed via the Perutka algorithm 
for the position 189/190 sense strand. In the presence of the ltrA gene, the integrants could 
lose the intron due to mRNA maturation. As a result, after screening and selecting for 
insertion, the plasmid pCUI-Cap0037 (189s) in the mutant was cured by spreading the cells 
on RCA at a pH of 6.5 containing 5’fluorouracil at 1 mM [167]. The colonies were then 
checked for plasmid loss by testing their sensitivity to Tm, Erm and PCR using LtrA 5D and 
LtrA 3R primers that are specific for the vector backbone. The mutant Cap0037::int was 
successfully generated by this second strategy. 
For the complementation experiment, CAP0037 CDS and its ribosomal binding site 
(RBS) were amplified by Cap0037-F-RBS BamHI and Cap0037-R-SfoI and cloned into a 
pSOS95 shuttle vector [154] by two restriction sites, BamHI and SfoI, to obtain the plasmid 
pSOS95-Cap0037. This pSOS95 vector allows the expression of CAP0037 under the 
constitutive thlA promoter. The plasmid pSOS95-Cap0037 was then electroporated into 
mutant Cap0037::int and selected on an RCA plate with Erm at 40 g/ml. The complementary 
strain carrying the plasmid was maintained in liquid MS culture under pressure from 
clarithromycin at 40 g/ml. 
Plasmid pBS2 was used for heterologous production of Cap0037. For construction of 
plasmid pBS2, the 630 bp CA_P0037 open reading frame was amplified by PCR using 
primers ygaS1hinCl and yghSrückCl with C. acetobutylicum WT genomic DNA as template. 
The PCR product was digested with NdeI and HindIII and ligated into respectively digested 
vector pET29a(+). Vector pET29a(+) contains a His-tag sequence that is added to the C-
terminus of the produced protein.  
Plasmids pDrive_86kurz, pDrive_144, pDrive_adcStart, and pDrive_sol were used for 
sequencing reaction of DNaseI protection assay (DNA Footprinting). For construction of 
pDrive_86kurz, pDrive_144, pDrive_adcStart, and pDrive_sol, the probes 85 (256 bp), 144 
(249 bp), adcStart (263 bp), and sol (245 bp) were amplified by PCR using genomic DNA 
form C. acetobutylicum WT as template and primers 86 fwd and 85 rev, 144 rev and 145 fwd, 
adcstart FP EcoRI fwd and adcstart FP EcoRV rev, and sol FP EcoRI fwd and sol FP EcoRV 
rev, respectively. PCR products were ligated into pDrive cloning vector.  The generated PCR 
probes 85 (256 bp), 144 (249 bp), adcStart (263 bp), and sol (245 bp) which contain parts of 
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respective promoter regions were used as probes for DNaseI protection assay (DNA 
Footprinting). 
6.5.3 Continuous culture 
Continuous fermentation was performed as previously described [42]. The cultures were 
maintained under acidogenesis, solventogenesis and alcohologenesis conditions, fed with 995 
mM total carbon, and maintained at a dilution rate of 0.05 h
-1
. Samples for the production 
profile analysis and mRNA extraction were prepared under steady states. Results from the 
mutant Clostridium acetobutylicum ∆cac1502∆uppCap0037::int were compared with the 
control strain Clostridium acetobutylicum ∆cac1502∆upp [42]. 
For the complementary strain, continuous culture under acidogenic condition was 
performed in the presence of clarithromycin at 40 g/ml for a short period to avoid losing the 
plasmid. The production profile was analyzed and compared with the mutant Cap0037::int. 
6.5.4 Isolation of total mRNA and microarray 
Total RNA was isolated from continuous cultures using the RNEasy kit protocol 
(Qiagen, Hilden, Germany), except for the cell breaking step that we adapted for C. 
acetobutylicum: 3 ml of culture were taken from the chemostat, transferred into a 15-ml 
Falcon tube, and immediately frozen in liquid nitrogen. The frozen culture was mechanically 
crushed in a mortar containing liquid nitrogen. After that, the extraction was processed using 
the Qiagen protocol. The quality and quality of the mRNA samples were controlled before 
proceeding to labeling, hybridization, one color microarray-based gene expression, and 
scanning using a Tecan MS200 scanner, followed by analysis using Feature Extraction 
V.11.5.1.1. The protocol and microarray slides used in this study were the same as described 
elsewhere [42] to obtain comparable results. 
6.5.5 Analytical methods 
The concentrations of the substrate and fermentation products were measured by high-
pressure liquid chromatography (HPLC, Agilent 1200 series, Massy, France). The separation 
was obtained with an Aminex HPX-87H column (300 x 7.8 mm, Biorad), at 14°C with 0.5 
mM H2SO4 at a flow rate of 0.5 ml/min. Detection was achieved by reading the refractive 
index and UV absorbance (210 nm). 
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6.5.6 Southern blot analysis 
Genomic DNA of the mutant Cap0037::int was digested with EcoRI restriction enzyme. 
The probe for hybridization was prepared by PCR using Intron probe-F and Intron probe-R 
primers and was then labeled using the DIG High Prime DNA Labeling and Detection Starter 
Kit II (Roche). The protocols for hybridization and detection were performed according to the 
Roche instructions. 
6.5.7 Expression and purification of His-tagged protein 
E. coli BL21 (DE3) cells (Novagen R & D Systems) containing pBS2 was used for 
overproduction of protein Cap0037. Cells were grown aerobically at 37 °C in LB medium 
supplemented with either kanamycin (50 µg/ml) or ampicillin (100 µg/ml) to OD600 0.7 and 
induced by addition of 1 mM isopropyl ß-D-1 thiogalactopyranoside (IPTG) at 37 °C, until 
stationary phase was reached. Cells were then harvested by centrifugation (4300 x g, 10 min, 
4 °C) and washed twice with buffer containing imidazole (10 mM). Wet weight of the cell 
pellet was determined and solubilized in three volumes of the buffer mentioned before. Cells 
were disrupted using a French
®
 pressure cell (4 MPa) (FRENCH
®
 Pressure Cell/Press, G. 
HEINEMANN Ultraschall- und Labortechnik, Schwäbisch Gmünd, Germany). The fusion 
protein was purified by nickel-nitrilotriacetic acid (NTA) affinity chromatography using Ni-
NTA Agarose (Qiagen GmbH, Hilden, Germany). For elution, imidazole buffers with 75, 
100, 200, and 250 mM imidazole were used. Purity of the protein was analyzed by SDS 
polyacrylamide gel electrophoresis, and protein concentration was quantified by Pierce BCA 
protein assay kit (Pierce, Rockford, USA) according to the instructions provided by 
manufacturer.  
6.5.8 Electromobility shift assays (EMSAs) 
For electromobility shift assays of the adc, CA_P0037/CA_P0036, and sol operon, 
respective DNA probes were amplified by PCR using genomic DNA from C. acetobutylicum 
ATCC 824 as template. For amplifying the 5ˈuntranslated region of the adc gene, the adc 
probe (318 bp), primers adc_forward and adc_reverse were used. For EMSAs to the 
5ˈuntranslated region of the CA_P0037/CA_P0036 operon, the CAP0037 probe (539 bp), 
primers 94_fwd and PEX1_kurz were used. For EMSAs to the 5ˈuntranslated region of the sol 
operon, sol probe (219 bp), primers sol_frag_F and sol_frag_R were used. The adcint probe 
(233 bp) was used as negative control and was amplified out of the internal region of the adc 
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gene, using primers adcmit1 and adcmit2. In the binding assays, DNA probes were mixed 
with increasing amounts of the respective fusion proteins in 20-µl reactions with 0.5 µl 
poly[d(I-C)] (2 µg/µl) and 2 µl band shift buffer (200 mM Tris, 500 mM Na-glutamate, 100 
mM MgCl2 x 6 H2O, 63.6 mM EDTA, 0.5 % Nonidet P-40 (v/v), 50 % glycerol (v/v)). After 
incubation for 20 min at room temperature, samples were loaded on a 2 % agarose gel in 1x 
TAE buffer (200 mM Tris, 100 mM acetate, 5 mM EDTA, pH 7.5), and separated by 
electrophoresis (70 V, 50 min). The gel was stained using ethidium bromide. 
For electromobility shift assays of ldhA and fld1, PCR DNA fragments of ldhA and 
fld1promoters were generated by two pairs of primers (ldh-prom-F and ldh-prom-R; fld1-
prom-F and fld1-prom-R) and DIG-labeled (with DIG High Prime DNA Labeling and 
Detection Starter Kit II (Roche)). Binding assays were done as described above. The detection 
of DNA shifts was performed according to Roche protocol.  
6.5.9 DNase I protection assays (DNA Footprinting) 
To determine the exact binding sites of protein Cap0037 at the 5ˈuntranslated region of 
the CA_P0037/CA_P0036 operon, adc operon, and sol operon, different DNA fragments 
(probes) were amplified by PCR (6.5.2). The primers generated restriction sites at both ends 
of the probes (6.5.2). Probes were radioactively 5ˈ labeled using [-
32
P] ATP. Labeling was 
performed in a 25 µl reaction with 20 pmol DNA, 2 µl polynucleotide kinase (10 U/µl) 
(Thermo Scientific, St. Leon-Rot, Germany), 2.5 µl Reaction Buffer (10x Binding Buffer (see 
below) and 2 µl BSA 100 mg/ml (w/v)), and 4 pmol [-
32
P] ATP (20 µCi). The reaction was 
incubated at 37 °C for 1 h. One end of the DNA was digested using EcoRV, removing a 5ˈ 
labeled phosphate. Purification of the labeled DNA was carried out by Microspin™ G-25 
columns (GE Healthcare, Buckinghamshire, UK) according to the instructions of the 
manufacturer. For protein binding, respective radio labeled DNA probe was mixed with 
increasing amounts of Cap0037 in a 20 µl reaction together with 0.5 µl poly[d(I-C)] (2 µg/µl) 
and 2 µl 10x Binding Buffer (500 mM Tris, 500 mM KCl, 50 mM MgCl2 x 6 H2O, 10 mM 
EDTA). After incubation for 30 min at 37 °C, 1.1 µl Buffer R1 (120 mM MgCl2 x 6 H2O, 120 
mM CaCl2 x 2 H2O) and 0.1 U DNase (Thermo Scientific, St. Leon-Rot, Germany) were 
added. Reaction was stopped after just 1 min by adding 1 µl EDTA (0.5 M, pH 8) and transfer 
on ice. The sample was purified by phenol chloroform extraction, the DNA was ethanol 
precipitated, and suspended in 3 µl of sequencing gel loading buffer (30 mg bromphenol blue, 
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30 mg xylene cyanole, 200 mEDTA (pH 8), ad 10 ml formamide).  After an incubation at 80 
°C for 2 min the DNase I digestion product was loaded on a 7 M urea 6 % polyacrylamide gel 
and separated at 1500 V, 46 mA, and 60 W for 2 h. Dideoxy sequencing reaction was 
performed using respective plasmid (6.5.2) and T7 Sequencing Kit (Affymertrix, Santa Clara, 
USA), and run in the same gel as the footprint sample. Gel was vacuum dried, exposed on 
Hyperfilm™ MP (Amersham Biosciences Europe GmbH; Freiburg) for 24 h, and developed 
with VCURIX 60V (AGFA Graphics GmbH & Co. KG, Düsseldorf, Germany). 
6.5.10 Bioinformatic tools 
6.5.10.1 Blast searches, amino acid sequence alignments and phylogenetic analysis  
Identification of orthologs was performed using the BLAST tool provided by NCBI 
[218]. Amino acid sequence alignment and the phylogenetic tree were processed using the 
phylogeny program [219]. 
6.5.10.2 Transmembrane protein prediction 
Cap0036 amino acid sequence was used as an input to find possible transmembrane 
regions using two bioinformatics web-based tools: TMpred [200] and OCTOPUS [201]. 
6.5.10.3 DNA binding motif search and promoter’ elements prediction 
Amino acid sequences of Cap0037 were subject to a search for the helix-turn-helix DNA 
binding motif using the NPS@ web-based bio-tool (https://npsa-prabi.ibcp.fr/)[202]. 
The prediction the promoter of different genes, BPROM web-based tool was used [203]. 
6.5.10.4 Putative Cap0037 regulon  
Construction of putative Cap0037 regulon was performed using an established 
comparative genomics method [220] implemented in the RegPredict webserver 
(http://regpredict.lbl.gov) [212] and Artemis Java Webstart [221]. Genes with potential 
upstream binding sites that had high scores and/or were conserved were rebuilt to improve 
search accuracy. Genome sequences and annotations of C. acetobutylicum were obtained from 
GenBank (http://www.ncbi.nlm.nih.gov/GenBank/).  
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6.5.11 Microarray data accession number 
The microarray data can be accessed at GEO through accession number GSE81273 and 
GSE69973 for the Cap0037::int mutant and the control strain [42], respectively. 
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Table S- 6-1 Bacterial strains, plasmids and primers used in this study 
Strain/plasmid Relevant characteristics Source 
 Clostridium acetobutylicum and Escherichia coli strains 
Control strain Clostridium acetobutylicum ∆cac1502∆upp [42] 
Mutant Cap37::int Clostridium acetobutylicum 
∆cac1502∆uppcap0037::int(189s) 
This study 
Complementary 
strain 
Clostridium acetobutylicum 
∆cac1502∆uppcap0037::int(189s) pSOS95-cap0037 
This study 
Escherichia coli 
TOP10 
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697 
galE15 galK16 rpsL(Str
R
) endA1 λ
-
 
Invitrogen 
 Plasmids  
pCR4-TOPO-Blunt Ap
r
 Km
r
 Invitrogen 
pMTL007C-E2 Cm
R
, Clostridial expression vector for the expression 
of ClosTron containing ErmRAM 
[84] 
pMTL007C-
E2::cap37(277a) 
Cm
R
, Clostridial expression vector for the expression 
of ClosTron containing ErmRAM, retargeting 
CA_P0037 277|278a 
This study 
pCUI catP, erm, ltrA, repL, upp, ColE1 origin, intron [182] 
pCUI-cap37(189s) catP, erm, ltrA, repL, upp, ColE1 origin, intron 
retargeting CA_P0037 189|190s 
This study 
pSOS95 Ap
r
 MLS
r
, repL gene, ColE1 origin [154] 
pSOS95-Cap0037 Ap
r
 MLS
r
, repL gene, ColE1 origin, Cap0037 operon This study 
pBS2 pET29a(+), adcRx6His-Fusion This study 
pDrive Ap
R
, Km
R
, pMB1 origin, lacPOZˈ This study 
pDrive_adcR pDrive vector with the promoter region of 
CA_P0037/CA_P0036 (+487 to -108) 
This study 
pDrive_86kurz pDrive vector with the promoter region of 
CA_P0037/CA_P0036 (-219 to +21) 
This study 
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pDrive_144 pDrive vector with the promoter region of 
CA_P0037/CA_P0036 (-233 to +6) 
This study 
pDrive_adcStart pDrive vector with the promoter region of the adc 
operon (-105 to +49) 
This study 
pDrive_sol pDrive vector with the promoter region of the sol 
operon (-233 to -15) 
This study 
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Primer Sequence 
CA_P0037n-189|190s -IBS aaaaaagcttataattatccttagaaaacattaaggtgcgcccagatagggtg 
CA_P0037n-189|190s -EBS1d cagattgtacaaatgtggtgataacagataagtcattaagagtaacttacctttctttgt 
CA_P0037n-189|190s -EBS2 tgaacgcaagtttctaatttcgattttttctcgatagaggaaagtgtct 
EBS universal cgaaattagaaacttgcgttcagtaaac 
CAP0037-277|278a-IBS aaaaaagcttataattatccttatgtttcgttccagtgcgcccagatagggtg 
CAP0037-277|278a-EBS1d cagattgtacaaatgtggtgataacagataagtcgttccagctaacttacctttctttgt 
CAP0037-277|278a-EBS2 tgaacgcaagtttctaatttcggttaaacatcgatagaggaaagtgtct 
CAP0037-R-b ttctctagcgtttacttttagaacaagag 
CAP0037-F-b atggatgaaactaatttaatttctaaaa 
CAP0037_F attttccccaaatctttcagagctttc 
CAP0037_R taagttcattatagtttgcgaaacaatg 
cap37-F-RBS-BamH1 aaaaaaggatccaggatctcaagcaaatcgcagaggacacagggtatggatgaa
actaatttaatttctaaaaaagaacttc 
cap37-R-SfoI ttttttttggcgccttatagtgataattttgattttaattcttctaaacattctc 
Intron probe-F accctcttcgggaaccgtacg 
Intron probe-R gacttaacactaactggggataccc 
REP-upp-F aaaacagctgggaggaatgaaataatgagtaaagttacac 
REP-upp-R aaaacagctgttattttgtaccgaataatctatctccagc 
ygas1hincl gaatagccatatggatgaaac 
ygas2rückcl tcctttaagctttagtgataattttgattttaattcttctaaac 
PEX1_kurz ggcaagctcatctaatgatacatccc 
PEX2_lang cccggattttaggaacctatctaatatagtc 
adcRpDrive cactccttatctatagttcg 
adcRpDrive_rev ctacgtcacaatatcggtcatc 
86 fwd gaattccctccaatattatc 
85 rev gatatccctccagttattctc 
144 rev agagaattcccattttaccttctattctaac 
145 fwd agagatatccattataacacatattg 
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adcstart FP EcoRV fwd acagatatcggcgaagttaatggcgtg 
adcstart FP EcoRI rev acagaattcgcagaatttttaggaagtg 
sol FP EcoRI fwd acagaattcctcaattctatttatgctcc 
sol FP EcoRV rev acagatatccaataaaaagcataggtc 
adc_forward gccaacattgcctataag 
adc_reverse gttaatggcgtgctaatttg 
94_fwd ctttatcaacttcctcaacggg 
adcmit1 gatgagcccttagtcagg 
adcmit2 cctactaaagtatctgaatcc 
sol_frag_F actcaattctatttatgctcc 
Sol_frag_R gcataggtcaaaaatataacag 
ldh-prom-F ctgcataatataaaatgcagatttttttaaac 
ldh-prom-R acaaatcctgctccgattactg 
fld1-prom-F gttatgtagaatttatatacataattagagc 
fld1-prom-R caataaattatgtt tattttcacc 
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Table S- 6-2 Relative transcript levels of selected genes of Cap0037::int C. 
acetobutylicum mutant in the three metabolic states: acidogenesis (AC), alcohologenesis 
(AL) and solventogenesis (SO) 
 Fold regulation 
Genes AC AL SO 
Arginine transport and metabolism    
CAC0316 argF/I 1.548 0.456 1.2632 
CAC0366 Predicted permease nd nd 0.792 
CAC0367 rocB 1.061 0.462 1.261 
CAC0368 gabT 1.023 0.645 1.121 
CAC0837 potD 0.589 0.951 0.844 
CAC0838 potC 0.587 0.780 0.632 
CAC0839 potB 0.424 0.604 0.481 
CAC0840 potA 0.579 0.822 0.721 
CAC0841 Predicted TR 0.960 0.996 0.944 
CAC0973 argG 2.919 1.145 1.550 
CAC0974 argH 2.733 0.984 1.660 
CAC1054 arginase 0.530 1.159 0.746 
CAC2388 argD 5.208 0.737 1.148 
CAC2389 argB 3.312 0.818 1.223 
CAC2390 argC 2.274 0.825 1.091 
CAC2391 argJ 4.518 1.139 1.866 
CAC2645 carA 6.963 4.182 3.305 
CAC2770 ABC transporter 0.677 0.418 0.393 
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CAC2771 ABC transporter 0.644 0.327 0.350 
CAC3618 ABC transporter 1.984 1.131 2.993 
CAC3619 ABC transporter 0.944 0.597 1.944 
CAC3620 ABC transporter 1.722 0.938 2.567 
CAC2074 ArgR 0.963 1.176 0.722 
Histidine and Tryptophan biosynthesis    
CAC0935 hisZ 5.395 0.950 1.827 
CAC0936 hisG 5.853 1.139 2.055 
CAC0937 hisD 3.958 1.040 1.583 
CAC0938 hisB 4.852 1.036 1.803 
CAC0939 hisH 4.781 0.953 1.578 
CAC0940 hisA 5.298 1.322 2.023 
CAC0941 hisF 3.473 0.775 1.146 
CAC0942 hisI-1 6.371 1.549 2.077 
CAC0943 hisI-2 3.827 0.958 0.991 
CAC0944 tkt 2.498 1.299 1.169 
CAC3031 hisC 0.714 0.557 0.515 
CAC3157 trpA 1.742 3.949 0.527 
CAC3158 trpB 2.810 4.231 1.069 
CAC3159 trpF 3.354 5.361 0.873 
CAC3160 trpC 2.053 4.431 0.642 
CAC3161 trpD 3.661 8.180 0.932 
CAC3162 pabA 2.838 6.782 0.586 
CAC3163 pabB 2.603 6.534 0.529 
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The putative CymR and IscR regulons    
CAC0093 LysR family TR 1.236 0.969 0.734 
CAC0094 FNR 1.163 2.140 1.263 
CAC0102 O-ahs sulfhydrylase 29.638 0.176 21.117 
CAC0103 cysC 33.316 0.100 43.961 
CAC0104 adenylylsulfate red 43.769 0.086 50.771 
CAC0105 ferredoxin 25.441 0.083 27.181 
CAC0106 sulfate transporter 16.736 0.107 10.029 
CAC0107 sulfate transporter 18.367 0.127 31.006 
CAC0108 sulfate transporter 32.540 0.111 41.051 
CAC0109 cysD 34.231 0.087 48.408 
CAC0110 cysN 58.430 0.109 29.921 
CAC0389 hyp. protein 1.493 0.746 1.110 
CAC0390 metB 2.168 0.837 1.861 
CAC0391 metC 1.404 0.683 1.165 
CAC0878 ABC transporter 2.950 1.019 1.175 
CAC0879 ABC transporter 7.680 1.462 2.092 
CAC0880 ABC transporter 9.142 1.156 1.734 
CAC0929 methyltransferase 1.858 0.638 1.825 
CAC0930 metB 3.005 0.374 4.302 
CAC0931 cysK 3.096 0.424 3.582 
CAC0984 ABC transporter 1.098 0.559 2.064 
CAC0985 ABC transporter 0.803 0.452 2.208 
CAC0986 lipoprotein 0.976 0.714 2.682 
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CAC1675 iscR 0.642 0.326 0.408 
CAC2235 cysK 8.393 0.524 6.179 
CAC2236 cymR 3.808 0.505 3.769 
CAC3325 ABC transporter 12.794 0.337 5.551 
CAC3326 ABC transporter 7.706 0.192 4.219 
CAC3327 ABC transporter 12.580 0.328 5.630 
Nucleic acid transport and metabolism    
CAC2644 carA 13.827 9.332 10.624 
CAC2645 carB 6.963 4.181 3.305 
CAC2650 pyrD 68.714 26.067 34.395 
CAC2651 pyrZ 95.625 35.050 38.377 
CAC2652 pyrF 101.855 31.113 39.511 
CAC2653 pyrI 53.008 17.150 18.604 
CAC2654 pyrB 80.451 25.042 33.751 
CAC1390 purE 1.569 0.753 1.224 
CAC1391 purC 3.023 1.018 0.799 
CAC1392 purF 6.053 0.830 0.865 
CAC1393 purM 2.866 0.505 0.456 
CAC1394 purN 5.316 0.830 0.747 
CAC1395 purH 3.984 0.812 0.745 
CAC1396 purD 3.690 0.999 0.700 
CAC1655 purQ/purL 4.219 0.756 0.746 
CAC2112 UraA/PyrP 6.361 1.778 3.019 
Cation transporters    
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CAC3551 Na+ ABC transporter 0.774 1.710 1.077 
CAC3550 Na+ ABC transporter 0.301 0.670 0.377 
CAC3679 kdpX 4.335 1.070 1.297 
CAC3681 kdpC 3.287 0.000 0.863 
CAC3680 kdpD 6.938 1.004 1.028 
Glycerol lipid metabolism    
CAC1319 glpF 0.432 0.271 0.393 
CAC1321 glpK 0.461 0.207 0.333 
CAC1322 glpA 3.428 0.297 2.549 
CAC0427 Glycerol3P ABC transporter 0.117 10000.000 1.451 
CAC0428 sugar permease 0.189 0.382 1.834 
CAC0429 Glycerol3P ABC transporter 0.177 0.000 1.292 
CAC0430 Glycerophosphodiester phosphodiesterase 0.168 0.753 1.254 
Mobility    
CAC0120 mcp 2.324 3.572 0.468 
CAC0250 mcp 0.967 1.670 0.620 
CAC0805 mcp 1.101 2.062 0.758 
CAC0815 mcp 0.053 0.680 0.487 
CAC0909 mcp 0.576 0.775 0.704 
CAC1387 mcp 3.790 4.590 0.959 
CAC2617 mcp 0.830 1.355 0.770 
CAC3352 mcp 0.369 1.401 0.213 
CAC3476 mcp 1.005 1.148 0.612 
CAC3688 mcp 1.009 2.150 0.762 
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Chemotaxis    
CAC0304 motA 1.113 3.168 0.277 
CAC0305 motB 0.550 1.496 0.181 
CAC1845 motB 1.543 1.399 0.747 
CAC1846 motA 0.952 0.903 0.562 
CAC2139 flgG 0.686 1.638 1.223 
CAC2140 flgG 0.719 1.031 0.661 
CAC2147 flhA 0.554 1.158 0.330 
CAC2148 fliR/flhB 0.337 0.621 0.186 
CAC2149 fliQ 0.215 0.408 0.193 
CAC2150 fliP 0.228 0.459 0.183 
CAC2151 fliZ 0.532 1.093 0.371 
CAC2154 flgE 0.473 0.788 0.258 
CAC2155 hyp. protein 0.674 1.114 0.238 
CAC2156 flgD 0.734 1.352 0.335 
CAC2157 fliK 0.937 1.793 0.398 
CAC2158 fliJ 0.433 0.874 0.351 
CAC2159 flg ATPase 0.875 1.670 0.920 
CAC2160 fliH 0.574 1.057 0.652 
CAC2161 fliG 0.548 1.094 0.729 
CAC2162 fliF 0.632 1.217 0.809 
CAC2163 fliE 0.673 1.246 1.003 
CAC2164 flgC 0.689 1.189 1.038 
CAC2165 flgB 0.745 1.139 0.918 
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CAC2205 fliD 0.696 2.464 0.395 
CAC2206 fliS 1.092 4.284 0.358 
CAC2211 flagellin 0.550 2.410 0.295 
CAC2212 flgK 0.476 1.728 0.212 
CAC2214 flgM 0.591 1.826 0.486 
CAC2215 fliY 0.487 2.733 0.529 
CAC2216 fliM 0.359 2.091 0.487 
Sporulation    
CAC0310 abrB 0.097 0.600 0.971 
CAC3647 abrB 7.097 2.539 1.316 
CAC0078 abrB 0.343 3.632 1.133 
CAC0903 histidine kinase 0.970 0.875 1.498 
CAC0323 histidine kinase 0.861 0.793 0.748 
CAC3319 histidine kinase 0.282 1.699 0.755 
CAC0437 histidine kinase 0.126 0.503 2.552 
CAC2071 spo0A 0.994 0.912 0.957 
CAC3735 spoIIIJ 0.863 0.984 0.736 
CAC2306 sigF 0.373 0.841 3.638 
CAC1689 sigK 1.149 0.821 4.438 
CAC1696 sigG 0.947 0.776 5.000 
CAC1695 sigE 1.035 0.698 5.000 
CAC2308 spoIIAA 0.000 0.815 3.529 
CAC0644  gerKA 0.719 0.796 1.103 
CAC0699 splB 0.625 0.594 0.406 
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CAC1620 spore protein 0.656 0.737 0.632 
CAC3729 spoJ 1.017 0.994 0.712 
 
 
 
191 
 
7 Chapter 7 Conclusion and future perspectives 
 
The metabolic engineering part of this thesis describes two recombination system to 
engineer C. acetobutylicum. Both of them uses upp as a counter-selectable marker. One 
system uses replicative plasmid and the other non-replicative plasmid. The non-replicative 
homologous recombination system is time-saving because it doesn’t need the flippase 
involving step to remove the selective marker as the replicative recombination system does to 
obtain a marker-less strain. Furthermore, the non-replicative homologous recombination 
system i)  does not leave an FRT scar in the genome, ii) offers the possibility to introduce 
point mutations and iii) allows the simultaneous deletion of two genes . Those two methods 
have been successfully used to engineer C. acetobutylicum strains. The replicative 
homologous system was employed to delete cac1502, upp, cac3535, ctfAB, ldhA, ptb, buk, 
rex, and to directly replace hbd with hbd1 gene. The non-replicative plasmids were 
successfully used to directly replace thlA with synthetic atoB gene and also to simultaneously 
delete hydA and thlA genes. 
The deletion of cac1502 and upp (with or without the deletion of cac3535) produced a 
convenient background strain that is useful for further metabolic engineering and for 
functional genomic studies of C. acetobutylicum. 
The deletion of ctfAB, ldhA, ptb, and buk resulted in C. acetobutylicum CAB1057 strain 
unable to produce lactate, acetone, and butyrate. Rex gene was deleted to eliminate the 
inhibition effect on the main metabolism fluxes. The replacement of hbd by hbd1 and of thlA 
by atoB has successfully pulled carbon flux to n-butanol production. In the final strain 
CAB1060, n-butanol was produced at high yield and selectivity. Along with the decrease in 
acetate production, the hydrogen production was also significantly low and most of the 
electrons from reduced ferredoxin were used to produced NAD(P)H. This is the best strain 
ever reported that produces n-butanol at high yield and selectivity. This strain was subjected 
to a new continuous fermentation process using i) in situ extraction of alcohols by distillation 
under low pressure and ii) high cell density cultures. This process proved to increase the titer, 
yield and productivity of n-butanol production to levels that have never been previously 
achieved in any organism. This process provides a means to selectively produce n-butanol 
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from different feedstocks at performance levels that are now compatible with a commercial 
process. However, this mutant could be further optimized to eliminate totally the acetate 
production. To do so, all the electrons from reduced ferredoxin should be used to produced 
NAD(P)H, thus, the ferredoxin-NAD(P)H- reductase has to be identified and overexpressed.  
By using the Genome Scale Model developed in our group, we demonstrated that C. 
acetobutylicum can potentially continuously produce several bio-chemicals if we manage to 
block hydrogen production. By simultaneously inactivating hydA and thlA, we managed to 
obtain a platform strain that no longer produces hydrogen. This platform strain was further 
engineered to continuously produce L-lactate and 1,3-propanediol at high yield, titer and 
productivities. Further work is currently carried out to construct strains producing either, 
isopropanol, 1,3-butanediol or isobutene.  
Lastly, in the strict anaerobe C. acetobutylicum, Cap0037 was found to directly or 
indirectly control a large set of genes belonging to the Rex, PerR and Fur regulons. This 
control drastically affects metabolism under both acidogenic and alcohologenic conditions. 
More study is needed to understand the regulatory mechanism of Cap0037, including 
clarification of the particular location of Cap0037 in the cell structure, finding the effectors 
and probably a second protein that may interact or compete with Cap0037 (such as Cap0036 
or Spo0A) in response to cell signals. This would be a valuable information to understand the 
function of this conserved protein in other firmicutes. 
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Abbreviations 
5'-FC 5-fluorocytosine  
5'-FOA 5-fluoroorotic acid  
5-FU 5-fluorouracil  
AB acetone, butanol 
ABE acetone, butanol, ethanol 
AC acidogenesis 
ACE Allele couple exchange  
ACK acetate kinase 
ADC acetoacetate decarboxylase 
ADHE aldehyde alcohol dehydrogenase 
ADP adenosine-5' diphosphate 
AL alcohologenesis 
ALSD acetolactate decarboxylase 
ALSS acetolactate synthase 
Apr ampicillin resistance 
asRNA antisense RNA  
ATP adenosine-5' triphosphate 
BCD butyryl coA dehydrogenase 
BDH butanol dehydrogenase 
BUK butyrate kinase 
CcpA catabolite control protein  
CGM Clostridium growth medium 
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CGMMG CGM with 50g/L Glucose and 0.1M MES, pH 6.3 
Cm
r
 chloramphenicol resistance 
Cm chloramphenicol 
CoA Coenzyme A 
COGs  Cluster Orthologous Groups 
CRT crotonase 
CsrA carbon storage regulator  
CTFA/B coA-transferase subunit A/B 
Ctrl Control 
DMSO Dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DTT dithiothretol 
EMP Embden-Meyerhof glycolytic pathway  
ETFA/B electron transfer flavoprotein subunit A/B 
Ery
R
 Erythromycin resistant 
FAD flavin adenine nucleotide 
Fd-ox oxidized ferredoxin 
FDP flavodiiron protein 
Fd-red reduced ferredoxin 
FLP flippase 
FMN flavin mononucleotide 
FNOR NAD(P) ferredoxin oxidoreductase 
FRT flippase recognition target 
Fur ferric uptake regulator  
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gDNA genomic DNA 
GSM Genome scale metabolic  
HBD hydroxybutyryl-coA dehydrogenase 
HYD hydrogenase 
j3TI j3TI methyltransferase 
LDH lactate dehydrogenase 
McrBC
-
 lacking methylcytosine-specific restriction system 
MLS
r
 macrolide lincosamide and streptogramin B resistance 
mRNA messenger RNA 
MT mutant  
NAD
+
 nicotinamide adenine dinucleotide 
NADH reduced nicotinamide adenine dinucleotide 
NADP
+
 nicotinamide adenine dinucleotide phosphate 
NADPH reduced nicotinamide adenine dinucleotide phosphate 
ORF open reading frame 
PCR polymerase chain reaction 
PerR peroxide repressor  
PFOR pyruvate ferredoxin oxidoreductase 
PTA phosphotransacetylase 
PTB phosphotransbutyrylase 
PTS phosphotransferase systems  
RBS   ribosome binding site 
RCM reinforced clostridial medium 
RecA
-
 homologous recombination abolished 
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repL Gram-positive origin of replication from pIM13 
Rex redox sensing transcriptional repressor  
SM synthetic medium 
SO solventogenesis 
sRNA small RNA 
THL thiolase 
Th
R
  thiamphenicol resistant 
Tm thiamphenicol 
UPRTase uracil phosphoribosyl-transferase 
WT wild-type  
Zeo
R
 zeomycin resistance 
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